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ABSTRACT 
Robyn J. Eisert: Interactions Between Chromodomains and Trimethyllysine Marks on 
Histone H3 Peptides 
(Under the Direction of Professor Marcey L. Waters) 
  
Recent findings suggest that a variety of post-translational modifications (PTMs) 
found on N-terminal tails of histones are intricately involved in DNA packaging and 
directly control levels of gene expression.  These modifications include methyllysine, 
methylarginine, phosposerine, phosphothreonine, and acetyllysine.  Methyllysine marks 
on the N-terminal tail histone H3 are known to recruit effector proteins that can modify 
chromatin structure and regulate gene expression.  Trimethyllysine 4 of histone H3 
recruits CHD1 (chromo-ATPase/helicase-DNA binding domain 1), which is part of a 
chromatin-remodeling complex associated with active transcription.  Additionally, 
trimethyllysine 9 of histone H3 recruits heterochromatin protein 1! (HP1!), which 
stabilizes heterochromatin, which is typically associated with repressed gene expression.  
I investigated the protein-protein interactions in each of these complexes to explore the 
driving force and the selectivity of recognition. 
 The tandem chromodomain of CHD1 binds H3 K4Me3 with an aromatic cage 
consisting of two tryptophan residues (Trp64 and Trp67) forming cation-" interactions 
with the trimethyllysine.  Arginine 2 of histone H3 is involved in an H-bond with the 
backbone of Gly66 of the tandem chromodomain and a cation-" interaction with Trp67.  
The effect of incorporating methylarginine and citrulline at position 2 in H3 K4Me3 on 
! "#!
CHD1 binding affinity was explored.  The results show that symmetric dimethylarginine 
and citrulline weakened binding affinity while asymmetric dimethylarginine enhanced 
binding affinity.  This study demonstrates the significance of these three modifications 
and how they may play a role in regulating gene expression by affecting protein-protein 
interactions. 
The HP1! chromodomain binds to H3 K9Me2 with a KD of 20 µM H3 K9Me3 
with a KD of 17 µM.  The chromodomain contains a three-membered aromatic cage and a 
glutamate (Glu52) around di- and trimethyllysine.  The aromatic residues are involved in 
a cation-" interaction with methyllysine and Glu52 forms a water-mediated H-bond to 
dimethyllysine.  The histone tail is also inserted between two #-strands of the 
chromodomain to form a 3-stranded #-sheet.  
First, Glu52 was modified to enhance selectivity for H3 K9Me3 over H3 K9Me2.  
The E52Q mutant had a 2.5 fold weaker binding affinity to H3 K9Me2 (KD=52 µM) and 
maintained the same binding affinity to H3 K9Me3 (KD=15 µM) most likely because 
glutamine is a weak H-bond acceptor compared to glutamate. 
 Second, #-sheet interactions between HP1! chromodomain and H3 K9Me3 were 
investigated.  Residue Thr6 of the histone tail forms cross-strand interactions with Ala25 
and Asp62 of the chromodomain.  Each of these three residues was systematically 
substituted for amino acids known to have high #-sheet propensity and form favorable 
sidechain-sidechain interactions.  These studies demonstrated the applicability of 
information gleaned from model systems and statistical studies to protein-protein 
recognition. 
! #!
Lastly, two PTM-recognition domains, derived from naturally occurring effector 
proteins were coupled together to create a coupled-receptor construct to visualize dual 
modifications on a single histone tail.  Two HP1! chromodomains were coupled to 
determine if they were functional for detecting a synthetic peptide with two H3 K9Me2 
sequences as proof that coupled receptors can have cooperative binding for a peptide with 
two dimethyllysine marks. 
 Taken together, these studies provide a new mechanistic insight into the protein-
protein interactions between chromodomains and methyllysine marks on N-terminal 
histone H3 tails, which are important for sequence selectivity and binding affinity. 
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mM   Millimolar 
µM   Micromolar 
MTBD  1,3,4,6,7,8-Hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine 
NHB site  Non-hydrogen bonded site   
NMR  Nuclear magnetic resonance 
PDB    Protein data bank 
PHD   Plant homeodomain  
Phe, F   Phenylalanine  
Pro, P   Proline  
PTM   Post-translational modification 
SDS-PAGE Sodium Dodecyl Sulfate-polyacrilamide gel electrophoresis 
Ser, S   Serine  
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tBu    t-Butyl  
TCEP  tris(2-carboxyethyl)phosphine 
TFA    Trifluoroacetic acid 
Thr, T   Threonine  
TIPS   Triisopropyl silane  
Trp, W   Tryptophan  
trt    Trityl  
Tyr, Y   Tyrosine  
Val, V   Valine
  
 
 
 
Chapter I 
INTRODUCTION 
 
A. Significance of This Research 
Recent findings have suggested that a variety of post-translational modifications 
(PTMs) on N-terminal tails of histones are intricately involved in DNA packaging and 
may directly control levels of gene expression. In fact, multiple modifications have been 
shown to occur simultaneously, resulting in different levels of expression, which have led 
to the “Histone Code” hypothesis.1 With this information in hand, there has been an effort 
to understand how recognition domains within effector proteins read these modifications.  
This research will provide insight into how molecular recognition and protein-protein 
interactions modulate selectivity of these domains for their intended targets.  
Additionally, a set of coupled PTM receptors have been developed which will be able to 
detect the presence of two modifications on a single histone tail.  
B. DNA Packaging 
The DNA within the nucleus of a eukaryotic cell is billions of base-pairs in length 
and several orders of magnitude longer than the nucleus in which the DNA is packaged.2, 
3 Despite the length of the eukaryotic genome, DNA is remarkably packaged into well-
organized higher structures while maintaining appropriate accessibility for replication 
and transcription.  Extensive research dating as far back as the 1940’s and pioneered by 
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Watson, Felsenfeld, Roger Kornberg and others has been performed to understand how 
appropriate packaging is maintained and regulated. 
The first order of DNA packaging is the nucleosome, which consists of 
approximately 147 base pairs of DNA, which are wrapped around a basic octameric 
protein complex referred as a histone.  Two of each of the histones, H2A, H2B, H3, and 
H4 subunits comprises the nucleosome core particle (Fig. 1.1).  Histone H1 keeps the 
DNA in place and interacts with the “linker” DNA, which is the DNA that connects two 
nucleosome.4, 5 The entire particle, including the DNA and histone subunits, was 
determined to take a disk-like shape with a approximate diameter of 100 Å, which was 
measured by X-ray diffraction.6  
 
 
Figure 1.1.  Nucleosome structure with DNA wrapped around the histone.  The 
different colors represent the four different histone subunits.  An example of a histone 
tail is boxed in.4 
 
Nucleosomes are further packaged into higher orders of chromatin structure (Fig. 
1.2).  Euchromatin is loosely packaged similar to beads on a string and is typically 
! &!
associated with activated transcription and replication.  Distinct from euchromatin is 
heterochromatin, which takes a more compact structure with genes that are typically not 
expressed.7 Regulating these structures properly is critical for proper transcription, 
replication, and cell division. 
 
Figure 1.2.  DNA packaging within a nucleus.  Adapted from a National Genome 
Research Institute image.8 
 
C. Epigenetics and Gene Expression 
The term “epigenetics” refers to changes in gene expression that are not 
controlled by DNA sequences.9 Condrad Waddington is credited with coining the term 
“epigenome” and proposing epigenetics as the means by which cells are able to obtain 
large diversity as they evolve from a stem cell despite having identical genomes.  
Waddington published a scheme demonstrating how a cell, which is depicted by the ball, 
starts with the same genotype, but can still develop different phenotypes depending on 
epigenetic markers, which are represented by the valleys (Fig. 1.3).10 Epigenetic modes 
of regulation include DNA methylation, which silences gene expression.  These marks 
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occur in 60% of promotor sites in the human genome.11 A second mode of regulation is 
RNA-associated silencing or RNA interference.12 The third mechanism of epigenetic 
gene regulation involves covalent post-translational modifications (PTMs) of proteins 
including histones, chromatin remodeling proteins, and transcriptional regulators.13 Only 
recently has it become clear that each of these three regulatory mechanisms are 
interconnected resulting in additional levels of complexity. For example, certain PTMs 
have been known to recruit DNA methyltransferases while DNA methyl marks can 
recruit histone modifying enzymes.14 Any aberrant regulation of these mechanisms can 
lead to a variety of diseases such as Rett syndrome, autoimmune diseases, and cancer.15 
Therefore, understanding how these epigenetic regulators work is necessary to fully 
understand cellular growth, development, and disease.  The focus of this research will be 
on histone modifications, specifically H3 methylation. 
 
 
Figure 1.3.  Waddington’s depiction of how the epigenetic landscape can lay out 
different paths leading to cellular diversity.16 
 
D. Significance of Histone Modifications  
Histone proteins have N-terminal tails, which are defined as unstructured regions 
of histones that protrude outwards from the nucleosome particle and are extended by 
! (!
regions that can make contacts with DNA.  Histone tails constitute 28% of the mass of 
the histone proteins (Fig. 1.1). These regions are highly conserved in eukaryotes and are 
composed primarily of basic residues, which are ideal for making salt-bridges with the 
sugar-phosphate backbone of DNA.4, 17, 18 There have been extensive documented 
occurrences of a wide variety of covalent modifications on histone tails.  These 
modifications include serine and threonine phosphorylation, lysine and arginine 
methylation, lysine acetylation, and several others (Fig. 1.4).19-23 
! !
Figure 1.4.  Examples of post-translational modifications.  (A) Trimethyllysine, (B) 
acetyllysine, (C) phosphoserine, (D) monomethylarginine, (E) symmetric 
dimethylarginine (DMAs), (F) asymmetric dimethylarginine (DMAa). 
 
For a long time PTMs on histone tails, namely lysine acetylation and methylation, 
have been known to play a role in regulating genetic processes such as replication, 
transcription, and DNA repair.18, 22 These modifications were initially believed to 
manipulate the electrostatic interactions between histones and DNA thereby loosening or 
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compacting chromatin.  For example, acetylation on lysine has been shown to sufficiently 
neutralize the positive charge of the basic side-chain and weaken protein-DNA 
interactions.24-26 Phosphorylation also places a negative charge on serines and threonines, 
which also disrupts interactions between histones and DNA.27, 28  
Wile PTMs do have an effect on the electrostatic properties of histones that can 
directly affect chromatin structure, evidence has shown that PTMs can also manipulate 
gene expression through more complex mechanisms. For instance, lysine acetylation does 
not only function by reducing protein-DNA interactons, but it is also capable of recruiting 
transcriptional activators such as TFIID.29 Phosphorylation of serine 10 on the Histone 
H3 tail has also been linked to both chromatin condensation and gene silencing in 
addition to loosening chromatin and gene activation, implying that this mark also recruits 
effector proteins to elicit a variety of cellular responses.28, 30, 31 Table 1.2 lists some of the 
most well-characterized PTMs and their effects on regulation gene expression. 
 
Table 1.1.  Examples of histone H3 modifications and their effect on gene 
expression.32-39 
H3 Modifications Residue Expression 
K4, K36, K79 Active 
Lysine Methylation 
K9, K27 Inactive 
Phosphorylation S10 Active 
 Lysine Acetylation K9, K14, K18, K23, K27 Active 
 
i.  “Cross-Talk” Between Histone Modifications  
The idea that PTMs can be read as a “code” has arisen in the past decade to 
explain how modifications are able to regulate gene expression.1 Site-specific 
modifications act as docking sites for recruiting effector proteins that are components of 
chromatin-remodeling complexes and transcriptional regulators.40 The “code” is further 
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complicated by the presence of multiple modifications that occur in a combinatorial 
fashion, which is often referred to as cross-talk, to illicit specific biological responses.41 
There are different ways in which modifications can affect one another.  Certain 
PTMs can either promote or reverse other modifications.  There are many examples of 
histone-modifying enzymes that contain recognition domains.  Inhibitor growth protein 2 
(ING2) is part of a tumor suppressor protein that responds to DNA damage.   ING2 
contains a domain that recognizes trimethyllysine 4 of Histone H3 (H3 K4Me3) and once 
bound to the histone, an HDAC (histone deacetylase) is stabilized and removes acetyl 
groups from neighboring acetylated lysine to turn off gene expression.33  
Another example of how one modification can inhibit other modifications is the 
cross-talk between lysine-4 and lysine-9 of Histone H3.  Chromatin immunoprecipitation 
experiments (ChIP) demonstrated that these two modifications have an inverted 
relationship with one another, which means that if one lysine is methylated then the other 
cannot be methylated.   This phenomenon is important for maintaining heterochromatin 
boundaries and for properly regulating gene expression.42 Another study demonstrated 
that JARID1C, which is encoded by an X-linked mental retardation gene, contains both a 
lysine recognition domain that targets H3 K9Me3 and a lysine demethylase domain 
(JmjC) that targets H3 K4Me3.  In patients with X-linked mental retardation there is a 
point mutation in JARID1C that causes a loss in demethylase activity, which causes a 
breakdown in the proper cross-talk between these two modifications.43 
Another method of cross-regulation between multiple modifications is through the 
use of multivalent effector proteins.  Dozens of proteins have been reported as 
multivalent, meaning that they are composed of multiple domains that recognize multiple 
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modifications.  These effectors can either bind to two different histone tails in the same 
nucleosome (trans) or to the same histone tail (cis).  The trans binding allows for one 
protein to make contacts with different promoters located near the same nucleosome.  
One example is the Bromodomain PHD Transcription Factor (BPTF), which contains an 
acetyllysine recognition domain (bromodomain) and a methyllysine recognition domain 
(PHD finger) on H4 and H3 respectively.44  The trans binding allows tighter, cooperative 
binding between the effector protein and histone tail.45  This mode of recognition also 
promotes enhanced selectivity because both modifications must be present for efficient 
binding. The TATA!binding protein!associated factor (TAFII250) is a subunit of the TFII 
transcription facter and is an example of a cis binder.  TAFII250 contains two 
bromodomains that recognize acetyllysine on H4 histones and binding is enhanced by 
two orders of magnitude when two acetyl marks are present as opposed to only one.29 
Effector proteins complexed with two different nucleosomes can also be 
crosslinked with one another.  Heterochromatin protein 1 (HP1) contains a methyllysine 
reading domain that targets H3 K9Me3.  Cross-linking between two HP1 proteins can 
condense euchromatin into genetically silent heterochromatin, which will be further 
discussed below.46, 47 
A third mechanism of cross-talk between modifications is by a binary “switch” 
system.  Phosphorylation of the hydroxyl side-chains of serine and threonine is a highly 
transient mark, especially compared to the more stably methyl mark.  When HP1 is 
bound to H3 K9Me3, chromatin is condensed into heterochromatin.  However, serine 10 
of Histone H3 is more readily susceptible to phosphorylation compared to lysine 
demethylation.  During M phase serine 10 is phosphorylation and as a result HP1 is 
! ,!
ejected from H3 K9Me3, which may be important for properly regulating condensation of 
chromosomes.48, 49 
Though many combinations of modifications and their means of cross-talk have 
been identified (Table 1.2), many PTMs that have the potential for cross-regulation 
remain unidentified.  Other concurrent modifications that have been identified still are 
not well understood.50 
 
Table 1.2.  Examples of histone modifications that have been shown to co-localize and 
their effect on genetic expression.39, 48, 51, 52 
Modification 1 (H3) Modification 2 (H3) Effect on Expression 
K9Me
3
 S10PO
4
-
 Active 
K4Me
3
 K27Me
3
 Inactive 
S10PO
4
- 
K14Ac Active 
K9Me
3
 K27Me
3
 Inactive 
 
ii.  Lysine Methylation on Histones 
Of the various covalent histone modifications reported, methylation is among the 
most ubiquitous, complex, and least understood of the covalent modifications and is the 
focus of this research.  This complexity is in part due to the different levels of lysine and 
arginine methylation including mono-, di-, or trimethyllysine (Fig. 1.3).  Unlike 
acetylation, which is generally associated with active expression, methylation is site-
specific and is associated with both active and suppressed gene expression.53 Therefore, 
understanding how methyl marks regulate gene expression has been complicated. 
Lysine is methylated by histone methyltransferases (HMTs), almost all of which 
contain an exymatic SET-domain.  These enzymes can act as exclusively as mono-, di-, 
or trimethyltrasferases or they can act as all three with S-adenosylmethionine (AdoMet) 
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as the methyl-donating cofactor (Fig. 1.5).   State-specific methylation is dependent on 
the size of the binding cleft and sequence specificity relies on specific H-bonds to amino 
acids surrounding the lysine substrate with a (K/R)-(STA) motif preceding the lysine 
substrate.54, 55 This sequence and methylation specificity further demonstrates the 
intricacy involved in lysine methylation. 
 
 
Figure 1.5 Scheme of lysine 9 methylation carried out by SET7/9, which is a 
monomethyltransferase.  This histone lysine is in red, AdoMet is in blue, which is 
converted to S-adenosyl homocysteine (AdoHcy), and SET7/9 residues are in black.54 
 
Less is known about lysine demethylation.  Until recently, methyllysine was 
thought to be an irreversible modification, which required phosphorylation of a 
neighboring amino acid to reverse the effects of the methyl mark.  While phosphorylation 
does act as a switch as previously described, two classes of lysine demethylases have 
been recently identified.  Lysine-specific demethylase-1 (LSD1) was the first 
demethylase to be identified and is specifically targets mono- and dimethyllysine.56 LSD1 
is a flavin-containing enzyme that relies on FAD for amine oxidation (Fig. 1.6A).  This 
enzyme requires that the amine be protonated and therefore is unable to target 
trimethyllysine.56, 57 Jumonji histone demethylases (JHDM) were identified as 
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demethylases that specifically target di- and trimethyllysine. This class of enzymes relies 
on the Fe(II) for catalysis via a iron-oxo intermediate (Fig. 1.6B).58, 59 
 
(A) 
 
(B) 
 
Figure 1.6.  (A) Scheme of LSD1-catalyzed demethylation of dimethyllysine.56  (B) 
Scheme of JHDM-catalyzed demethylation of trimethyllysine.59 
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Various types of “reader” domains interpret methyllysine.  These domains are 
selective for methylation states and for the amino acid sequence (Table 1.3). There are 
two general families of reader domains that recognize methyllysine, the Royal and PHD 
families.  The members of the Royal family are composed of four #-strands, three form a 
#-sheet while the forth only becomes part of the #-sheet once the histone peptide is 
inserted between the forth strand and another strand for form a 5-stranded #-barrel.  The 
methyllysine typically interacts with loop regions of the domain (Fig. 1.7).60 Unlike the 
Royal family, the PHD finger family only has two #-strands connecting two zinc-fingers 
(Fig. 1.8).44, 61  
 
Table 1.3.  Families of reader domains and examples of methyl marks that they target.61 
 Reader Domain PTM Mark 
Chromodomain H3 K9Me2/3, H3 K27Me2/3 
Double Chromodomain H3 K4Me1/2/3 
Chromo barrel H3 K36Me2/3 
Tudor H3 K79Me3, H4K20Me3 
Double/tandem tudor H3 K4Me3, H4 K20Me1/2/3 
R
oy
al
 
MBT H4 K20Me1/2, H1 K26Me1/2, H3 K4Me1, H4 K9Me1/2 
PHD finger H3 K4Me3, H3 K9Me3, H3 K36Me3 
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(A) 
 
(B) 
 
(C) 
 
Figure 1.7.  (A) Topology of Royal family domains.61 (B) Crystal structure of H3 K4Me3 
peptide bound to CHD1 tandem chromodomains.  Chromo1 (cyan), chromo2 (magenta), 
linker (grey), histone tail (green). (PDB 2B2W).  (C) Crystal structure of H3 K9Me3 
peptide (yellow), bound to HP1 chromodomain (grey).  (PDB 1KNE) 
 
(A) 
 
(B) 
 
(C) 
 
Figure 1.8.  (A) Topology of the PHD family domains (pink indicates were members 
of the aromatic cage are located). (B) Crystal structure of H3K4me3 peptide with 
BPTF PHD finger (PDB 2F6J).  (C) Crystal structure of H3K4 peptide with BHC80 
PHD finger (PDB 2PUY). 61 
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Though these two families are topologically different, the modes of recognition 
have striking similarities.  They all involve the use of an aromatic cage for recognizing 
methyllysine, which is stabilized by a cation-" interaction.62 The state specific readout of 
methyllysine will be addressed in further detail in Chapter III.61, 63 They also mediate 
sequence selectivity through similar means.  In solution histone tails have no structure.  
Once in complex with recognition domain, they form an antiparallel #-sheet motif with 
the domain, which will also be addressed in further detail in Chapter IV.44, 61, 64 There has 
been significant progress in understanding how these reader domains maintain selectivity 
because different methyl-marks are linked very different biological responses. 
 iii.  Lysine 4 of Histone H3 Tail 
Methylation used to be associated primarily with silent chromatin, however 
methylation of lysine 4 on the Histone H3 (H3 K4Me2/3) is typically associated with 
active chromatin while dimethylation is present on both active and silent euchromatin.65  
This methylation is catalyzed several methyltransferases including SET1 and SET7/9.66, 
67 Several proteins have been identified that interact specifically with H3 K4Me2/3 
including BPTF, CHD1 and WDR5.  As will be addressed in Chapter II, CHD1 (chromo-
ATPase/helicase-DNA binding domain 1) is part of a chromatin-remodeling complex is 
recruited by H3 K4Me3.  This complex contains HAT activity, which provides another 
example of a PTM that is responsible for perpetuating further histone modifications.  
WDR5 only binds H3 K4Me2 when R2 is also methylated.  WDR5 is believed to recruit 
SET1 to add a third methyl group to H3 K4Me2, which can then activate gene expression 
by recruiting chromatin-remodeling proteins. 
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 iv.  Lysine 9 of Histone H3 Tail 
Trimethyllation of lysine 9 on H3 (H3 K9Me3) is typically associated with 
genetically silent heterochromatin.68 Methylation of H3 K9 is catalyzed by a number of 
different enzymes in humans including Suv39h1, G9a, ESET, GLP, and RIZ, which have 
been linked to silenced gene expression.53  
HP1 contains an N-terminal chromodomain (CD) and a C-terminal chromo 
shadow domain (CSD). The two domains of HP1 are separated by a hinge region (Fig. 
1.9A). The chromodomain, which is a member of the Royal family of methyllysine 
readers, is highly selective for H3 K9Me3 over other methylated lysine marks, such as H3 
K4Me3.   Point mutations to the chromodomain not only disrupt binding to H3 K9Me3, 
but it also inhibits the localization of HP1 to heterochromatin, stabilization of 
heterochromatin, and gene-silencing.  Therefore proper targeting of HP1 via the 
chromodomain is necessary for maintaining proper chromatin function.69, 70  
There has been some debate over how HP1 regulates gene expression once bound 
to H3 K9Me3. Phage display libraries demonstrated that CSD can mediate protein-protein 
interactions.  The experiments showed that CSD binds a specific pentapeptide consensus 
sequence, PxVxL.  This study was incredibly revealing because this consensus sequence 
is present in human, mouse, and fly HP1 homologs resulting in dimerization.46 A more 
current study additionally suggested that chromodomains of two HP1 proteins can also 
cross-link, which permits further oligomerization of HP1. A current proposed mechanism 
by which HP1 can condense euchromatin into heterochromatin is by oligomerization 
between HP1 thereby cross-linking two separate nucleosomes (Fig. 1.9B).47 Once cross-
linked, chromatin is condensed preventing replication and transcription machinery from 
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reaching promoter sites.  The CSD has also been shown to interact with other proteins 
such as SUV39H1, which can perpetuate H3 K9Me3 methylation and result in the 
spreading of heterochromatin.70 
 
(A) 
 
(B) 
 
Figure 1.9.  (A) Scheme of HP1 with the chromodomain shown in blue, the chromo 
shadow domain in red, and an unstructured hinged region between them.  (B) A model 
depicting possible HP1 CD-CD and CSD-CSD interactions leading to oligomerization 
of histones.47 
 
There is a need to understand interactions between lysine 9 methylation of 
Histone H3 and HP1 because these two proteins critical for controlling genetic expression 
and maintaining a stable genome during key points of development and the cell cycle.71  
Aberrant methylation of H3 K9 due to deregulation of SUV39H1 drastically affects 
recruitment of HP1 and heterochromatin maintenance.  For example, both upregulation 
and down regulation of SUV39H1 and histone H3 methylation have been linked to 
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cancer states.72, 73 These conflicting roles of lysine 9 methylation and HP1 makes 
understanding their roles in growth, development, and disease elusive. 
E. Project Goals 
Though a number of effector proteins such as HP1 and CHD1 have been 
identified, there is a need to establish a clear understanding of how these proteins interact 
with PTMs.  In this work we had two general goals.  The first was to investigate 
interactions between the chromodomains of CHD1 and HP1! and H3 K4Me3 and H3 
K9Me3, respectively.  Specifically, we set out to investigate how H3 R2 modifications 
(DMAa, DMAs, and citrullination) influence binding of CHD1 tandem chromodomain to 
H3 K4Me3.  We also investigated interactions between the aromatic cage of the HP1 
chromodomain to di- and trimethyllysine 9 of H3.  Third, we studied how sequence 
selectivity of HP1 chromodomain for H3 K9Me3 can be manipulated by making point 
mutations to both the chromodomain and histone tail.  These studies have implications 
for the cross-regulation between arginine 2 and lysine 4 of the Histone H3.  They also 
give insight into the molecular recognition of chromodomains for histone tails. The 
second goal of this work is to develop a technique to study PTMs that occur in 
conjunction with one another.  
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Chapter II 
EFFECTS OF ARGININE MODIFICATIONS ON CHD1 TANDEM 
CHROMODOMAIN RECOGNITION 
 
A. Background 
 i. Arginine Modifications 
Four distinct modified arginine residues on histone tails have been reported, 
which include monomethylarginine, asymmetric dimethylarginine (DMAa), symmetric 
dimethylarginine (DMAs), and citrulline (Cit).  Each of these modifications has a drastic 
effect on the electronics and chemical properties of arginine, which will be discussed, 
and, therefore, influence effector protein recognition.  In this research, I sought to 
understand how these modifications regulate recognition of the tandem chromodomains 
from the effector protein, CHD1. 
ii.  Arginine Methylation 
Arginine methylation is a modification ubiquitous to N-terminal histone tails.  
The two forms of dimethylation are each catalyzed by a different family of protein 
arginine methylation transferases (PRMTs).  Type I enzymes catalyze asymmetric 
dimethylation while type II enzymes catalyze symmetric dimethylation.1 These types of 
enzymes are thought to have opposing effects on gene expression.  PRMT1 is a type I 
enzyme that methylates H4 R3.2 The acetyltransferase, p300, is subsequently activated 
and acetylates lysine residues on H4.  The result is an up-regulation of gene expression.3 
! %(!
Less is known about type II enzymes.  However, PRMT5 has been identified and are 
known to place symmetric dimethyl marks on histone tails in vito, which are correlated 
with gene silencing.4-6 
Methylarginine can regulate gene expression through several possible 
mechanisms.  First, dimethylargine has been shown to act as a “switch” and block the 
binding of effector proteins.7  Proteins that contain methyllysine-specific domains such as 
PHD fingers, chromo, Tudor, and WD40 domains can be affected by methylation of a 
neighboring arginine.  Specifically, WDR5 is a transcriptional activator with a WD40 
domain that selectively recognizes H3 K4Me3.
8 Serine and cysteine residues in WDR5 
make important H-bonds with unmethylated Arg2.  However, upon methylation of 
arginine those contacts are disrupted and WDR5 can no longer dock onto the histone tail 
and gene transcription is silenced.8 
Effector proteins can also be recruited to dimethylarginine and can act as 
transcription repressors or activators.  For example, the DNA methyltransferase 
DNMT3A contains a PHD finger, which binds DMAs marks at the Arg3 site of H4.  
Once bound, DNM3A can methylated DNA, which silences expression.9 Alternatively, a 
DMAa mark on Arg3 of H4 can act as a docking site for the Tudor domain of TDRD3. 
Though the mechanism of TDRD3 is unclear, it is a known transcriptional cooactivator.10 
A number of other DMAa marks have also been reported as docking sites for 
transcriptional activators while DMAs marks recruit repressors.11  
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iii.  Arginine Citrullination  
The arginine deimination reaction, also commonly referred to as citrullination, is 
a modification known for its role in disease states such as multiple sclerosis and 
rheumatoid arthritis.12, 13 Citrullination of arginine is a modification that regulates a 
multitude of biological functions including regulations of the cytoskeleton, the myelin 
basic protein important for the central nervous system, and gene expression.14  
Arginine deimination in histone proteins is an epigenetic modification catalyzed 
by the enzymes arginine deiminase 4 (PAD4) (Fig. 2.1A, B).15, 16 Recent evidence from 
in vivo and in vitro experiments has also suggested that PAD4 reverses the effects 
CARM1-catalyzed arginine methylation by performing arginine demethylimination.  In 
fact, ChIP assays have shown that arginine methylation and citrullination are inversely 
correlated on histone proteins.17 While the role of citrullination is largely unknown, this 
modification is known to act as a transcriptional repression mark that prevents the 
transcriptional machinery from binding to chromatin (Fig. 2.1C).18 
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(A) 
 
(B) 
 
(C) 
 
Figure 2.1.  (A) Comparison of arginine asymmetric dimethylarginine (DMAa) and 
citrulline (Cit).   (B) Proposed deimination mechanism by PAD4.15  (C) Instances of 
citrullination observed in vivo and in vitro.  Red indicates gene repression, green is gene 
activation, and yellow is unknown.18 
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 iv. Citrulline and Methylarginine Interactions with Tryptophan 
To understand how arginine methylation and deimination affects the cation-" 
interaction with aromatic binding pockets, an interaction critical in the read-out of PTMs, 
Hughes compared the cation-" and citrulline-" interactions using #-hairpins as model 
systems (Fig. 2.2).19 NMR analysis revealed dimethylarginine (both symmetric and 
asymmetric) and tryptophan have an interaction energy of  -1.0 kcal/mol, which is two-
fold more favorable than the unmodified arginine with an interaction of -0.5 kcal/mol.  
The increased surface area of the dimethylarginine permitted a more favorable van der 
Waals interaction with tryptophan, which improved the interaction energy and folding.  
Citrulline and tryptophan have an interaction energy of -0.2 kcal/mol, which is 
approximately a two-fold weaker interaction energy than arginine with tryptophan.  
Citrulline is a neutral amino acid and therefore any favorable cation-" interaction with 
tryptophan is lost, resulting in a decrease in folding (data not published). 
 
 
Figure 2.2.  Cation-" and citrulline-" interactions with tryptophan in a #-hairpin. 
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v.  Function of CHD1 
CHD1 (chromo-ATPase/helicase-DNA binding domain 1) is a known ATP-
dependent chromatin remodeling factor that regulates gene transcription.20 CHD1 
contains a set of N-terminal tandem chromodomains.  Previously, effector proteins 
containing chromodomains were implicated in transcriptional repression.  However, 
CHD1 also contains a helicase/ATPase domain, which has been implicated in DNA 
repair, replication, and transcriptional activation.  The third motif within CHD1 is a DNA 
binding domain (Figure 2.3A).21 In yeast, this protein occurs as part of the larger 
SAGA/SLIK histone acetyl transferase complex.  It was also demonstrated that one of 
two chromodomains within CHD1 is responsible for the recognition of methylated Lys4 
of the Histone H3 tail.  This methyl-binding chromodomain activity is critical for 
acetyltransferase activity and has been linked to transcriptional activation.22 
Several studies demonstrated that the human CHD1 tandem chromodomain in 
recognize trimethyllysine 4 of the Histone H3 tail (H3 K4Me3) several orders of 
magnitude weaker than tandem chromodomains in budding yeast CHD1.  While the 
function of CHD1 in various species is unclear, it is understood that methyllysine 
recognition of CHD1 is critical for proper transcriptional activity.23, 24 To further 
understand the interactions between the tandem chromodomains of human CHD1 and 
trimethyllysine 4 of the H3 tail, the chromodomains and histone tail peptide were co-
crystallized (Fig. 2.3B). 
From the crystal structure, it is evident that the histone tail binds at an acidic 
surface, which forms an interface between Chromo1 and Chromo2 (Fig. 2.3C).  Most 
chromodomains that recognize trimethyllysine require an aromatic cage consisting of 
! &.!
three aromatic residues.25, 26 However, recognition of H3 K4Me3 by CHD1 is mediated by 
a two-membered aromatic cage consisting of Trp64 and Trp67.  While the lack of a third 
electron-rich aromatic cage ring may disfavor binding, the crystal structure indicates that 
Arg2 of the H3 tail is involved in a cation-" interaction with Trp67.  Additionally Arg2 is 
able to form a hydrogen-bond (H-bond) to the carbonyl backbone of Gly66 (Figure 2.4). 
 
(A) 
 
(B) 
 
(C) 
 
Figure 2.3.  (A) The conserved domains in human CHD1.  (B) The H3 K4Me3 peptide 
bound to CHD1 tandem chromodomains.  Chromo1 (cyan), chromo2 (magenta), linker 
(grey), histone tail (green).  (C) Electrostatic potential map of CHD1 bound to H3 K4Me3 
peptide.  Acidic regions are indicated with red and the basic regions are blue.23 
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Figure 2.4 The aromatic cage of CHD1 with the H3 K4Me3 peptide.  The histone tail is 
in red and the residues from the chromodomain are in blue.23 
 
Interestingly, no other lysine methyl mark has an arginine at the n-2 position, 
making Arg2 unique for this system and an important residue for selectivity.  Enzymatic 
studies have shown that Arg2 is also subject to asymmetric dimethylation catalyzed by 
CARM1 (coactivator-associated arginine methyltransferase 1) and this activity has been 
linked to the transcriptional coactivator machinery.27, 28 This enzymatic activity prompted 
further research to determine how Arg2 methylation affects CHD1 binding.  Anisotropy 
experiments confirmed that the chromodomains have a four-fold stronger KD for H3 
K4Me3 over the peptide containing both trimethyllysine and DMAa (5 µM and 24 µM 
respectively).  The structure of the tandem chromodomains with the doubly modified 
peptide indicated that the dimethyl mark on Arg2 inhibit the H-bond to Gly66.  It was 
therefore suggested that Arg2 methylation silences the Lys4 methyl mark.23 
B. Goal 
From past research is it clear that recognition of H3 K4Me3 by the tandem 
chromodomains of CHD1 is critical for the proper regulation of gene expression.22  It is 
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also evident that Arg2 is important for selectivity and binding affinity.  In this work we 
aimed to further understand how arginine methylation and citrullination affect CHD1 
selectivity and determine how these results compare to the #-hairpin model system.  
C. Results 
i.  Peptide Design and Synthesis 
In previous studies examining the binding of H3 K4Me3 histone tails to the CHD1 
tandem chromodomain, peptides were labeled on the N-terminus with fluorescein for the 
purpose of measuring binding by fluorescence anisotropy (Fig. 2.5A).23, 29 However, 
Asp150 of the tandem chromodomain is known to form a H-bond to the N-terminal 
amine of the histone tail.  It was a concern that the placement of a large aromatic 
fluorophore such as fluorescein may have influenced the previously measured 
dissociation constant.  This concern was supported by the isothermal titration calorimetry 
measurements reported in the same article, which provided a KD of 38 µM between 
CHD1 chromodomains and H3 K4Me3.
23 Additionally, reports have suggested that 
placing a fluorophore a minimum of four amino acids from the binding site is necessary 
for accurate measurements.29 
Therefore, a histone tail was redesigned to incorporate a fluorophore on the C-
terminus of the histone tail linked by an amide bond to a non-native lysine.  Lysine with 
the orthogonal protecting group, iVDde (1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidne)-3-
methylbutyl), was incorporated at the C-terminus allowing for 5(6)-carboxyfluorescein 
(5(6)-FAM) to be conjugated to the peptide after synthesis and prior to the final cleavage 
by TFA. (Fig. 2.5B).   Originally, I used Wang resin was used as the solid support for 
peptide synthesis because it yields a free C-terminal carboxylic acid.  However, after 
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repeated failed attempts at synthesizing the peptide using various activators, it was clear 
that deprotection of Lys(iVDde) with 2% hydrazine was not compatible with Wang resin.  
Therefore Wang resin was substituted for clear amide resin, which yields a C-terminal 
amide as opposed to a carboxylic acid.  Amide resins are known to be more stable than 
carboxylic acid resins and, therefore, it was hypothesized that the new resin would be 
compatible with the Lys(ivDde).  Additionally, N-Hydroxybenzotriazole (HOBt) and O-
Benzotriazole-N,N,N’,N’-tetramethyl-uronium (HBTU), which are the standard 
activation agents used in solid phase peptide synthesis (SPPS), were ineffective in 
coupling 5(6)-FAM to the C-terminal lysine of the peptide.  Therefore, 
diisopropylcarbodiimide (DIC) and HOBt were used instead.  Despite low yields, the 
synthesis shown in Fig. 2.6 was successful. 
 
 
 
Figure 2.5.  Structures of 5(6)-FAM-labelled H3 K4Me3 histone tail peptides with 
fluorescein shown in green, K4Me3 in blue, and Arg2 in red.  (A) Peptide used by 
Flanagan and coworkers,23 (B) peptide used in this research. 
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Figure 2.6.  Synthetic scheme of H3 K4Me3 peptides.  (MTBD is 7-methyl-1,5,7-
triazabicyclo[4.4.0]dec-5-ene and DMF is dimethylformamide)  
 
ii. Structural Characterization 
The CHD1 tandem chromodomain was expressed and purified from BL21 DE3 E. 
coli using a plasmid provided by the Khorasanizadeh group at the University of 
Virginia.23 The structural integrity of the CHD1 tandem chromodomain was confirmed 
using circular dichroism.  Much like HP1 chromodomains, which will be discussed later, 
CHD1 tandem chromodomains are composed primarily of !-helices.  Therefore the CD 
spectra of the protein consisted of two strong minima at 208 nm and 222 nm as shown in 
Fig. 2.7, which confirmed the global structure of the protein. 
The thermal stability of the tandem chromodomain was also evaluated by thermal 
denaturation, which was monitored by circular dichroism at 222 nm.  The purpose was to 
confirm the stability of the protein at 25 oC because all previously published binding data 
were only performed at 15 oC. As shown in Fig. 2.8, the sigmoidal curve indicates that 
the protein remains fully folded up to 30 oC and has a melting temperature of 
approximately 33 oC.  For this reason all samples were initially incubated at only 4 oC for 
thirty minutes to prevent denaturation and then allowed to incubate for ten minutes at 
room temperature prior to binding experiments. 
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Figure 2.7. Circular dichroism spectra of CHD1 tandem chromodomains (25 µM) at 25 
oC in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  This curve is the average of 
three runs. 
   
 
Figure 2.8. Thermal denaturation monitored by circular dichroism at 222 nm of CHD1 
tandem in 10 mM sodium phosphate, pH 7.4, and 2 mM DTT. 
 
iii.  Binding Studies 
Fluorescence anisotropy was used to measure the dissociation constants of the 
CHD1 tandem chromodomain with H3 K4Me3 parent peptide, as well as, the with the 
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Arg2 variant peptides.  Anisotropy revealed non-specific binding of the parent and 
DMAa peptides at chromodomain concentrations above approximately 125 µM.30 
Therefore, those data points were omitted from the final binding curves with a negligible 
effect on the dissociation constants.  The final binding curves are shown in Fig. 2.9 and 
the dissociation constants and $G values are summarized in Table 2.1.   
As shown in Table 2.1, the binding affinity of CHD1 chromodomains for the 
parent peptide containing KMe3 was found to have a KD of 21 µM as compared to 5.2 
µM as previously published in the literature.23 The 4-fold decrease in binding affinity 
with the parent histone tail compared to the literature value may be the result of 
differences in experimental conditions or from placing the fluorophore on the C-terminus 
as opposed to the N-terminus.  At the N-terminus, fluorescein may interact directly with 
the aromatic pocket of the tandem chromodomains or intramolecularly with neighboring 
amino acid side-chains that would have otherwise been involved in molecular recognition 
with the chromodomains.  Previous data had also been measured at 15 oC while the data 
shown here was measured at 25 oC, which can have an effect on measured binding 
constants.  While speculative, these possibilities are likely to be the cause of the different 
binding affinities. 
Also of note is the tighter binding affinity of H3 K4Me3 DMAa (KD=15±2 µM) 
compared to the literature value (KD=24±4 µM).  The difference in these values may also 
be contributed to different experimental conditions.  The results reported here are further 
supported by the work of Strahl and coworkers who used peptide microarrays to 
demonstrate that asymmetric dimethylation of Arg2 in conjunction with trimethylation of 
Lys4 on the Histone H3 tail peptide enhances binding affinity of CHD1.31 Alternatively, 
! &*!
incorporating DMAs weakened binding by more than 3-fold compared to the DMAa 
variant (KD=42 µM). 
The incorporation of citrulline in the H3 K4Me3 peptide significantly disrupted 
binding by nearly an order of magnitude compared to the parent and DMAa-containing 
peptides (Fig. 2.8).  As with the DMAa studies, these results are also consistent with 
those published by Strahl and coworkers who demonstrated that incorporation of 
citrulline in the 2-position of H3 K4Me3 weakened binding of CHD1.
31 
 
 
Figure 2.9. Final fluorescence anisotropy binding experiments of CHD1 tandem 
chromodomains with 0.5 µM H3 K4Me3 (parent), H3 K4Me3 DMAa, H3 K4Me3 
DMAs, and H3 K4Me3 Cit2. Experiments were performed in 50 mM potassium 
phosphate buffer pH 8.0, 25 mM NaCl, and 5 mM TCEP at 25 °C. Each curve is an 
average of 3 runs.    
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Table 2.1.  Dissociation constants (µM) of human CHD1 tandem chomodomain and 
H3 K4Me3 and the mutants.  The R
2 values were calculated using Kaleidagraph and 
are given in parenthesis.  The! $Go values (kcal/mol) were calculated using the 
following equation: $Go=RTln(KD).  The data was measured in 50 mM potassium 
phosphate buffer (pH 8), 25 mM NaCl, with 5 mM TCEP at 25oC.  Error is 
determined from 3 replicates. 
H3 K4 Me3 Literature KD
23
 Experimental KD 
(µM) 
Experimental $;o 
(kcal/mol) 
Parent 5.2±0.6 21 ± 2 (0.996) -6.4 ± 0.1 
DMAa 24±4 15 ± 2 (0.995) -6.6 ± 0.1 
DMAs n.a. 43 ± 5 (0.996) -6.0 ± 0.1 
Cit2 n.a. 160 ± 14 (0.999) -5.2 ± 0.1 
 
D. Discussion 
It is evident from studies involving the H3 K4Me3 histone tail and the three Arg2 
variants that the residue incorporated into the Arg2 position is important for controlling 
recognition of the CHD1 tandem chromodomains in vitro.  Each modified arginine side-
chain influences the binding affinity between the chromodomain and the N-terminal 
histone tail. 
Interestingly, asymmetric and symmetric dimethylarginine have opposing effects 
on chromodomain recognition with the H3 K4Me3 DMAs peptide binding 4-fold weaker 
than the DMAa containing-peptide. Previous studies using hairpin models showed that 
the interaction energies between both dimethylarginine and tryptophan are equivalent.  
However, in the context of a larger protein, the two different dimethylarginine marks are 
important for selectivity and have distinct roles in the regulation of gene expression, 
which has been demonstrated in the case of H4 R8.11 
i.  Effects of DMAa   
The improved binding affinity of the DMAa-containing peptide and CHD1 
chromodomain (15 µM) relative to unmethylated Arg contradicts the data previously 
! &,!
reported by Khorasanizadeh et al.23 Asymmetric dimethylation Arg2 was reported to 
interfere with a H-bond to the backbone carbonyl of Gly66 of the tandem chromodomain 
and therefore weaken binding from 5 µM to 24 µM.23 Additionally, methyl groups are 
known to be electron donating, which would weaken the ability of arginine to act as a H-
bond donor.23 However, in the case of DMAa, one nitrogen within the guanidinium group 
remains unmethylated, which still makes it a possible H-bond donor and capable of 
forming a H-bond to the carbonyl backbone of Gly66.  
The slightly improved binding affinity of the DMAa-containing H3 peptide 
relative to the parent peptide is most likely the result of improved van der Waals contacts 
with Trp67.  Upon examination of the electrostatic potential map (Fig. 2.9), it is apparent 
that the addition of two methyl groups on arginine significantly increases the surface area 
of the guanidinium group and results in the distribution of the positive charge across the 
side-chain (Fig. 2.10).19   This charge distribution permits stronger van der Waals 
contacts with Trp67.  The methyl groups allow for interactions with the indole ring of 
tryptophan to be entropically more favorable due to an added hydrophobic component.19 
It appears that any effects on the H-bond between Gly66 and DMAa are negated by the 
cation-" interaction and van der Waals contacts between DMAa and Trp67. 
Interestingly, methylation of Arg2 by CARM1 has been implicated in 
transcriptional activation.28 Therefore enhanced recognition of CHD1, a known 
transcriptional activator, for the DMAa variant histone peptide may further explain the 
biological significance of asymmetric arginine methylation. 
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Figure 2.10.  Electrostatic potential maps depicting (A) arginine, (B) DMAa and (C) 
DMAa. Electrostatic potential maps were generated with MacSpartan: HF/6-31g*; 
isodensity value = 0.02; range = 50 (red, electron rich) to 200 kcal/mol (blue, electron 
poor). 
 
ii.  Effects of DMAs   
The DMAs variant had a weakened affinity of 42 µM and a $$G of 0.4 kcal/mol 
compared to the parent peptide and 0.6 kcal/mol compared to the DMAa counterpart.  
Previous NMR studies using #-hairpin models to investigate cross-strand cation-" 
interactions demonstrated that peptides with either DMAa or DMAs had similar 
interaction energies with tryptophan (data not published).  However, the #-hairpin is a 
simplified model that does not take into account the importance of neighboring residues 
in the chromodomain, orientation, and charge distribution as seen within the more 
complex histone tail-chromodomain complex.  CHD1 also H-bonds to arginine, which 
varies in strength depending on what modifications are present on the side chain.  The H-
bond between Arg2 and the carbonyl of Gly66 is also important for CHD1 recognition.  
The presence of one methyl group on each nitrogen within the guanidinium of DMAs 
may weaken or inhibit H-bonding to Gly66 due to steric crowding, which can contribute 
to weakened binding affinity. 
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The DMAs modification is not catalyzed by CARM1.  Symmetric dimethylation 
is carried out by type II protein arginine methyltransferases (PRMTs) while CARM1 is a 
type I PRMT.  The most well characterized type II PRMT is PRMT5.  Though very little 
is known about the effects of the DMAs mark, PRMT5 does associate with the SWI/SNF 
complex, which is a chromatin remodeling complex that suppresses expression of tumor 
suppressor proteins and is associated with cell proliferation.32 The weakened binding 
affinity that CHD1 has for the DMAs variant is consistent with the repressed gene 
expression associated with type II PRMTs.33 However, the effects of symmetric 
dimethylation and the identification of the type II PRMTs responsible remain largely 
unknown. 
iii.  Effects of Citrulline 
Deimination has been suggested as nature’s method for reversing the effects of 
arginine methylation.  Therefore, we wanted to determine how incorporation of Cit2 
influences the binding affinity of the H3 K4Me3 peptide to the CHD1 tandem 
chromodomains.  Citrullination of Arg2 in the histone tail significantly disrupts binding 
by a factor of eight with a $$G of 1.2 kcal/mol. There are two possible explanations for 
the decrease in binding affinity.  The first is a loss in cation-" interactions and the second 
is a loss of an H-bond. 
Citrulline is capable of participating in polar-" interactions.  However, citrulline 
does not have the cationic character found in arginine and methylarginine, which results 
in the loss of the favorable cation-" interaction with Trp67.  In the #-hairpin model 
system employed by Hughes (data not published), the difference between arginine and 
citrulline was approximately 0.3 kcal/mol.  The larger effect that deimination has on 
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binding to CHD1 may be attributed to the loss of the H-bond with Gly66 because 
citrulline is a significantly weaker H-bond donor compared to arginine, DMAa, or 
DMAs.  These two factors both contribute to the clear disruption of binding to the CHD1 
tandem chromodomains.   
iv.  Conclusions 
Asymmetric and symmetric methylation and deimination are three modifications 
that are known to occur within nature and notably on N-terminal histone tails.  Each of 
these arginine modifications has a distinct impact on the recognition of CHD1 
chromodomains for histone peptides.  What is clear from these studies is that DMAa and 
DMAs are not equivalent modifications and are capable of having opposite outcomes on 
the read-out of PTMs.  Evidence has even demonstrated that DMAa and DMAs have 
opposing effects on gene expression with DMAa acting as a transcriptional activating 
mark and DMAs acting as a suppressing mark.2, 6 Furthermore, deimination does not 
simply reverse the effects of arginine methylation.  Rather the loss of the positive charge 
is a change that is significant enough to disrupt binding of effector proteins such as 
CHD1 and perhaps silence gene expression.  While the effects of H3 K4Me3 variants on 
CHD1 recognition have been substantiated here and by Strahl and coworkers, much can 
still be learned about how these three modifications affect the Histone Code. 
E.  Experimental 
i.  Protein Expression and Purification 
The Khorasanizadeh Group at the University of Virginia supplied the PET11a 
plasmid containing the coding region of human CHD1 Chromodomain with an N-
terminal 6-Histidine tag.  E. coli BL21 (DE3) gold cells were transformed with the 
! '&!
plasmid and were grown as 1.5 L cultures in LB media with 50 mg/L ampicillin at 37oC.  
At A600=0.5-0.7, the cultures were induced with 0.1 mM isopropyl "-D-1-
thiogalactopyranoside (IPTG).  The temperature of the shaker was reduced to 18 oC and 
the cultures are allowed to incubate overnight. The cells were harvested by centrifugation 
for 20 mins at 4500 rpm using a Sorvall RC-3B refrigerated centrifuge with a H6000A 
swinging bucket rotor.  The supernatant was discarded and the cells were resuspended in 
approximately 30 mL NiA buffer (5 mM imidazole, 50 mM potassium phosphate, pH 
7.4, 150 mM NaCl, 0.01% sodium azide) and stored at -80oC for a later time. 
The cells (40 mL) were thawed and subsequently lysed by sonication (Branson 
102C CE, 1 min 30 sec with a 0.5 sec pulse and 1.5 sec off) in the presence of DNase, 
cOmplete, EDTA-free Protease Inhibitor Cocktail Tablets (Roche Applied Sciences) and 
a final concentration of 1 mM phenylmethanesulfonylfluoride (PMSF).  The lysate was 
centrifuged at 17000 rmp for 60 mins to yield a clear supernatant using a Sorvall RC-3B 
refrigerated superspeed centrifuge with an SS-34 rotor.  The supernatant was filtered 
through a sterile 2 µM filter.  The protein was purified using Nickel affinity 
chromatography using a gravity column with 10 mL Nickel-NTA agarose resin slurry 
from Qiagen.  NiB buffer (250 mM imidazole, 50 mM potassium phosphate, pH 7.4, 150 
mM NaCl, 0.01% sodium azide) was used to elute the protein. After the flowthrough was 
collected, the column was washed with 150 mL NiA then 50 mL of 95:5 NiA:NiB and 50 
mL of 90:10 NiA:NiB.  The protein was eluted in 5-10 mL fractions using NiB.  The 
purity was confirmed using SDS-PAGE (Fig. 2.11).  The protein was then dialyzed in 1L 
50 mM potassium phosphate pH 8.0, 25 mM NaCl. 
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Figure 2.11.  Purity of CHD1 Chromodomain by 15% SDS-PAGE.  (1) Ladder, (2) 
Supernatant, (3) Flowthrough and NiA wash, (4) 5% B wash, (5) 10% B wash, (6-15) 
100% B wash.  Fractions from lanes 6-10 were pooled. 
 
ii.  Peptide Synthesis and Purification 
Histone tails (residues 1-15 of the H3 tail with a C-terminal tyrosine) were 
synthesized using automated solid phase peptide synthesis with a Thuramed Tetras 
synthesizer on a 0.06 mmol scale.  Fmoc protected amino acids were used with Clear-
Amide resin from Peptides International, Inc.  Amino acid residues were activated with 
HBTU (O-benzotriazole-N,N,N’,N’,-tetramethyluronium hexafluorophosphate) and 
HOBT (N-hydroxybenzotriazole) with DIPEA (diisopropylethylamine) in DMF (N,N-
dimethylformamide) using four equivalents of amino acid, activator, and DIPEA.  Amino 
acids were deprotected twice with 2% DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) and 2% 
piperidine in DMF for 15 mins each step.  Each amino acid was coupled on double cycles 
of 30 mins each to improve coupling.  Fmoc-Lys(ivDde)-OH was the second amino acid 
to be coupled for a total of 5 hrs using two molar equivalents.  Fmoc-Cit-OH, Fmoc-
SDMA(Boc)2-OH, or Fmoc-ADMA(Pbf)-OH were coupled at position 2 using two molar 
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equivalents.  Boc-Ala-OH was used as the final residue the C-terminus so Lys(ivDde) 
could be deprotected with hydrazine.  Fmoc-Lys(Me)2-OH was coupled at position 9 for 
10 hrs methylated at the end of the peptide synthesis with the N-terminal amine still Boc-
protected.  Methylation was performed with 10.8 mL MTBD and 37.4 µL iodomethane in 
5mL DMF and bubbled with N2 for 4-5 hrs with a vented septum.  The iVDde  protecting 
group was deprotected from lysine by washing with 10 mL of 2% hydrazine in DMF 3 
times for 3 mins each time.  The 5(6)-carboxyfluorescein (5(6)-FAM) was coupled to the 
free amine as follows.  First 34 mg 5(6)-FAM (1.5 eq) and 12.2 mg HOBt (1.5 eq) were 
combined in 5 mL DMF then 15.8 mL diisopropylcarbodiimide (1.7 eq) were added and 
the solution was allowed to react for ten mins at room temperature.  The solution was 
then added to the resin, which was bubbled overnight with nitrogen gas.  Cleavage of the 
peptides from the resin was performed in 95% trifluoroacetic acid (TFA), 2.5% H2O, 
2.5% triisopropylsilane (TIPS) for three hrs.  TFA was evaporated by blowing the peptide 
with nitrogen, and cold diethyl ether was used to precipitate the product.  The product 
was extracted with deionized MilliQ water and lyophilized to a powder.   
Peptides were purified by reversed-phase HPLC.  A Waters semi-preparative 
HPLC system with an Atlantis Prep OBD dC-18 semi-preparative column was used for 
separation with a gradient of 0% to 100% solvent B over 60 mins with solvent A (95:5 
water:acetonitrile, 0.1% TFA) and solvent B (95:5 acetonitrile:water, 0.1% TFA).  This 
purification process was repeated twice to remove impurities.  Peptides were lyophilized 
and the molecular weight was confirmed by ESI-TOF mass spectrometry (Table 2.2).   
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iii. Circular Dichroism 
CD measurements were performed on an Aviv 62DS Circular Dichroism 
Spectrometer.  CD data was obtained for the chromodomain at 33.3 #M concentration in 
10 mM Na2HPO4, pH 7.4, 2 mM DTT.  Wavelength scans were performed in triplicate 
and averaged.  Scans were performed at 25o C from 260-185 nm.  All scans were 
corrected by subtracting the spectrum of the buffer used in the experiment and the signal 
was converted to Mean Residue Ellipticity (MRE) using Eq. 2.1.  Where signal refers to 
circular dichroism signal, l is path length in cm, c is conentration in M, and r is the 
number of amino acid residues. 
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                                         Eq. 2.1 
Thermal denaturation experiments were preformed using the same buffer and 
concentrations as described above and measurements were taken between 275 and 366 K.  
The melting curves were normalized to show the fraction folded using Eq. 2.2 where!12!
is MRE,!1D!is the MRE for the fully denatured protein, and $F is MRE for initially folded 
protein.!
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iv.  Anisotropy 
Binding assays were performed using a POLARstar Omega microplate reader 
with untreated 96 half area flat bottom plates.   CHD1 chromodomain was prepared using 
1:2 serial dilutions (0 µM to 500 µM) in 50 mM potassium phosphate buffer, pH 8, 25 
mM NaCl that CHD1 chromodomain was dialyzed in and 5 mM TCEP was added to it.  
The protein was centrifuged for 1 min at 4000 rpm to draw down any air bubbles.  A 1 
! '*!
µM stock of H3 K4Me3 was prepared (&492=78,000 cm
=1M-1) in 50 mM potassium 
phosphate buffer, pH 8, 25 mM NaCl.  The chromodomain and peptide were mixed in the 
microplate with 50 µL of chromodomain and 50 µL of peptide.  This reduced the 
concentration of peptide, TCEP, and chromodomain by half (0.5 µM peptide, 2.5 mM 
TCEP , 0 µM to 250 µM chromodomain).  The samples were mixed by pipetting them 
ten times while introducing as few air bubbles as possible and centrifuged at 3000 rpm 
for 1 min using a Sorvall T1 centrifuged with a T20 microplate rotor to remove any 
additional air bubbles.  All samples were allowed to reach equilibrium for 30 mins at 4oC 
then at ambient temperature for 10 mins prior to analysis.  Measurements were taken with 
an excitation wavelength of 485 nm and an emission wavelength at 520 nm.  The data 
was fitted using Eq. 2.3 in Kaleidagraph where r is anisotropy, r0 is the initial anisotropy, 
r% is the maximum anisotropy, p is the total concentration of fluorescein-labeled peptide, 
[c] is the total chromodomain concentration added, and KD is the dissociation constant.  
The values for r0, r%, and KD were treated as floating variables. 
 
                                       Eq. 2.3 
 
Once the values for r% and r0 were determined from the curve fit, the fraction of 
bound chromodomain was calculated using Equation 2.4.  The data was re-plotted as 
fraction bound as a function of chromodomain concentration to give the final data as 
shown in Fig. 2.6. 
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                                     Eq. 2.4 
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Table 2.2. Mass spectrometry data for the peptides synthesized for this study. 
Peptide Expected Mass (Da) Observed Mass (Da) 
H3 K4Me3 2251.6 2251.2 
H3 K4Me3 Cit 2252.2 2252.8 
H3 K4Me3 DMAa 2279.2 2279.8 
H3 K4Me3 DMAs 2279.2 2279.3 
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Chapter III 
ENHANCING THE SELECTIVITY OF THE AROMATIC CAGE OF HP1! 
CHROMODOMAIN FOR TRIMETHYLLYSINE 9 OF HISTONE H3  
!
A.  Background 
Lysine methylation is a post-translational modification that is pervasive 
throughout the entire proteome, including histones.1-3 Lysine can have up to three 
different methylation states including mono-, di-, or tri-methylation.  Each methylation 
state affects DNA expression differently.  For example, trimethyllysine 9 of the Histone 
H3 (H3 K9Me3) is localized at heterochromatin and associated with silencing expression 
while H3 K9Me1 is localized at active euchromatin.
4-6 Therefore, the proper read-out of 
the different methyl states by effector proteins is critical for proper gene expression.   
The recognition of lysine methyl marks by effector proteins is mediated by 
contacts made between the methylammonium of methyllysine and an aromatic cage.7, 8 
The aromatic cage is a motif that is prevalent in all methyllysine reader domains.  
Importantly, this motif is not present in domains that target un-modified lysine such as 
the PHD (plant homeodomain) finger found in BHC80.9 The aromatic cage is composed 
of two to four aromatic amino acid residues that are involved in cation-" interactions with 
methyllysine.7 The cation-" interaction is due to the presence of a negative quadrapole 
moment resulting in negative electrostatic potential on the faces of the preorganized 
aromatic rings within the cage.  The negative quadrupoles can, therefore, be involved in 
! ('!
favorable electrostatic interactions with cationic residues such as lysine.8 N-methylated 
lysine also has additional polarized methyl groups, which can be involved in favorable 
cation-" interactions with the aromatic cage (Fig. 3.1).   As a result, interactions with the 
aromatic cage are further stabilized with only a modest hydrophobic contribution.7, 10 
 
 
 
Figure 3.1.  Possible interaction geometries between Trp-Lys and Trp-Lys(Me3).
4 
 
Though aromatic cages are found in all methyllysine “readers”, many of them 
vary in composition and structure to obtain the desired selectivity for mono-, di-, or 
trimethyllysine.  For example, readers have two modes of selection for lysines with lower 
methylation states.  First, some cages that are found in malignant brain tumor (MBT) 
modules form a deep groove, which binds mono- and dimethyllysine, but excludes 
bulkier trimethyllysine.11, 12 Other cages such as those found in HP1 or CHD1 
chromodomains10, 13 form surface grooves, which are shallow, but wide enough to 
accommodate higher methylation states such di- or trimethyllysine.14  
Additionally, many aromatic cages are supplemented with a neighboring acidic 
residue such as aspartate or glutamate, which is capable of forming either a direct or 
water-mediated H-bond to methyllysines other than KMe3 via an NH from the methyl 
NH
N+
H
H
H
H
H
NH
N+
H
H
CH3
H3C
H
H
H
! ((!
lysine. 10-12, 14, 15 Li and coworkers manipulated the composition of the BPTF PHD finger 
aromatic cage to reverse its selectivity for di- and tri-methyllysine.16 The wild-type PHD 
finger binds H3K4Me3 and H3 K4Me2 with KD values of 3 µM and 6 µM respectively.  
However, by substituting Tyr17 of the aromatic cage for glutamate, the selectivity of the 
PHD finger was reversed to favor H3 K4Me2 (KD = 7 µM) over H3 K4Me3 (KD = 15 
µM).  Comparing the crystal structures of the wild-type and Y17E PHD finger confirmed 
that the change in selectivity is the result of the incorporation of a direct H-bond between 
Y17E and dimethyllysine 4 (Fig. 3.2).  The re-engineering of the BPTF PHD finger 
highlighted the significant role of the H-bond in the recognition of lower methylation 
states of lysine.16 
 
(A) 
 
(B) 
 
Figure 3.2.  The aromatic cage of the BPTF PHD finger (green) with the 
dimethyllysine of H3 K4Me2 (yellow).  (A) shows the wild-type aromatic cage with 
water-mediated H-bonds to KMe2 shown in red (PDB 2FSA) and (B) shows the Y17E 
mutant with the direct H-bond to KMe2 in red (PDB 2RI7).
16 This image was 
generated using PyMol. 
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Unlike the BPTF PHD finger, the chromodomain is a surface-groove binding 
domain with an aromatic cage composed of two tyrosine residues, a tryptophan, and a 
glutamate (Fig. 3.3).  This particular chromodomain shows a slight preference for H3 
K9Me3 over H3 K9Me2.
10 In the structure containing dimethyllysine, the glutamate is 
involved in a water-mediated H-bond to the dimethyllysine.  However, when in complex 
with the trimethyllysine, the water molecule is slightly displaced from the cage.  Since 
trimethyllysine has no lone pair of electrons, it cannot be involved in a H-bond.  
Additionally, upon mutation of glutamate to alanine, a minimal change in binding affinity 
to H3 K9Me3 is observed while mutating the aromatic residues to alanine disrupts 
binding.  These results indicate that glutamate is not important for binding to 
trimethyllysine.10 However, these experiments were not repeated with H3 K9Me2 and it is 
possible that the H-bond to dimethyllysine is important for binding in addition to the 
cation-" interaction. 
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Figure 3.3.  Structure of H3 K9Me2 (yellow) and H3 K9Me3 (red) in the aromatic 
cage of HP1 chromodomain (blue and green respectively)  The water-mediated H-
bond between Glu52 and K9Me2 is depicted in black.  PDB numbers for 
chromodomain bound to H3 K9Me2 and H3 K9Me3 are 1KNA and 1KNE 
respectively.10 This image was generated using PyMol. 
 
B.   Significance 
The purpose of this research was to further investigate the significance of Glu52 
of HP1! chromodomain to understand if and how Glu52 enhances binding to H3K9Me2.   
The glutamate was mutated to residues incapable of forming a favorable H-bond to 
dimethyllysine, but still able to maintain favorable interactions with trimethyllysine.  By 
making mutations to Glu52 we gained a better understanding of how aromatic cages are 
selective for various lysine methylation states and we were able to enhance the selectivity 
of chromodomain for H3 K9Me3 over H3 K9Me2.  
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C.  Results 
i.  System Design 
The importance of the water-mediated H-bond between Glu52 and the N-H group 
on dimethyllysine has previously been implicated in stabilizing the binding event 
between HP1! chromodomain and H3 K9Me2.
10 Substitution of Glu52 for residues 
unable to form a water mediated H-bond to lysine should weaken interactions with 
dimethyllysine while having a positive or limited effect on interactions with the H3 
K9Me3 peptide. 
The first set of mutations incorporated the aromatic residues, phenylalanine and 
tryptophan, at position 52.  Supplementing the aromatic cage with a fourth aromatic 
amino acid adds an additional cation-" interaction with trimethyllysine 9.  Phenylalanine 
was also selected because it is the smallest of the aromatic residues, which reduces steric 
hindrance within the binding pocket of the chromodomain.  Tryptophan was chosen 
because it is known to have the most favorable cation-" interaction with trimethyllysine 
compared to the smaller aromatic residues due to the larger aromatic face.17 
The second set of mutations to Glu52 that were explored included the 
hydrophobic amino acids, isoleucine and valine.  It was postulated that these two residues 
can maintain favorable van der Waals contacts with the methyl groups on trimethyllysine 
9.  Since these residues lack a H-bond donor or acceptor, they are unable to form the 
water-mediated H-bond to dimethyllysine and therefore should reduce binding to H3 
K9Me2 and improve selectivity for H3 K9Me3. 
The third set of mutations included the polar residues, aspartate and glutamine.  
Though aspartate is capable of forming a H-bond to water, the alkyl chain is shorter by 
! (,!
one methylene group as compared to glutamate.  By shortening the distance between 
E52D and lysine 9, the H-bond network responsible for stabilizing the HP1 
chromodomain-H3 K9Me2 complex will be disrupted, which in turn will disfavor binding 
to dimethyllysine.  Glutamine is structurally similar to glutamate.  However, an amide is 
a considerably weaker H-bond acceptor than a carboxylic acid and should therefore be 
favored within the aromatic cage without interacting with dimethyllysine 9. 
ii.  Structural Characterization 
The structural integrity of the six chromodomain Glu52 mutants was examined by 
circular dichroism.  The two minima at 208 nm and 222 nm are characteristic of !-helical 
structure and are known to mask the weaker signal at 210 nm, which is characteristic of 
#-sheet structure.  The maximum peak coincides with an exciton coupling peak, which is 
related to the orientation of aromatic sidechains such as those in the aromatic cage.18 
The CD spectra indicate that the E52W mutant chromodomain had an overall 
destabilizing effect on the global structure of chromodomain and therefore no further 
studies were performed using this mutant (Fig. 3.4).  However, the phenylalanine 
mutation did not perturb on the global structure of the chromodomain indicating that any 
observed changes in binding affinity to the E52F mutant are not due to a variation in the 
global structure of the protein. 
The CD spectra of E52V and E52I mutants (Fig. 3.5) indicate that these point 
mutations had no effect on the minima at 208 nm and 222 nm, which indicates no change 
to the !-helix within the chromodomain and most likely a minimal change if any to the 
global structure of the protein.  There is a loss of signal at 232 nm, which suggests a 
small perturbation in the aromatic cage which can be expected due to the mutation.  
! ).!
The final set of mutations including E52D and E52Q had the least effect on the global 
structure of chromodomains (Fig. 3.6).  The minima at 208 nm and 222 nm are within 
error of the minima for the wild-type chromodomain.  The exciton coupling peak at 232 
nm is also consistent with the wild-type protein. 
 
                                  
 
Figure 3.4.   Circular dichroism spectra comparison of HP1! chromodomain to the 
mutants, E52W and E52F at 25 oC in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  
These are the averages of three runs. 
 
/-%...!
/-....!
/+...!
/)...!
/'...!
/%...!
.!
%...!
'...!
%..! %-.! %%.! %&.! %'.! %(.! %).!
<'
=!
"#
$
%
!&
'
(
!#
'
)
*+
,
-!
./0$*$1%23!"1'-!
34!56!
34!7(%5!
34!7(%8!
! )-!
 
 
Figure 3.5.   Circular dichroism spectra comparison of HP1! chromodomain (blue) to 
the mutants, E52I (red) and E52V (green) at 25 oC in 10 mM sodium phosphate pH 7.4 
with 2 mM DTT. These are the averages of three runs. 
 
 
Figure 3.6. Circular dichroism spectra comparison of HP1! chromodomain (blue) to the 
mutants, E52D (red) and E52Q (green) at 25 oC in 10 mM sodium phosphate pH 7.4 
with 2 mM DTT. These are the averages of three runs. 
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Wile the five chromodomain E52 mutants have a minimal effect on the protein 
structure, thermal denaturation experiments were nevertheless conducted to determine 
whether substituting Glu52 for Phe, Ile, Val, Asp, or Gln affected the stability of the 
protein (Fig. 3.7 through Fig. 3.9).  The melting temperature was estimated by examining 
the inflection point of each curve (Table 3.1).  Though there is some deviation from the 
melting temperature of the native chromodomain (47 oC), all chromodomain mutants are 
stable at 25 oC, which is the temperature at which all subsequent binding experiments 
were conducted.   
 
                                  
 
Figure 3.7.  Thermal denaturation monitored by circular dichroism at 222 nm of HP1! 
chromodomain WT (blue) and E52F (red) in 10 mM sodium phosphate pH 7.4 and 2 mM 
DTT. 
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Figure 3.8.  Thermal denaturation monitored by circular dichroism at 222 nm of HP1! 
chromodomain WT (blue), E52I (red), and E52V (green) in 10 mM sodium phosphate pH 
7.4 and 2 mM DTT. 
 
 
Figure 3.9.  Thermal denaturation monitored by circular dichroism at 222 nm of HP1! 
chromodomain WT (blue), E52D (red), and E52Q (green) in 10 mM sodium phosphate 
pH 7.4 and 2 mM DTT. 
 
Table 3.1.  Approximate melting temperatures of chromodomain and the Glu52 mutants 
determined using the thermal denaturation data highlighted in Fig. 3.8 and Fig. 3.9. 
 WT E52F E52I E52V E52D E52Q 
Tm (
 o 
C) 47 53 39 42 43 43 
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iii.  Isothermal Titration Calorimetry Studies 
Isothermal titration calorimetry (ITC) was employed as an initial technique for 
measuring the dissociation constant and thermodynamic parameters of native HP1! 
chromodomain bound to H3 K9Me3 (Fig. 3.10, Table 3.2). The n value was determined 
to be 1.1, which indicates a stoichiometric ration of 1:1 of chromodomain to histone tail.  
The binding event is enthalpically driven with a $H of -10.3 kcal/mol.  The dissociation 
constant was determined to be 13±1! µM, which differs from the literature value 
previously published (Table 3.2).  However any differences can be attributed to varying 
conditions as previous ITC measurements were taken at 15 oC instead of 25 oC, which has 
been shown to improve the dissociation constant when using monomethyllysine 9 histone 
tail peptide as the ligand.19 
As will be discussed further in the following section, the dissociation constant 
between chromodomain and H3 K9Me3 measured using fluorescence anisotropy was 
determined to be 17 µM (Table 3.3), similar to the constant measured by ITC.  Therefore, 
the KD was verified using two independent methods.  Due to the large quantity of 
material required for the ITC experiment, anisotropy was chosen as the preferred method 
for all further measurements. 
 
! )(!
 
Figure 3.10.  Binding HP1! chromodomain to H3 K9Me3 histone tail by isothermal 
titration calorimetry. (Top)  Raw data for peptide injections into the chromodomain (the 
first injection was omitted).  (Bottom)  Integrated heats of injection after subtracting the 
heat of dilution.  Measurements were taken at 25 oC in 50 mM potassium phosphate pH 
8.0, 25 mM NaCl, 2mM DTT. 
 
Table 3.2.  Summary of thermodynamic parameters from the ITC experiment in Fig. 3.10. 
 N KD (µM) $H (kcal/mol) T$S (kcal/mol) $G (kcal/mol) 
Literature
20
 0.99 2.5 ± 0.1 -9.83 -2.46 -7.36 
Experimental
20
 1.1 13 ± 1 -10.3 -3.63 -6.7 
 
iv.  Binding Studies 
Initially, fluorescence anisotropy experiments were performed using histone 
peptides labeled at the N-terminus with 5(6)-TAMRA.  This fluorophore was chosen for 
its high quantum yield and its resistance to photobleaching as compared to 5(6)-FAM.  
Additionally, a single-cell Cary Eclipse Fluorescence Spectrophotometer from Varian 
was used.  Several repetitions of anisotropy experiments with wild-type HP1! 
! ))!
chromodomain and H3 K9Me3 yielded different dissociation constants with large error 
(Fig. 3.11).   
 
 
Figure 3.11. Fluorescence anisotropy binding experiments of 100 nM 5(6)-TAMRA H3 
K9Me3 histone tail with wild-type chromodomain from two different days.  The 
experiments were performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, 
and 4 mM DTT at 25 °C. Each curve is an average of 2 runs.  On day 1 the KD was 42 ± 
15 µM and the R2 was 0.971. On day 2 the KD was 17 ± 4 µM and the R
2
 was 0.987. 
 
A fluorescence emission experiment was used to determine if 5(6)-TAMRA was 
interacting with HP1! chromodomain.  An increase in emission is indicative of a non-
specific interaction between a fluorophore and the receptor.  As shown in Fig. 3.12 
fluorescence emission increased significantly with increased chromodomain 
concentration.  A similar experiment was repeated using 5(6)-FAM at the fluorophore to 
determine whether this would be a viable substitute.  Since no significant change in 
fluorescence emission was observed, 5(6)-FAM was chosen as the fluorophore for future 
studies.  Additionally, a Polarstar plate reader was used for remaining studies.  The 
concentration of peptide was also increased from 100 nM to 1 µM because the 
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dissociation constants were determined to be higher than 10 µM.  The ideal concentration 
for a labeled ligand in a binding assay is at least ten-fold lower than the dissociation 
constant. 
 
 
Figure 3.12.  Fluorescence emission of 100 nM H3 K9Me3 labeled with either 5(6)-
TAMRA or 5(6)-FAM and increasing concentrations of HP1! Chromodomian in 50 
mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each 
curve is an average of 2 runs. 
 
The dissociation constants between the chromodomain and di- and tri-
methyllysine 9 Histone H3 tail were measured using the new experimental anisotropy 
conditions (Fig. 3.13).   The data show that the KD values are nearly identical for both the 
di and tri-methylated peptides (KD=20 µM and 17 µM respectively) thus demonstrating 
the lack of selectivity that chromodomain has for the higher methylation states. 
Chromodomain E52 mutations involving the three hydrophobic residues, Phe 
(Fig. 3.14), Ile (Fig. 3.15), and Val (Fig. 3.16) had a two to three-fold decrease in binding 
affinity to both dimethyl and trimethyllysine histone tails (Table 3.3).  It is possible that 
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substituting glutamate with residues that are dissimilar in polarity may have distorted the 
aromatic cage or disrupted any electrostatic interactions with lysine 9.  Substitution of 
glutamate with bulkier residues such as phenylalanine may have also resulted in a steric 
clash with other neighboring amino acids that can distort the binding pocket.   
Additionally, E52 is a solvent-exposed acidic residue.  Substituting such a residue with 
one that is hydrophobic results in an unfavorable solvation energy, which may also 
destabilize the aromatic cage.  This distortion is consistent with the circular dichroism 
collected for E52I and E52V in which the exiton coupling peak at 232 nm, which is 
known to be influenced by the orientation of neighboring aromatic residues, was 
weakened for both mutants.21 
Chromodomain E52D had a minimal effect on binding affinity to H3 K9Me2 with 
a KD of 19 µM (Fig. 3.17), which demonstrates that the aspartate may still be able to 
maintain the water-mediated H-bond to the dimethyllysine.  However, binding to the 
trimethyllysine is improved by a factor of two with a KD of 9 µM.   Aspartate is a shorter 
amino acid than glutamate by one methylene.   Therefore, the aromatic cage with 
aspartate may have a reduced steric clash with the third methyl group of trimethyllysine.  
Interestingly, Chromodomain E52Q is a 2.5-fold weaker dissociation constant 
with H3 K9Me2 (52 µM) compared to the native protein while the dissociation constant 
with H3 K9Me3 (15 µM) is unaffected by the mutation (Fig. 3.18).  The loss of the H-
bond to the dimethyllysine can account for the difference in binding affinity.  The similar 
conformation between glutamine and glutamate explains the comparable binding affinity 
to H3 K9Me3.  This observation supports the argument that the water-mediated H-bond 
does play a role in chromodomain binding to H3 K9Me2.  
! ),!
Table 3.3.  Dissociation constants (µM) of Drosophila chromodomain and H3 K9Me3 
and the mutants using the data from Fig. 3.10 through Fig. 3.13.  The R2 values were 
calculated using Kaleidagraph and are given in parenthesis.  The $G (kcal/mol) is given 
in brackets and was calculated using the following equation:!$Go=-RTln(KD).  The data 
was measured in 50 mM potassium phosphate buffer (pH 8), 25 mM NaCl, with 4 mM 
DTT at 25 oC.  
Chromodomain H3 K9Me2 H3 K9Me3 
Wild-Type 
20 ± 4 (0.990) 
[-6.4 ± 0.1] 
17 ± 3 (0.994) 
[-6.5 ± 0.1] 
E52F 
52 ± 5 (0.998) 
[-5.8 ± 0.1] 
40 ± 9 (0.991) 
[-6.0 ± 0.1] 
E52I 
83 ± 20 (0.992) 
[-5.6 ± 0.1] 
47 ± 8 (0.996) 
[-5.9 ± 0.1] 
E52V 
67 ± 11 (0.997) 
[-5.7 ± 0.1] 
39 ± 9 (0.992) 
[-6.0 ± 0.1] 
E52D 
19 ± 2 (0.995) 
[-6.4 ± 0.1] 
9 ± 1 (0.994) 
[-6.9 ± 1] 
E52Q 
52 ± 7 (0.995) 
[-5.8 ± 0.1] 
15 ± 3 (0.990) 
[-6.6 ± 0.1] 
 
 
Figure 3.13.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me2/3 histone tail with wild-type chromodomain.  The experiments were performed 
in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
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Figure 3.14.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me2/3 histone tail with E52F chromodomain.   The experiments were performed in 50 
mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each 
curve is an average of 3 runs. 
 
 
Figure 3.15.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me2/3 histone tail with E52I chromodomain.   The experiments were performed in 50 
mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each 
curve is an average of 3 runs. 
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Figure 3.16.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me2/3 histone tail with E52V chromodomain.   The experiments were performed in 
50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
 
 
Figure 3.17.  Fluorescence anisotropy binding experiments of 1 µM5(6)-FAM H3 
K9Me2/3 histone tail with E52D chromodomain.   The experiments were performed in 
50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
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Figure 3.18.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me2/3 histone tail with E52Q chromodomain. Experiments were performed in 50 mM 
potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each curve 
is an average of 3 runs. 
 
D.  Discussion 
The aromatic cage within the HP1! chromodomain is critical for recognition of 
methyllysine 9 on the Histone H3 tail and has been shown to have only a small 
preference for trimethyllysine.  The purpose of this project was to investigate how 
selectivity is maintained by the aromatic cage and to improve the selectivity of HP1! 
chromodomain for H3 K9Me3 over H3 K9Me2.  This goal was to be accomplished by 
substituting E52, which forms a water-mediated H-bond to the lone electron pair on 
dimethyllysine, with residues that would form favorable contacts with trimethyllysine 
while removing the H-bond to dimethyllysine.  
The E52F mutation was incorporated to explore the effects of adding a forth 
cation-"! interaction while E52V and E52I were incorporated to explore hydrophobic 
0
0.2
0.4
0.6
0.8
1
0 50 100 150 200 250
H3 K9Me3
H3 K9Me2
F
ra
c
ti
o
n
 B
o
u
n
d
Chromodomain Concentration (µM)
! *&!
contacts with the methyl groups on lysine 9.  The E52F and E52V mutations weakened 
binding by at least two-fold while showing no improvement in selectivity.  The E52I 
mutation improved selectivity by two-fold, but the binding to both di- and tri-methylated 
peptides were also significantly weakened. The negative charge and conformation of 
glutamate may be key to stabilizing the recognition of the aromatic cage for both di- and 
trimethyllysine.  Without this charge no H-bond network can be formed to dimethyllysine 
and no electrostatic interactions can occur with trimethyllysine. 
Substituting glutamate for the two polar residues, glutamine and aspartate, both 
improved selectivity for H3 K9Me3.  Chromodomain E52D maintained the same binding 
affinity to H3 K9Me2 while improving affinity to H3 K9Me3 by two-fold (KD=9 µM).  It 
is likely that the stabilizing water-mediated H-bond is maintained between E52D and 
K9Me2.  However, the two-fold enhancement of binding to H3 K9Me3 may be attributed 
to the shorter alkyl chain of aspartate, which provides additional space within the 
aromatic cage for the trimethyllysine to fit into. 
Chromodomain E52Q had a 2.5 fold weaker binding affinity to H3 K9Me2 
(KD=52 µM) and maintained the same binding affinity to H3 K9Me3 (KD=15 µM).  The 
significant loss in binding affinity to the dimethylated histone peptide is likely to be due 
to the weakened H-bond between dimethyllysine and glutamine.  Glutamine, though a 
polar amino acid, is not a strong H-bond acceptor compared to glutamate and, therefore, 
cannot form the water-mediated H-bond to dimethyllysine.  This observation is consistent 
with the results from the hydrophobic mutations, which displayed a weakened binding 
affinity to both methylated peptides.  However, the unaltered binding affinity to the 
trimethyllysine implies that the negative charge of glutamate is not the major driving 
! *'!
force for recognition.  This observation was surprising because glutamate is able to form 
a favorable electrostatic interaction with the positively charged trimethyllysine, which 
was expected to be important for recognition.  Rather, the similar structures of glutamine 
and glutamate can be important for maintaining the integrity of the aromatic cage 
structure and the polarity of glutamine may be important for favorable solvation energy. 
The aromatic cage in a methyllysine recognition domain is important for 
maintaining selectivity for specific methylation states.  Several factors that are suspected 
to contribute to selectivity include the depth of the binding pocket and the composition of 
the aromatic cage.  While there appears to be some trends in binding pocket composition, 
for example more aromatic residues in the cage aids in the recognition of higher 
methylation states, the trends are not always consistent and not well understood.  
Understanding the factors that contribute to this selectivity is critical for understanding 
the readout of the Histone Code.  From these studies it has been demonstrated that 
introducing glutamine, which is a neutral polar residue with a structure similar to 
glutamate, is a successful method for enhancing the specificity of chromodomain for 
trimethyllysine 9 of the Histone H3 tail. 
E.  Experimental 
i.  Protein Expression and Purification 
The Khorasanizadeh Lab at the University of Virginia supplied the PET11a 
plasmid containing the coding region of Drosophila HP1! chromodomain (residues 17-
76) with an N-terminal 6-Histidine tag.10 Mutagenesis was carried out as described 
below.  The total reaction volumes were 50 µL with 1 µL DNA plasmid (~30 ng/µL), 1 
µL dimethyl sulfoxide (DMSO), 1 µL of forward and reverse primers (0.01 mmol), 2.5 
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µL dNTP mix (10 mM), 5 µL 5X PFU buffer, 36.5 µL dH2O, and 2 µL PfuUltra hotstart 
DNA polymerase (Strategene) was added last. The thermocycler settings are described in 
Table 3.4 and primers are given in Table 3.5.  The sequences were confirmed by next-
generation sequencing at the UNC core facility.  The DNA was expressed and isolated 
from DH5! E. coli cells using a Fermentas Genejet Plasmid miniprep kit.  E. coli BL21 
(DE3) gold cells were transformed with the plasmid and were grown on ampicillin-
containing plates at 37oC over night.  A colony was selected and grown in 100 mL LB 
with 50 mg/mL Amp overnight at 37oC.  The next morning 15 mL of the starter culture 
were added 1.5 L LB media with 50 mg/L ampicillin at 37 oC.  At A600=0.5-0.7, 0.1 mM 
IPTG was added to the cultures and the temperature was reduced to 18 oC overnight. The 
cells were harvested by centrifugation for 20 mins at 4500 rpm.  The cells were 
resuspended in approximately 30 mL NiA buffer (5 mM imidazole, 50 mM potassium 
phosphate, pH 7.4, 150 mM NaCl, 0.01% sodium azide) and stored at -80  oC. 
The cells were lysed and purified as described in Chapter II.  Representative 
figures of the wild-type chromodomain after purification are shown in Fig. 3.19A.  The 
protein was then dialyzed in 50 mM potassium phosphate pH 8.0, 25 mM NaCl.  If purity 
of the chromodomain proteins were less than 95% then the proteins were subsequently 
purified by size exclusion using an S75 superdex FPLC column at 4 oC.  The first 
chromodomain purified showed two proteins after FPLC purification (Fig. 3.19B).  There 
is a naturally occurring cysteine within HP1! chromodomain.  A sample of the purified 
protein was treated with reducing and denaturing agents to confirm that the impurity was 
due to dimerization, which can disrupted using DTT as described in the anisotropy 
experiments (Fig. 3.19C).    
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(A) 
 
(B) 
 
(C) 
 
Figure 3.19.  (A) Purity of HP1! chromodomain on a 15% SDS-PAGE after purification 
by Ni affinity chromatography.  (B) Purity of HP1! chromodomain on a 15% SDS-
PAGE after purification by size exclusion following Ni affinity.  (C) The disulfide bonds 
were reduced by adding the following denaturants to a small sample of purified HP1! 
chromodomain for SDS-PAGE analysis: (1) 2 mM DTT, (2) 100 mM DTT, (3) 1% Triton 
X-100, and (4) 4 mM urea. 
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Table 3.4.  Thermocycler conditions for Site-Directed Mutagenesis. 
Temperature (oC) Time Cycles 
Hot start: 95 30 sec 1 
Melt: 95 
Anneal: 60 
Extend: 68 
1 min 
1 min 
13 min 
5 
Melt: 95 
Anneal: 55 
Extend: 68 
1 min 
1 min 
10 min 
16 
Find extend: 72 5 min 1 
Pause: 4 hold  
 
Table 3.5.  The forward primers used for mutagenesis.  The site of mutation is in red. 
Mutant Primer Sequence 
E52F GGC TAT CCC GAA ACT TTT AAC ACG TGG GAG CCG 
E52W GGC TAT CCC GAA ACT TGG AAC ACG TGG GAG CCG 
E52V GGC TAT CCC GAA ACT GTG AAC ACG TGG GAG CCG 
E52L GGC TAT CCC GAA ACT CTG AAC ACG TGG GAG CCG 
E52I GGC TAT CCC GAA ACT ATC AAC ACG TGG GAG CCG 
E52D GC TAT CCC GAA ACT GAT AAC ACG TGG GAG C 
E52Q GC TAT CCC GAA ACT CAG AAC ACG TGG GAG C 
 
 
 
 
 
 
 
 
 
 
! *+!
ii.  Peptide Synthesis 
Histone tails (residues 1-15 of the H3 tail with a C-terminal tyrosine) were 
synthesized using automated solid phase peptide synthesis with a Thuramed tetras 
synthesizer on a 0.06 mmol scale.  Fmoc protected amino acids were used with a Wang 
resin from Peptides International, Inc.  Amino acid residues were activated with HBTU 
(O-benzotriazole-N,N,N’,N’,-tetramethyluronium hexafluorophosphate) and HOBT (N-
hydroxybenzotriazole) with DIPEA (diisopropylethylamine) in DMF (N,N-
dimethylformamide).  Amino acids were deprotected twice with 2% DBU (1,8-
diazabicyclo[5.4.0]undec-7-ene) and 2% piperidine in DMF for 15 mins each step.  Each 
amino acid was coupled on double cycles of 30 mins each to improve coupling.  Fmoc 
protected dimethyllysine was coupled at position 9, which was methylated before the 
final Fmoc-deprotection of the N-terminal alanine with 10.8 mL MTBD and 37.4 mL 
iodomethane in 5mL DMF and bubbled with N2 for 4-5 hrs.  The final Fmoc was cleaved 
with 2 washes with 20% piperidine for 15 mins each and 5(6)-carboxyfluorescein 
(Anaspec) was coupled using 2 equivalents of the fluorophore, HOBt, HBTU, and 
DIPEA and allowed to react overnight under nitrogen gas.  Cleavage of the peptides from 
the resin was performed in 95% trifluoroacetic acid (TFA), 2.5% H2O, 2.5% 
triisopropylsilane (TIPS) for three hrs.  The TFA was evaporated off by blowing the 
reaction with nitrogen.  Cold diethyl ether was used to precipitate the product.  The 
product was extracted with deionized water and subsequently lyophilized to a powder for 
HPLC.   
Peptides were purified by reversed-phase HPLC.  A waters semi-preparative 
HPLC system with an Atlantis Prep OBD dC-18 semi-preparative column was used for 
! *,!
separation with a gradient of 0% to 100% solvent B over 60 mins with solvent A (95:5 
water:acetonitrile, 0.1% TFA) and solvent B (95:5 acetonitrile:water, 0.1% TFA).  
Peptides were then lyophilized and the molecular weight of the peptide was confirmed by 
ESI-TOF mass spectrometry (Table 3.6).   
iii.  Circular Dichroism 
CD measurements were performed on an Aviv 62DS Circular Dichroism 
Spectrometer.  CD data was obtained for the chromodomain at 33.3 #M concentration in 
10 mM Na2HPO4, pH 7.4, 2 mM DTT.  Wavelength scans were performed in triplicate 
and averaged.  Scans were performed at 25 oC from 260-185 nm.  All scans were 
corrected by subtracting the spectrum of the buffer used in the experiment and the signal 
was converted to Mean Residue Ellipticity (MRE) using Eq. 3.1.  Where signal refers to 
circular dichroism signal, l is path length in cm, c is concentration in M, and r is the 
number of amino acid residues. 
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3Thermal denaturation experiments were preformed using the same buffer and 
concentrations as described above and measurements were taken between 275 and 366 K.  
The melting curves were normalized to show the fraction folded using Eq. 3.2 where!12!
is MRE,! 1D! is the MRE for the fully denatured protein, and $F is MRE for the fully 
folded protein!
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iv.  Anisotropy 
Binding assays were performed using a POLARstar Omega microplate reader 
using untreated 96 half area flat bottom plates.  Chromodomain was prepared by making 
serial 1:2 dilutions in the 0 to 600 µM range and mixed by pipetting 15 times while 
avoiding adding any air bubbles.  The samples were centrifuged for 1 minute at 4000 rpm 
to draw any particulates to the bottom and removed air bubbles.  A 2 µM stock of H3 
K9Me2/3 was prepared (&492=78,000 cm
=1M-1) in 50 mM potassium phosphate buffer, pH 
8, 25 mM NaCl, 8mM DTT.  The chromodomain and peptide were mixed in the 
microplate with 50 µL of chromodomain and 50 µL of peptide.  This reduced the 
concentration of peptide, DTT, and chromodomain by half (1 µM peptide, 4 mM DTT, 0 
µM to 300 µM chromodomain).  The samples were mixed by pipetting them ten times 
while introducing as few air bubbles as possible.  The samples were centrifuged for 1 
minute at 4000 rpm to remove any air bubbles and allowed to reach equilibrium for 30 
mins prior to analysis at 25 oC. Measurements were taken with an excitation wavelength 
of 485 nm and an emission wavelength at 520 nm.  The data was fitted using Eq. 2.3.  
The fraction of chromodomain bound was calculated using Equation 2.4.  The data was 
re-plotted as fraction bound as a function of chromodomain concentration to give the 
final data as shown in Fig. 3.6.  The binding energy ($Go) was calculated using equation 
3.3: 
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Table 3.6.   Mass spectrometry data for the peptides synthesized for this study. 
Peptide Expected Mass (Da) Experimental Mass (Da) 
H3 K9Me2 2109.0 2110.0 
H3 K9Me3 2124.1 2124.7 
 
v. Isothermal Titration Calorimetry 
ITC was performed using a Micro Cal VP-ITC.  The dialysis buffer (50 mM 
potassium phosphate pH 8, 25 mM NaCl) that had been used to dialyze chromodomain 
was also used for ITC with 2 mM DTT subsequently added.  Desalted and lyophilized H3 
K9Me3 peptide was dissolved in the same buffer, also with 2 mM DTT to obtain a 
concentration of 947 µM histone tail peptide and degassed for 10 mins.  Measurements 
were made using 55 automatic injections of 5 µL peptide into 50 mM chromodomain at 
25 oC with 3 mins between injections. The heat of dilution was measured by titrating 
peptide into buffer and subtracted from the raw data.  The curves were analyzed with the 
Micro Cal software using a non-linear least squares fitting. 
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Chapter IV 
#-SHEET INTERACTIONS BETWEEN HP1! CHROMODOMAIN AND 
TRIMETHYLLYSINE 9 OF HISTONE H3  
 
A.   Background 
i.  Read-out of Trimethyllysine 9 of Histone H3 by HP1!  chromodomain 
Methylation of the Histone H3 protein at various lysine residues is among the 
most important and complex modifications.1 For example, trimethyllysine 9 of histone 
H3 (H3 K9Me3) is a modification that recruits the effector protein, heterochromatin 
protein 1 (HP1) via the highly conserved chromodomain.2-5 Once recruited to the 
nucleosome, HP1 is believed to prevent gene expression by condensing DNA into tightly 
packed and genetically silent heterochromatin.6   
However, there are a wide variety of other effector proteins containing 
chromodomains that recognize methyllysine marks and they can have opposing effects on 
gene expression.  The mode of sequence selectivity of effector proteins for different 
methylated lysine residues has been difficult to elucidate due to the high sequence 
homology between different chromodomains and the sequences surrounding 
methyllysines on histone tails (Fig. 4.1).7  
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(A) 
 
(B) 
N-terminus-ARTKQTARK(Me3)STGGKAPRKQLATKAARK(Me3)SAPATGGVK… 
Figure 4.1. (A) Sequence alignment of chromodomains from Drosophila (Dm) HP1! 
and polycomb proteins and the corresponding human (Hs) isoforms.  The conserved 
residues are highlighted in black and the similar residues are highlighted in grey.  The 
aromatic residues that make up the cage are highlighted in yellow.  Ala25 and Asp62 
of HP1! chromodomain, which make up the binding region, and the corresponding 
residues in the isoforms are highlighted in red (NCBI Accession numbers in the order 
that each sequence is listed are: AAF52618, CAG33047, NP_009207, CAG33699, 
NP_524199, CAA54839, AAH14967, NP_055107, CAQ07275, NP_065700).   (B) 
Residues 1-36 of the Histone H3 tail.  The residues surrounding Lys9 and Lys27 are 
highlighted in yellow and green respectively. 
 
Crystallography and NMR studies of the HP1! chromodomain bound to the H3 
K9Me3 tail have been used to understand the nature of the interactions between the 
chromodomain and trimethylated histone tail.2  The binding of H3 K9Me3 by the 
chromodomain is mediated by two modes of recognition.  The first is the cation-" 
interaction between the trimethyllysine 9 of the Histone H3 tail and a three-member 
aromatic cage of the chromodomain.8 The second is the formation of an anti-parallel 
three-stranded #-sheet motif with four amino acids surrounding Lysine 9 of the Histone 
H3 tail (TARK9S) as the central strand and two #-strands of the chromodomain as the 
edge strands (Figure 4.2).  Van der Waals contacts between side chains and H-bonds 
between the amide backbones of the chromodomain and histone tail are key for 
selectivity and for stabilizing the complex.7, 9  
! +)!
(A) 
 
 (B) 
 
Figure 4.2. (A) Pymol representation of the crystal structure of HP1! chromodomain  
(green) in complex with H3 K9Me3 histone tail (yellow) with the backbone H-bonds in 
red.  (B)!#-strands of the chromodomain and histone tail with the H-bonds between the 
backbones shown by dashes.  The Ala25 and Asp62 of chromodomain are highlighted 
in green and Thr6 of the histone tail is highlighted in yellow.2!
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ii.  #-Sheet Structure 
Applying the factors that contributed to #-sheet stability to understanding the 
selectivity of the HP1! chromodomain for H3 K9Me3 is a method that has not yet been 
considered for understanding the chromodomain-histone tail complex.  A #-sheet can 
either be parallel with the N-termini of two strands aligned or the antiparallel motif with 
the C-terminus of one strand aligned with the N-terminus of the other, which is observed 
in the histone tail-chromodomain complex (Fig. 4.2).   
In the anti-parallel #-sheet there are two type of positions referred to as the non-
hydrogen bonded (NHB) site and the hydrogen bonded (HB) site (Fig. 4.3).  In the NHB 
site the amide backbone of two cross-strand amino acids are not involved in H-bonds. 
The NHB and HB sites have significant differences that influence which amino acids are 
favored in those sites.  First, the !-carbons in HB sites are separated by 5.5 Å while !-
carbons in NHB are only separated by 4.5 Å.  Second, rotamer conformations differ 
significantly in the two sites, which influences which residues have a higher preference in 
the NHB versus HB sites.10, 11   
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                (A) 
 
                (B) 
 
Figure 4.3.  (A) An example of both a parallel and antiparallel #-sheet structure with 
the NHB and HB sites of the antiparallel strands. (B) Side view of an antiparallel #-
hairpin with the amino acid side chains depicted as “R”. 
 
Extensive research has been performed to establish what amino acids have the 
highest propensity in #-sheets and which are the most stabilizing.  Early statistical 
analyses were performed using structures from the Protein Data Bank to measure the 
distribution of amino acids in #-sheets.  Amino acids with #-branched or aromatic side 
chains were shown to have the highest #-sheet propensity.  Amino acids that are small, 
conformationally restrictive (proline), or charged had the lowest propensity.12, 13 Wouters 
! +,!
and Curmi also performed statistical correlation analysis to determine which cross-strand 
amino acids are preferred in the HB or NHB sites.  One important finding demonstrated 
that #- and (-branched amino acids are most commonly found in NHB sites.11  
Smith and Regan measured interaction energies between cross-strand amino acid 
pairs by making pair-wise mutations to the B1 domain of Streptococcal protein G in an 
solvent-exposed HB site.14 Their findings corroborated the initial statistical analysis 
showing that pairs composed of #-branched and aromatic residues had the most favorable 
interaction energy and favorable charge-charge interactions between side chain pairs 
were the least stabilizing.14 
Previous studies involving #-hairpins have shown that "-" interactions between 
two cross-strand aromatic residues, such as two Trp 15 and two Phe residues,16 are highly 
stabilizing.  The cation-" interaction of Trp and Phe with Lys and Arg is another 
favorable cross-strand interaction.17   
B. Goal 
Herein we have substituted naturally occurring amino acids at the A25 position of 
HP1! chromodomain, the T6 position of H3 K9Me3, and  the D62 position of HP1! 
chromodomain for those with higher #-sheet propensity.  We also incorporated known 
favorable cross-strand pairs into the D62 and A25 sites.  The purpose of this research is 
three-fold.  First is to evaluate the selectivity of the recognition domain for H3 K9Me3, 
the second is to determine whether binding can be optimized by mutating residues within 
the chromodomain and histone tail peptide.  The third goal is to measure how previous 
studies from #-sheet models and statistical studies compare in the context of protein-
protein recognition and the HP1! chromodomain-H3 K9Me3 complex provides a simple 
! ,.!
model to meet this end.  6<=!>=?@AB?!C>DE!B<=?=!?B@F"=?!F=EDG?B>HB=!<DI!"GCD>EHB"DG!
HJD@B! #/?<==B! K>DK=G?"BL! HGF! ?BHJ"A"BL! C>DE! ?BHB"?B"M?! HGF! EDF=A! ?L?B=E?! MHG! J=!
HKKA"=F!BD!H!J"DADN"MHAAL!>=A=#HGB!?L?B=E!BD!EHG"K@AHB=!K>DB="G/K>DB="G!>=MDNG"B"DG0!
C. Results 
i. Experimental Design  
The #-sheet interactions between H3 K9Me3 and the HP1! chromodomain were 
explored using a number of trimethyllysine 9 Histone H3 tail peptides with mutations to 
the Thr6 position and HP1! chromodomain proteins with mutations to either the Ala25 
or Asp62 positions.  The Thr6 residue of the histone tail was chosen because alanine 
scans have demonstrated its significance in binding and sequence selectivity.  The 
threonine is also solvent exposed and does not make significant contacts with the interior 
of the protein.  The Ala25 and Asp62 positions were chosen, in part, due to their cross-
strand location from Thr6 in the binding pocket.  These two residues in the 
chromodomain were also ideal because they are not known to have high #-sheet 
propensity or to form particularly favorable cross-strand interactions with threonine.  
Sidechain-sidechain (SC-SC) interactions vary depending on whether residues are in the 
NHB or HB positions.11, 13 Since the Ala25-Thr6 and Thr6-Asp62 pairs occur in NHB 
and HB positions respectively, the histone tail-chromodomain complex is an ideal system 
to further explore which interactions are preferred in each position.  Additionally, they 
are solvent exposed residues that appear to form minimal contacts with other amino acids 
within the chromodomain or histone tail.  Therefore these residues were mutated to those 
with higher #-sheet propensity such as #-branched residues including isoleucine and 
threonine and the aromatic residue, phenylalanine. Mutations were also incorporated to 
! ,-!
include amino acid residues known to form favorable SC-SC interactions including 
hydrophobic packing, H-bonding, cation-", and ")" interactions.  By incorporating 
amino acids known to stabilize #-sheet structure into the HP1! chromodomain and 
histone, the #-sheet-mediated interaction between the two molecules should be stabilized.   
ii. Structural Characterization 
Circular dichroism experiments were used to investigate the effect that various 
mutations had on global structure of the chromodomain.  Since the signal from the !-
helix at 208 nm and 222 nm was expected to mask any signal from #-sheet structure at 
210 nm, only two minima at 208 nm and 222 nm were expected to be observed.18 These 
minima are present and similar in the spectra of the Ala25 chromodomain mutants (Fig. 
4.4).  The global structures of the Asp62 mutants deviate more from the wild-type 
chromodomain, but still have the strong minima at 208 nm and 222 nm and the exciton 
coupling peak at 232 nm, which arises from interactions between aromatic residues in the 
aromatic cage (Fig. 4.5).  Thus, there appears to be no significant alteration in the global 
structure due to the various mutations. 
 
 
 
! ,%!
 
Figure 4.4.   Circular dichroism spectra comparison of HP1! chromodomain to the 
Ala25 mutants at 25 oC in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  These 
are the averages of three runs. 
 
 
Figure 4.5.   Circular dichroism spectra comparison of HP1! chromodomain to the 
Asp25 mutants at 25 oC in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  These 
are the averages of three runs. 
 
Thermal denaturation profile of the HP1! chromodomain and the mutants were 
monitored by circular dichroism at 222 nm to determine how the different point 
mutations affected the overall stability of the chromodomain.  Exploring the stability of 
the chromodomain and the five mutants is very relevant to the research because it is 
/-%...!
/-....!
/+...!
/)...!
/'...!
/%...!
.!
%...!
'...!
)...!
+...!
%..! %-.! %%.! %&.! %'.! %(.! %).!
?
@
A
!"
#
$
%
!&
'
+(
!#
'
)
*+
,
-!
./0$*$1%23!"1'-!
56!
O%(8!
O%(P!
O%(Q!
O%(6!
/-%...!
/-....!
/+...!
/)...!
/'...!
/%...!
.!
%...!
'...!
%..! %-.! %%.! %&.! %'.! %(.! %).!
?
@
A
!"
#
$
%
!&
'
+(
!#
'
)
*-
1
-!
./0$*$1%23!"1'-!
56!
4)%8!
4)%9!
4)%P!
4)%6!
! ,&!
necessary to confirm that any decreases in binding affinity are not due to the instability of 
the protein.  It is also important to confirm whether any improvement in binding affinity 
is due to an increased stability of the mutant chromodomains is a result of favorable 
interactions between the histone tail and the non-native amino acid residues in the Asp62 
or Ala25 positions.  The melting temperature of the wild-type protein was measured to be 
approximately 47 oC (Fig. 4.6, Fig. 4.7, Table 4.1).  Each of the mutants had a melting 
temperature between 45 oC and 49 oC, clearly showing that the various point mutations 
resulted in an insignificant effect on global stability.  This experiment also indicates that 
wild-type and mutant chromodomains are thermally stable at 25 oC, the temperature at 
which all subsequent binding experiments were carried out.   
Thermal denaturation and renaturation experiments were also carried out to 
demonstrate that once denatured, mutant chromodomain are able to refold equally as well 
as the wild-type protein (Fig. 4.8). Only D62I and A25K mutants were used in these 
experiments as representatives of the other Asp62 and Ala 25 mutants.  As expected, 
once denatured, the chromodomain is not able to fully refold into its native structure.  
However about 80% of the protein refolds as do the mutant chromodomains.  Once again, 
these experiments confirm that the mutant proteins are as stable as the wild-type protein. 
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Figure 4.6.   Thermal denaturation curves monitored by circular dichroism at 222 nm 
of HP1! chromodomain Ala25 mutants in 10 mM sodium phosphate pH 7.4 with 2 
mM DTT.   
 
 
Figure 4.7.   Thermal denaturation curves monitored by circular dichroism at 222 nm 
of HP1! chromodomain Asp62 mutants in 10 mM sodium phosphate pH 7.4 with 2 
mM DTT. 
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Table 4.1.  Approximate melting temperatures of HP1! chromodomain Ala25 and 
Asp62 mutants determined using the thermal denaturation data highlighted in Fig. 4.5 
and Fig. 4.6.  
HP1! chromodomain mutants Tm ( 
oC) 
Wild-type 47 
A25F 47 
A25K 47 
A25L 48 
A25T 47 
D62F 45 
D62I 45 
D62K 48 
D62T 48 
 
 
Figure 4.8. Thermal denaturation and renaturation curves monitored by circular 
dichroism at 222 nm of wild-type HP1! chromodomain and the D62I and A25K 
mutants in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  The solid line indicates 
denaturation while the dotted line indicates renaturation 
 
iii.  Native Chromodomain-Histone Tail Binding 
The dissociation constants between chromodomain and histone tail were 
measured using fluorescence anisotropy.  In previous binding studies, which were 
performed at 15 oC, a KD value of 10 µM was measured for the HP1! chromodomain and 
H3 K9Me3.
8 However, the PolarStar platereader used in the Waters lab is unable to take 
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measurements below a temperature of 25 oC.  Therefore, a new dissociation constant 
between the native histone tail and HP1! chromodomain was measured at 25 oC and was 
determined to be 17 µM.  This decrease in binding affinity was expected based on 
previous binding studies between HP1! chromodomain and monomethyllysine 9 Histone 
H3 tail, which demonstrated a decrease in binding affinity when the temperature was 
raised from 15o C to 25o C.19 
iv.  Mutations to H3 K9Me3 at T6 with Wild-Type Chromodomain 
Jacobs et al. previously reported alanine scans of H3 K9Me3 and found that T6A 
hindered binding by 7-fold, which was proposed to be due to loss of complementary 
interactions between the larger threonine residue and the chromodomain.2 However, no 
other mutations were explored to examine the scope of the selectivity between the 
chromodomain and H3 K9Me3.   Hence, Thr6 was replaced with four other amino acids 
know to have high #-sheet propensity including lysine, isoleucine, phenylalanine and 
leucine which were expected to make favorable SC-SC interactions with A25 and D62 as 
well as the other chromodomain mutants (Fig. 4.9). 
 
! ,*!
 
Figure 4.9. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail T6 mutants with wild-type chromodomain.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM 
DTT at 25 °C. Each curve is an average of 3 runs. 
 
Interestingly, none of the four point mutations had a significantly negative effect 
on binding to the wild-type chromodomain.   The T6K histone tail had a slightly 
improved binding constant to the native chromodomain (10 µM versus 17 µM, 
respectively).  Complementary charged residues in a #-sheet are known to have a 
favorable side-chain interaction in the H-bonded (HB) site of a #-sheet.14,11  In this case, 
having a basic lysine cross-strand from aspartic acid, which is an HB site, may result in a 
favorable electrostatic interaction.  Additionally, the long hydrophobic chain of lysine 
can form van der Waals contacts with Ala25.  The other amino acids substituted into the 
T6 position of the histone tail also have hydrophobic character, potentially allowing them 
to maintain similar packing interactions within the binding pocket that T6A could not.  A 
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recent study demonstrated the mammalian HP1! chromodomain, which has 70% 
homology to Drosophila HP1! chromodomain, is more promiscuous than previously 
believed and recognizes dimethyllysine27 of histone H1.4.20 The sequence surrounding 
K27 of H1.4 is KARK(me)3S as opposed to TARK(me)3S.  From these studies it is 
evident that drosophila HP1! can interact with other methyllysine marks in vitro and 
may be able to do so in vivo as well. 
v.  Chromodomain Mutations at A25 with Wild-Type H3 K9Me3 
Four point mutations to the Ala25 position were studied, which include A25F, 
A25K, A25L, and A25T (Fig. 4.10, Table 4.2).  As expected, A25F, A25L, and A25T 
had either similar or more favorable binding affinities than the native chromodomain.  
The residues, Phe, Leu, and Thr have all been shown statistically to have higher #-sheet 
propensities and are thermodynamically favored in #-sheets over alanine (Table 4.3).12,21  
Incorporating residues known to have a stabilizing effect on #-sheet structures may also 
stabilize the three-stranded #-sheet formed when chromodomain binds to the histone tail. 
However, the A25K mutant chromodomain was shown to hinder binding to the histone 
tail peptide, which will be discussed in further detail below. 
 
! ,,!
 
Figure 4.10.   Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with Ala25 mutants.   The experiments were performed in 50 mM 
potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each 
curve is an average of 3 runs.  
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Table 4.2.  Dissociation constants (µM) of Drosophila HP1! chromodomain and H3 K9Me3 and the 
mutants with R2 value given in parenthesis.  The $Go values are given in brackets (kcal/mol) and were 
calculated using the following equation: $Go=-RTln(KD).  The data was measured in 50 mM potassium 
phosphate buffer (pH 8.0), 25 mM NaCl, with 4 mM DTT at 25 oC. 
Histone Tail 
Chromodomain 
WT T6K T6I T6F T6L 
WT 
17±3 (0.994) 
[-6.5±0.1] 
10±1 (0.998) 
[-6.8] 
27± 5(0.993) 
[-6.2] 
20±2 (0.996) 
[-6.4] 
24±4 (0.996) 
[-6.3] 
A25F 
14±1 (0.999) 
[-6.6] 
16±1 (0.999) 
[-6.5] 
46±5 (0.997) 
[-5.9] 
66±6 (0.998) 
[-5.7] 
33±4 (0.998) 
[-6.1] 
A25K 
77±8 (0.997) 
[-5.6] 
253±33 (0.998) 
[-4.9] 
180±26 (0.997) 
[-5.1] 
203±18 (0.999) 
[-5.0] 
376±72 (0.996) 
[-4.7] 
A25L 
17±1 (0.999) 
[-6.5] 
13±3 (0.991) 
[-6.7] 
19±2 (0.997) 
[-6.4] 
26±4 (0.995) 
[-6.2] 
26±6 (0.990) 
[-6.2] 
A25T 
9±1 (0.998) 
[-6.9] 
10±1 (0.998) 
[-6.8] 
47±5 (0.996) 
[-5.9] 
64±5 (0.998) 
[-5.7] 
44±3 (0.999) 
[-5.9] 
D62F 
6±1 (0.995) 
[-7.1] 
12±2 (0.997) 
[-6.7] 
24±4 (0.996) 
[-6.3] 
13±2 (0.995) 
[-6.7] 
28±3 (0.995) 
[-6.2] 
 D62I 
37±3 (0.999) 
[-6.0] 
46±5 (0.998) 
[-5.9] 
48±4 (0.990) 
[-5.9] 
108±20 (0.992) 
[-5.7] 
45±13 (0.989) 
[-5.9] 
 D62K 
9±2 (0.990) 
[-6.9] 
30±3 (0.998) 
[-6.2] 
17±3 (0.994) 
[-6.5] 
16±2 (0.996) 
[-6.5] 
10±1 (0.996) 
[-6.8] 
 D62T 
39±4 (0.997) 
[-6.0] 
58±8 (0.996) 
[-5.8] 
76±11 (0.996) 
[-5.6] 
138±20 (0.996) 
[-5.3] 
26±5 (0.993) 
[-6.2] 
 
Table 4.3.  #-Sheet forming propensities of amino acids relevant to this study.  
Amino Acid Statisticala B1b 
Ile 1.67 -1.25 
Phe 1.33 -1.08 
Leu 1.22 -0.45 
Thr 1.17 -1.36 
Ala 0.72 0 
Lys 0.69 -0.35 
Asp 0.39 0.85 
a The normalized frequencies of each amino acid in a #-sheet.12   
b$$G333K (kcal/mol) of amino acid residues relative to alanine when substituted into 
position 53 of the B1 domain of Staphylococcal IgG binding protein G.21 
 
 
 
 
! -.-!
 
vi. Chromodomain A25K Analyzed by the Double-Mutant Cycle 
One interesting chromodomain mutant was A25K, a mutation that inhibited 
binding to every histone tail peptide.  Lysine is known to have a high #-sheet propensity.  
Additionally, lysine residues can participate in favorable cation-" interactions, which can 
stabilize #-hairpins and #-sheets.  Therefore, the A25K mutation to the chromodomain 
was expected to enhance binding to the T6F histone tail.  However, the dissociation 
constants of A25K to the native and T6F histone tail were 77 µM and 203 µM, 
respectively.  Additionally, the dissociation constants to the other histone tail T6 mutants 
were at least an order of magnitude greater than the native chromodomain (Fig. 4.11, 
Table 4.1). 
 
 
 
Figure 4.11. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail (wild-type and T6F) with chromodomain (wild-type and A25K).   
The experiments were performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM 
NaCl, and 4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
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Two possible explanations can account for the drastic decrease in binding affinity.  
First, the incorporation of a basic residue into the chromodomain may have resulted in an 
electrostatic repulsion with the histone tail, which is a highly basic peptide.  For example, 
R8 of H3 may be involved in a charge-charge repulsion with A25K.  Second, there is a 
highly conserved lysine at position 46, which is in a loop region of the chromodomain.  
The K46 is also cross-strand from A25K and neighbors the aromatic residues that form 
the cage around K9 of the histone tail (Fig. 4.12).  A charge-charge repulsion may disrupt 
this region of the chromodomain and may be responsible for the weakened binding 
affinity to the histone tail peptides.  To address this question a double-mutant cycle was 
used to determine unfavorable or favorable interaction energy between A25K and K46 on 
binding to the H3 K9Me3 peptide (Fig. 4.13).
22 This study cannot be used to investigate 
interaction energies between R8 and A25K because R8 is required for binding, which 
will be addressed later in this chapter. 
A double-mutant cycle is a common technique used to measure the interaction 
energy between two amino acids of interest, which can either be in the same protein or be 
involved protein-protein recognition.22 In a double-mutant cycle each amino acid is 
individually mutated to an amino acid that is not expected to be involved in stabilizing or 
destabilizing interactions with the other amino acid.  This change may still have an effect 
on the stability of the protein and, therefore, both amino acids are mutated to create the 
double-mutant.  Performing a double mutation should correct for any effects the single 
change may have had.  If the two residues are not coupled, then the free energy of the 
native protein equals the energy of the double-mutant minus the energies of the single 
! -.&!
mutants.  If the residues are coupled then a change in the free energy will be observed.22, 
23  
To measure the interaction energy between K46 and A25K, the residues were 
individually changed to alanine and then the double-mutant was constructed to complete 
the cycle.  The sum of the energies from chromodomain A25K/K46 and A25/K46A 
minus the sum of A25/K46 and A25K/K46A gives the interaction energy between A25K 
and K46. The data from the double-mutant cycle was highly unanticipated.  For a double-
mutant cycle to be effective, replacing two interacting residues with two non-interacting 
residues should account for any perturbation a single mutation has on the system.  This 
way the $$G between two residues of interest can be calculated.  In this study if K46 and 
A25K have a repulsive interaction then changing K46 to alanine should improve binding.  
Since two cross-strand alanine side chains are not involved in non-covalent interactions, 
the chromodomain A25/K46A mutant should slightly recover binding, but not enhance 
binding compared to the native chromodomain.  Here, the K46A mutation significantly 
improved binding by nearly an order of magnitude (KD=2 µM) and was in fact the best 
binder of all chromodomain mutants.  The double mutation A25K/K46A mutation 
recovered the binding affinity of the chromodomain A25K mutant and corrected for the 
effects of the single mutants (Fig. 4.14, Table 4.4).  The calculated $$G between A25K 
and K46 was calculated to be -0.1 kcal/mol, which is within error of 0 kcal/mol 
indicating a minimal interaction between A25K and K46.  Therefore, the A25K mutant 
may weaken binding due to a charge-charge repulsion with the basic histone tail. 
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Figure 4.12.  Structure depicting the chromodomain (silver) bound to histone tail 
(yellow).  Residues K46, A25, and D62 are shown in green (PDB: 1KNE). 2 This 
structure was generated using PyMol. 
 
 
Figure 4.13. Depiction of the double-mutant cycle used to measure the interaction 
energy between A25K and K46 of the HP1! chromodomain and the histone tail. 
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Figure 4.14. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 wild-type histone tail with chromodomain for the A25K/K46 double-mutant 
cycle.   The experiments were performed in 50 mM potassium buffer pH 8.0, 25 mM 
NaCl, and 4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
 
Table 4.4. Fluorescence anisotropy binding data from Fig. 4.21 for the HP1! 
chromodomain A25K/K46 double-mutant cycle.  The KD values are in µM with R
2 in 
parenthesis.  The $G values are given in brackets (kcal/mol) and were calculated using 
the following equation: $Go=-RTln(KD)The experiments were performed in 50 mM 
potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each curve 
is an average of 3 runs. 
chromodomain mutants H3 K9Me3 WT 
A25K/K46 
77±8 (0.997) 
[-5.6] 
A25/K46 (wild-type) 
17±3 (0.994) 
[-6.5] 
A25K/K46A 
11±2 (0.991) 
[-6.8] 
A25/K46A 
2±0.5 (0.991) 
[-7.8] 
 
NMR studies by Jacobs and coworkers demonstrated the region in which K46 to 
have a minimal change in {1H}–15N NOE values between the bound and unbound state, 
which demonstrates the importance of pre-organization of chromodomain when binding 
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to H3 K9Me3.  Alanine is also known to be residue with the highest !-helix propensity 
compared to other amino acids including lysine.24 Since K46 occurs between a #-strand 
and short !-helix (Fig. 4.12), it may be that replacing lysine with alanine altered the 
structure of the random-coiled region, which may improve binding affinity.   
To address this question, circular dichroism studies were performed to ascertain 
how the K46A mutation affected both the global structure and thermal stability of HP1! 
chromodomain (Fig. 4.15, Fig. 4.16).  The global structures of the proteins that were used 
in the double-mutant cycle are all consistent with distinct minima at 208 nm and 222 nm 
and a maximum at 232 nm.  The A25K/K46A mutant gives a slightly enhanced signal 
compared to the other three.  The thermal denaturation experiments showed that the 
A25K mutant and the A25K/K46A mutant have melting temperatures similar to the wild-
type protein.  However, the K46A mutant has a melting temperature about 9 oC lower 
than the wild-type chromodomain (Fig. 4.16, Table 4.5).  These results suggest that there 
is one of two possibilities.  First, any change in conformation near the binding pocket of 
chromodomain due to the K46A mutation is too subtle to be detected by circular 
dichroism.  Second, the K46A mutation may not enhance the stability of the 
chromodomain, but instead affect conformation or molecular interactions with the histone 
tail peptide by replacing a basic amino acid with a neutral one. 
! -.*!
 
Figure 4.15. Circular dichroism spectra of HP1! chromodomain (wild-type and 
A25/K46 mutants) to for A25K/K46 double-mutant cycle at 25 oC in 10 mM sodium 
phosphate pH 7.4 with 2 mM DTT.  These are the averages of three runs. 
 
 
Figure 4.16. Thermal denaturation monitored by circular dichroism (222 nm) of HP1! 
chromodomain (wild-type and A25/K46 mutants) to for A25K/K46 double-mutant cycle 
at 25 oC in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  These are the averages of 
three runs. 
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Table 4.5.  Approximate melting temperatures of HP1! chromodomain wild-type and 
A25/K46 mutants determined using the thermal denaturation data highlighted in Fig. 
4.16.  
chromodomain mutants Tm (
 oC) 
Wild-type 47 
A25K/K46 48 
A25K/K46A 45 
A25/K46A 38 
 
vii. Chromodomain Mutations at D62 with Wild-Type H3 K9Me3 
The mutations to the D62 position of the chromodomain that were studied include 
D62F, D62I, D62K, and D62T (Fig. 4.17, Table 4.2).  The only mutant that had a weaker 
binding to the native histone tail was D62I (37 µM versus 17 µM for the wild-type).  
Despite isoleucine having a higher #-sheet propensity compared to aspartate, 
incorporating a hydrophobic residue to the most solvent exposed strand of the 
chromodomain-histone tail complex results in weaker binding.  This may be a result of 
unfavorable solvation energy or a steric clash with T6. 
Unlike A25K, the D62K mutation improved binding to the native histone tail by 
2-fold compared to the wild-type chromodomain. The difference between affinities of 
A25K and D62K may be explained because the exposed basic amine of lysine is readily 
solvated rather than forming unfavorable charge-charge repulsion with basic residues on 
the histone tail such as R8.   
The improved binding affinity of D62K compared to the wild-type chromodomain 
for H3 K9Me3 is consistent with previous thermodynamic studies by Smith and Regan. 
21 
Lysine was shown to have a significantly higher #-sheet propensity compared to aspartate 
with a $$G of -1.1 kcal/mol when measured in an HB site.  Additionally, the alkyl chain 
of lysine may be able to form a hydrophobic packing interaction with threonine.  
! -.,!
Interestingly, a phenylalanine mutation at the D62 position favors binding to the 
histone tail by approximately 3-fold, with a KD of 6 µM (Fig. 4.17).  There are a number 
of factors that may contribute to this observed improvement.  Aromatic residues such as 
phenylalanine have been shown in both statistical, mutational, and hairpin studies to have 
a significantly higher #-sheet propensity than aspartate.13,14,25  Additionally, previous 
research has demonstrated the stabilizing effects of a diagonal cation-" interaction in #-
hairpins.17,26  In the chromodomain-histone tail complex, D62 is in a diagonal cross-
strand position from R8 of the histone tail and may form a cation-" interaction, which can 
stabilize the complex.  A double-mutant cycle to determine the interaction energy with 
D62F and R8 of the histone tail was not possible due to the importance of R8 for binding. 
 
 
Figure 4.17. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with Asp62 mutants.   The experiments were performed in 50 mM 
potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each 
curve is an average of 3 runs. 
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viii.  Trends Between Mutant Chromodomain and Histone Tails 
There are some general trends between mutant chromodomain and mutant histone 
tails.  For example, A25F and A25T both had similar binding affinities for the wild-type 
histone tail and the T6K histone tail.  However, binding affinity is less favorable when a 
bulky or #-branched residue is substituted in the T6 position of the histone tail.  Steric 
clash is a likely explanation for the decrease in affinity.  The D62T and D62F mutations 
have very different trends, which will be discussed in detail below. 
ix. Orientation of Cross-Strand Pairs 
Extensive consideration has previously been given to the orientation of cross-
strand amino acids residues.  It is evident from mutational studies to the B1 domain of 
Streptococcal protein G and in #-hairpin model systems that reversing the cross-strand 
positions of two amino acids significantly decreases the stability of the protein.14,27  This 
is an observation that was further explored by investigating the effects of amino acid 
orientation in the HP1! chromodomain and histone tail complex. 
The results indicate that reversing the orientation of two residues has a drastic 
effect on the binding of the histone tail by the chromodomain.  The previous study using 
the B1 domain explored Thr-Phe cross-strand pairs and the interaction energies improved 
when threonine was located on the N-terminal #-strand and phenylalanine on the C-
terminal #-strand.  However, when positions were reversed the $G was disfavored by 
0.55 kcal/mol.  This discrepancy in interaction energy was credited to differences in local 
geometry around each amino acid.14   
In the case of the chromodomain-H3 K9Me3 complex, the chromodomain D62F 
mutant improved binding by 3-fold as previously discussed (Fig. 4.18).  However when 
! ---!
the orientation of the Thr and Phe residues was reversed (D62T/T6F), the dissociation 
constant increased to 138 µM ($$G=1.8 kcal/mol). This measurement is consistent with 
the loss of a diagonal cation-" interaction between D62F and R8 of the histone tail that 
occurs by reversing the positions of the Thr and Phe residues (Fig. 4.19).  Additionally, 
there is probably a steric clash due to rotamer preferences of the D62T and T6F.  An 
interaction of this type may not be visible between the T6F mutant and the native 
chromodomain if there is a favorable electrostatic interaction between R8 and D62, 
which is lost when D62 is mutated to a threonine.  Additionally, incorporating a bulky 
amino acid such as phenylalanine in a central #-strand has been suggested to result in 
steric crowding.11 
Consistent with the D62F/T6 pair, the A25F/T6 pair was favored relative to the 
A25T/T6F pair by a factor of four ($$G=0.9 kcal/mol) (Fig. 4.18).  Thus, based on the 
studies involving the D62F/T and A25F/T mutants, the intrinsic #-sheet forming 
propensities of the amino acid residues are not the only contributing factors to the 
formation of the chromodomain-histone tail complex.   The interactions of the amino 
acids with neighboring residues and water molecules must play an important role as well, 
as has been shown in other systems.28 
! --%!
 
Figure 4.18. Comparison of the various fluorescence anisotropy binding experiments of 
5(6)-Fam-labeled H3 K9Me3 with chromodomain, focusing on Thr/Phe pairs. 
Experiments were done in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, 
and 4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
 
 
Figure 4.19.  PyMol image of H3 K9Me3 (yellow) bound to HP1! chromodomain D62F 
(green).  The conformation of D62F represents the context dependent preferred rotamer 
and does not reflect an energy-minimized structure (PDB 1KNE). 
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A double-mutant cycle was used to measure the interaction energy between D62F 
and R8 to determine whether they are involved in a cation-" interaction.  In a double-
mutant cycle, the two residues of interest are systematically mutated for an amino acid 
that should have little to no effect on interaction energy.  To complete the cycle both 
residues are mutated (Fig. 4.20).   
 
 
Figure 4.20.  Depiction of the double-mutant cycle used to measure the interaction 
energy between R8 of the histone tail and D62 of the chromodomain. 
 
The results from the double-mutant cycle proved to be inconclusive.  Due to the 
significance of R8 in the histone tail in chromodomain recognition, binding to the R8A 
mutant was severely inhibited (Fig. 4.21, Table 4.6).  As shown in Table 4.3, both the 
D62A and D62F chromodomain mutants had a KD of over 200 µM to the R8A histone 
tail.  It was interesting to see that chromodomain D62A had a KD of 8 µM to the native 
histone tail.  Alanine has a statistically higher #-sheet propensity than asparate and has 
been reported to be more energetically favorable by -0.85 kcal/mol in an HB site.21 
Therefore substitution of D62 with alanine may have a stabilizing effect on #-sheet 
interactions with the histone tail peptide. 
! --'!
 
Figure 4.21. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with chromodomain for the D62/R8 double-mutant cycle.   The 
experiments were performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM 
NaCl, and 4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
 
Table 4.6. Fluorescence anisotropy binding data from Fig. 4.14. The dissociation 
constants are in µM with the R2 in parenthesis.  The $G values are given in brackets 
(kcal/mol) and were calculated using the following equation: $Go=-RTln(KD).    
 H3 K9Me3 WT H3 K9Me3 R8A 
D62F 
6±1 (0.995) 
[-7.1] 
251±53 (0.995) 
[-4.9] 
D62A 
8±1 (0.995) 
[-6.9] 
332±165 (0.981) 
[-4.7] 
 
x.  Comparison of Hydrogen-Bonded and Non-Hydrogen-Bonded Sites  
The differences between cross-strand pairs in HB and NHB sites have been 
extensively explored using statistical correlation studies.11 Therefore, significant 
comparisons were made between the NHB and HB sites of the chromodomain-histone 
tail complex (A25/T6 and T6/D62 respectively). 
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The D62F/T6 pair in the HB site favored binding affinity over the A25F/T6 pair 
in the NHB site (Fig. 4.14).  Statistical correlation studies have demonstrated that there is 
a 2-fold higher correlation of Phe/Thr pairs in the HB site than in the NHB site of a #-
sheet.11 Based on simple modeling with PyMol, which places the side chain in its 
statistically preferred conformation, it is possible that the phenylalanine is splayed away 
from the histone tail.  Additionally, the right-handed twist of the #-sheet formed between 
the chromodomain and histone tail would likely direct side-chains at position 25 away 
from R8. Therefore, the cation-" interaction with R8 of the histone tail compared to 
D62F would be weakened (Fig. 4.22). 
 
 
Figure 4.22. PyMol image of H3 K9Me3 (yellow) bound to HP1! chromodomain A25F 
(green).  The conformation of A25F represents the context dependent preferred rotamer 
and does not reflect an energy-minimized structure (generated from PDB 1KNE). 
 
The interaction between two aromatic rings, which are known to be an important 
element in protein stability and recognition16,29,30, also showed different binding 
preferences depending on whether they were placed in the HB or NHB site.  
chromodomain D62F in complex with H3 K9Me3 T6F has a slightly improved affinity of 
13 µM (Fig. 4.23).  Using PyMol as a simplistic model, the two aromatic phenylalanine 
O%(8!
T+!
4)%!
6)!
! --)!
residues are shown to align ideally to form the favorable aromatic offset-stacked motif in 
their preferred rotomeric states to allow for a favorable quadrupole-quadrupole 
interaction (Fig. 4.24A).29 Although this is an unminimized structure, it suggests that the 
preferred conformation will predispose these side-chains to interact favorably.  This 
structure is also consistent with the statistical analysis by Wouters and Curmi who 
showed that Phe-Phe pairs often take a gauche-/gauche+ conformation, which results in 
an offset stacked "-" interaction.11 
 
 
Figure 4.23. Comparison of the fluorescence anisotropy binding experiments of 5(6)-
Fam-labeled H3 K9Me3 with chromodomain focusing on Phe/Phe interactions.  
Experiments were done in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, 
and 4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
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(A) 
 
(B) 
 
Figure 4.24. PyMol image of (A) H3 K9Me3 T6F (yellow) bound to HP1! 
chromodomain D62F (green) and (B) H3 K9Me3 T6F (yellow) bound to HP1! 
chromodomain A25F (green).  The conformation of the mutants represents the context 
dependent preferred rotamer and does not reflect an energy-minimized structure 
(generated from PDB 1KNE). 
 
In contrast, chromodomain A25F binds H3 K9Me3 T6F with a KD of 66 µM, 
which is 4-fold weaker than with the native histone tail and between chromodomain 
D62F and the T6F peptide (Fig. 4.23).  It is possible that introducing two bulky aromatic 
residues to the interior and conformationally restricting two #-strands of the 3-stranded #-
sheet results in steric hindrance.  Furthermore, R8 of the histone tail, which is in close 
proximity to D62F, is further from A25F due to the right-handed twist of the #-sheet.  
Thus a favorable cation-" interaction between R8 and D62F is likely not able to form.  
Lastly, statistical analysis has shown that Phe-Phe pairs have a significantly higher 
correlation in a HB site over a NHB site.  This difference is attributed to the favorable 
offset-stacked orientation observed in the HB site that doesn’t necessarily occur in the 
NHB site (Fig. 4.24).11 Interestingly, the favored D62F/T6F pair occurs in the HB site 
while the A25F/T6F pair is in the NHB site, which is consistent with the previous 
statistical analysis.    
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Binding affinity between chromodomain and histone tails with cross-strand 
threonine pairs is also site-specific.  Incorporating a threonine mutation at position 62 
reduces binding affinity to H3 K9Me3 by two-fold (KD=39 µM) compared to the native 
chromodomain (KD=17 µM) while incorporating a threonine at position 25 enhances 
binding affinity by two-fold compared to the native chromodomain (KD=9 µM) (Fig. 
4.25). 
In general, #-branched residues have a higher statistical pair correlation in HB 
sites compared to NHB sites, including Thr-Thr pairs.10, 11 Statistical analyses have 
demonstrated that cross-strand Thr-Thr pairs have a preference for the gauche+ rotamer 
conformation, which favors inter-residue H-bond between the hydroxyl groups of the 
threonine side chains (Fig. 4.26).  In an HB site, both Thr residues must be in the 
unfavorable gauche- rotamer conformation to accommodate the H-bond between the 
hydroxyl groups.10 Experimental results reported Smith and Regan supported the analysis 
that Thr-Thr pairs are disfavored in the HB position when various cross-strand pairs were 
incorporated into a HB position of the B1 domain of Streptococcal protein G.  They 
showed that Thr-Thr pairs had an unfavorable interaction energy,14 which is consistent 
with the findings here showing the Thr-Thr pairs in the HB site of the chromodomain-
histone tail complex (positions 6 and 62 respectively)  weakened binding affinity. 
! --,!
 
Figure 4.25. Comparison of the fluorescence anisotropy binding experiments of 5(6)-
Fam-labeled H3 K9Me3 with chromodomain focusing on Thr/Thr interactions.  
Experiments were done in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 
4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
 
 
Figure 4.26.  Superposition of 37 Thr-Thr pairs that shows the preference for the 
gauche+ gauche+ conformation.  Most of the hydroxyl groups in the side chains are 
aligned to accommodate a inter-residue H-bond.  Hydroxyl group are red while amides 
are blue and carbons are white.10 
 
D.  Conclusions 
We have used the HP1! chromodomain and H3 K9Me3 peptide to investigate 
how information gleaned from #-hairpin models and statistical analysis of #-sheet 
propensity and stability apply to protein-protein recognition.  Additionally, these studies 
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permitted us to examine the scope of the selectivity of the HP1! chromodomain for its 
intended target.  Our data has shown that changing residues not known to be favored in 
#-sheet structures such as alanine or aspartic acid to those such as lysine, threonine, and 
phenylalanine21 can have a drastic positive or negative effect on binding depending on 
the site of the mutation.  The system is complicated by the surrounding amino acids, 
which can form unfavorable charge-charge interactions, such as between A25K and R8 
of the histone tail of the chromodomain repulsion or favorable cation-" interactions such 
as D62F of the chromodomain and R8.  Solvation and steric hindrance are two additional 
factors that may also influence how the orientation of two cross-strand residues affects 
binding.  The findings have also demonstrated the possible variations at the T6 position 
of the Histone H3 tail. While alanine scans have shown that shortening the residue 
reduces binding by 7-fold, incorporating bulky amino acids capable of packing against 
A25 and D62 is equally as favorable as the native threonine. 
 The information gathered from these studies can be utilized in a number of 
applications. Regan et al recently redesigned tetratricopeptide repeat and its ligand with a 
KD in the low micromolar range to enhance selectivity and applied their findings for use 
in Western blots.31 Detection of PTMs in histone proteins is a difficult, but important 
endeavor necessary for unveiling the “Histone Code”.  Mass spectrometry has its 
limitations32 and antibodies are expensive and difficult to manufacture.  Using the 
chromodomain mutants with higher affinity H3 K9Me3 and incorporating the E52Q 
mutation discussed in Chapter III, which will give higher selectivity for trimethyllysine, 
can be used as a detection method for PTMs in the future. 
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E. Experimental 
i.  Protein Expression and purification 
The DNA plasmid containing the cloning region of Drosophila HP1! 
chromodomain was supplied by the Khorasanizadeh lab.19 Mutagenesis, expression, and 
purification were performed as previously described in Chapter III and purity was 
confirmed by SDS-PAGE.  The primers used for mutagenesis are given in Table 4.7. 
 
Table 4.7.  Forward primers used for mutagenesis of HP1! chromodomain at Ala25 and 
Asp62.  The site of mutation is in red. 
Mutant Primer Sequence 
A25F GAG GAG GAG GAG TAC TTC GTG GAA AAG ATC ATC 
A25K GAG GAG GAG GAG TAC AAA GTG GAA AAG ATC ATC 
A25L GAG GAG GAG GAG TAC CTC GTG GAA AAG ATC ATC 
A25T GAG GAG GAG GAG TAC ACC GTG GAA AAG ATC ATC 
A25W G GAG GAG GAG TAC TGG GTG GAA AAG ATC 
D62F CCG GAG AAC AAT CTC TTC TGC CAG GAT CTT ATC CAG 
D62I CCG GAG AAC AAT CTC ATC TGC CAG GAT CTT ATC CAG 
D62K CCG GAG AAC AAT CTC AAA TGC CAG GAT CTT ATC 
D62T CCG GAG AAC AAT CTC ACC TGC CAG GAT CTT ATC CAG 
D62A CCG GAG AAC AAT CTC GCC TGC CAG GAT CTT ATC 
K46A G TAC TAT CTG AAA TGG GCG GGC TAT CCC GAA AC 
 
ii.  Peptide synthesis and purification 
Histone peptides were synthesized as previously described in Chapter III.  See 
Table 4.8 for mass spec analysis. 
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Table 4.8.   Mass spectrometry data for the peptides synthesized for this study. 
Peptide Expected Mass (Da) Experimental Mass (Da) 
H3 K9Me3 2124.1 2124.7 
H3 K9Me3 T6F 2170.1 2169.8 
H3 K9Me3 T6I 2136.1 2136.1 
H3 K9Me3 T6K 2151.1 2151.0 
H3 K9Me3 T6L 2136.1 2136.1 
H3 K9Me3 T6A 2094.0 2094.0 
H3 K9Me3 R8A 2039.0 2038.8 
 
iii. Circular Dichroism 
CD measurements were performed on an Aviv 62DS Circular Dichroism 
Spectrometer.  All CD experiments were performed as described in Chapter III. 
iv.  Anisotropy 
As explained in Chapter III, all experiments were carried using a Polarstar plate 
reader with 1 µM histone tail peptide labeled with 5(6)-carboxyfluorescein.  However, 
during the initial studies using the #-sheet mutants, a number of inconsistencies were 
observed.  Much like with the CHD1 chromodomain studies nonspecific binding was 
observed at higher chromodomain concentrations and, therefore, had to omit data 
points.33 
Several controls were performed to determine the optimal experimental 
conditions.  To control for aggregation, a sample of chromodomain was centrifuged in a 
microcentrifuge at 13,000 rpm for 10 mins using a Sorvall Biofuge pico centrifuge with 
rotor number 3325B to remove precipitates and binding to H3 K9Me3 T6K was 
compared to chromodomain that had not been centrifuged (Fig.4.27, Table 4.9).  The 
dissociation constants measured using the centrifuged samples and non-centrifuged 
samples are very similar and the concentrations before and after centrifugation were the 
same.  Therefore, protein aggregation was not a concern. 
! -%&!
 
 
Figure 4.27. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 T6K histone tail with wild-type chromodomain.  The centrifuged sample of 
chromodomain was centrifuged at 13000 rpm for ten minutes at 4 oC.   The experiments 
were performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM 
DTT at 25 °C. Each curve is an average of 3 runs.   
 
Table 4.9.    A summary of the dissociation constants (µM) with R2 in parenthesis.  The 
data corresponds to the curves in Figure 4.27. 
Not Centrifuged Centrifuged 
10±1 (0.998) 7±1 (0.995) 
 
Another variable that had to be controlled for was the type of microplate used for 
the measurements.  Costar produces plates with a treated surface to prevent protein and 
small molecules from binding to the plate as well as a plate with an untreated surface.  
Binding of the wild-type chromodomain to the H3 K9Me3 T6K peptide was measured 
using both microplates (Fig. 4.28, Table 4.10).  The data from the untreated plates 
provided more favorable dissociation constants and the error was considerably lower.  
The chromodomain does not interact with the untreated hydrophobic polystyrene plates, 
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but may interact with the hydrophilic surface of the treated plate.  Therefore, the 
untreated plates were used for all anisotropy experiments. 
 
 
 
Figure 4.28. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 T6K histone tail with wild-type chromodomain using untreated and treated 
microplates.   The experiments were performed in 50 mM potassium phosphate buffer 
pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C.  Each curve is an average of 3 runs.   
 
Table 4.10.  A summary of the KD (µM) with R
2 in parenthesis.  The data corresponds to 
the curves in Figure 4.28. 
Untreated Plate Treated Plate 
10±1 (0.998) 26±6 (0.993) 
 
A final control that was performed tested whether 5(6)-carboxyfluorescein was 
interacting with the chromodomain directly.  Therefore the fluorescence signal from all 
chromodomain and histone tail data was calculated from the raw polarization 
measurements using the Polarstar software.  A 25% decrease in fluorescence signal was 
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observed in all of the data that had been collected from 0 to 300 µM chromdomain (Fig. 
4.27).   Fluorescence intensity of fluorescein depends strongly on the environment such 
as varying protein concentrations.  Since the decrease in signal was consistent 
irrespective of the binding affinity and because 5(6)-carboxyfluorescein is the standard 
fluorophore used for investigating chromodomain-histone tail interactions, the 
fluorophore was used for all binding studies. 
After all controls were performed the final experimental conditions were 
established.  A POLARstar Omega microplate reader with untreated 96 half-area flat 
bottom plates (Costar 3694) was used for anisotropy measurements.   Concentrated 
stocks of histone peptide with 5(6)-FAM on the N-terminus were prepared in 50 mM 
potassium phosphate, pH 8.0, 25 mM NaCl.  The concentrations were measured using 
e492=78,000 M
-1cm-1 with a Perkin Elmer Lambda35 UV/VIS Spectrometer.  A histone 
tail solution was then prepared with 2 µM peptide, 8 mM DTT and the same buffer as 
described above.  Using a multichannel pipette, 50 µL peptide was added to each well of 
the Costar 3694 plate. 
The chromodomain was thawed on ice and a 400 µL solution was prepared at 600 
µM and 8 subsequent serial dilutions were made (1:2).  Solutions were mixed by 
pipetting approximately twenty times and rather than by vortexing to avoid introducing 
air bubbles into the sample.  The solutions were added to clear microplates (Costar 3795) 
with buffer as a blank, centrifuged for 1 min at 4,000 rpm to remove air bubbles and to 
draw any particulates to the bottom of the wells.  Then 50 µL of chromodomain sample 
was added to the Costar 3694 plates using a multichannel pipette and mixed with the H3 
peptide by pipetting the solution approximately ten times.  This method of preparation 
! -%)!
reduced the final concentrations of chromodomain, peptide, and DTT by half.  The plates 
were centrifuged at 4000 rpm for 1 min to remove air bubbles. 
All samples were allowed to reach equilibrium for 30-60 mins before 
measurements were taken.  A timed experiment confirmed that there was no change in 
anisotropy signal between 30 and 60 mins.  Measurements were taken with an excitation 
wavelength of 485 nm and an emission at 520 nm.  The data was analyzed using Eq. 2.3 
and the fraction of histone tail bound was calculated using Eq 2.4.  The $Go was 
calculated using Eq. 3.3. All binding curves except those previous highlighted are shown 
below in Fig. 4.29-4.36.  Not all of the binding curves show a plateau because at the 
higher concentrations required for saturation, the chromodomain would aggregate. 
v.  Double-Mutant Cycle 
Single and double mutations for studying A25K/K46 interactions were made to 
the HP1! chromodomain by expressing the following mutants: A25K/K46A, 
A25K/K46A, A25/K46A.  The circular dichroism spectra and melting temperatures were 
measured as described above as where the dissociation constants.  The $$G was 
calculated as shown in Eq. 4.4: 
 
                  
! 
""G
A 25K#K 46 = "G
o
A 25K /K 46 #"G
o
A 25 /K 46 #"G
o
A 25K /K 46A #"G
o
A 25 /K 46A    Eq. 4.4 
 
 Single mutations for studying D62F/ H3 R8 interactions were made to the HP1! 
chromodomain by expressing D62F and D62A chromodomain mutants.  The histone tail, 
H3 K9Me3 R8A was synthesized as previously described in Chapter III (see Table 4.4 for 
masses).  The circular dichroism spectra and melting temperatures were measured as 
! -%*!
described above as where the dissociation constants.  The $$G was calculated as shown 
in equation 4.5: 
 
                   
! 
""G
D62F#R 8 = "G
o
D62F /R 8 #"G
o
D62F /R 8A #"G
o
D62A /R 8 #"G
o
D62A /R 8A      Eq. 4.5 
 
 
Figure 4.29. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain A25F.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
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Figure 4.30. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain A25L.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
 
 
Figure 4.31. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain A25K.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
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Figure 4.32. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain A25T.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
 
 
Figure 4.33. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain D62F.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
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Figure 4.34. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain D62I.   The experiments were performed 
in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
 
 
Figure 4.35. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain D62K.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
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Figure 4.36. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail mutants with chromodomain D62T.   The experiments were 
performed in 50 mM potassium phosphate buffer pH 8.0, 25 mM NaCl, and 4 mM DTT 
at 25 °C. Each curve is an average of 3 runs. 
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Chapter V 
TOWARDS DEVELOPING RECEPTORS FOR DETECTING DUAL POST-
TRANSLATIONAL HISTONE MODIFICATIONS 
 
A. Background 
i.  Cross-Regulation Between Post-Translational Modifications 
 Histone modifications most commonly occur in combination to create a “code”, 
which can drastically alter how they are “read” by effector proteins.  For example when 
Ser10 on H3 becomes phosphorylated it acts as a switch, ejecting HP1 from this histone 
to reactivate gene expression.1 Dual modifications are also capable of recruiting 
multivalent effector proteins such as TAF1 (TATA!binding protein!associated 
factor!1), which can bind to multi-acetylated sites.2 Some modifications are also known 
to promote or inhibit further modifications.  For example, specific lysine methyl marks 
can recruit histone deacetylases (HDAC) or histone acetyltransferases (HATs) to 
perpetuate gene silencing or expression.3 Significant research has been performed to 
determine which modifications occur in conjunction with one another and to understand 
how multiple modifications elicit specific biological functions.  However, there are still 
many modifications and potential combinations of modifications that must be identified. 
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ii.  Identifying Post-Translational Modifications 
Two techniques are presently used to identify PTMs in histones: mass 
spectrometry and antibodies for ChIP and Western blot analysis.4 Both of these methods 
are excellent for identifying a single PTM in proteins, but they are not necessarily 
practical for identifying combinations of PTMs within a single protein.5 
Two protocols can be applied to mass spectrometry to analyze PTMs including 
the “bottom-up” approach and the “top-down” approach (Fig. 5.1).  In the “bottom-up” 
approach, proteins are digested with proteases into peptide fragments, which are then 
analyzed by ESI.    This technique gives information on the peptide sequences as well as 
the exact location of the modifications.  However, since multiple proteins, which may 
have varying modifications, are present within the digest it is difficult to determine if two 
modifications came from the same protein.  Additionally, some fragments may be too 
small or not in a high enough level to detect.5, 6 
In the “top-down” method the proteins are fragmented in the gas phase within the 
mass spectrometer to produce a “ladder” of peptide fragments.  The primary structure of 
the modified protein can be compared to an unmodified protein to isolate the site of 
modification.  Often, the protein is not fully fragmented to generate the entire ladder and 
some of the more labile modifications such as phosphorylation can be dislodged from the 
protein and will remain undetected.5, 6 It is also difficult to differentiate modifications that 
have similar molecular weights, such as KMe3 and KAc, which differ by only one mass 
unit.  While it is possible to fully characterize a modified protein by mass spectrometry, 
the combination of approaches required does not make this a practical method. 
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Figure 5.1.  In the bottom-up approach (top), proteins of interest are digested 
with a protease, and the resulting peptides are analyzed in the gas phase by mass 
spectrometry.  MS is used to determine the mass of the peptides and MS/MS is 
used to determine the peptide sequences and the modifications.  In the top-down 
approach (bottom), protein ions are fragmented while in the gas phase and 
analyzed in the mass spectrometer, yielding the molecular mass of the protein as 
well as protein ion fragment ladders, which is used to determine the primary 
structure of the protein.6 
 
The use of antibodies is also a very common strategy for identifying PTMs and 
for isolating them.  This powerful technique can be used to identify specific PTM sites 
within a mixture of proteins.  However, there are several drawbacks to using antibodies in 
addition to their cost and their inconsistency.  Antibodies are not always sequence 
selective, they do not always select for specific methylation states, and they are 
influenced by the presence of neighboring PTMs, which makes determining which 
modifications are present within a sample difficult and uncertain.7 Mixed protein samples 
with various PTMs are often difficult to visualize using both one- and two-dimensional 
gel electrophoresis especially if some proteins are in lower populations or if they co-
! -&+!
migrate.  Additionally, it is nearly impossible to determine whether multiple PTMs that 
are visualized with antibodies are present in the same protein or in two different 
proteins.5 
B. Goal 
A new approach that overcomes the limitations of the methods available to 
analyze PTMs would be highly beneficial. In this research two PTM-recognition 
domains, or receptors, derived from naturally occurring effector proteins were coupled 
together to create a coupled-receptor construct to visualize dual modifications on a single 
histone tail.  I first coupled two HP1! chromodomains to determine if they were 
functional for detecting a synthetic peptide with two H3 K9Me2 sequences as proof that 
coupled receptors can have cooperative binding for a peptide with two methyllysine 
marks. 
C. Results and Discussion 
i.  Initial System Design 
The initial design of the coupled receptors involved linking them non-covalently 
so the recognition domains could be easily interchangeable to detect different sets of 
PTMs.  To do this, the receptors were to be linked to one of two different peptides, which 
are capable of forming a parallel, heterodimeric coiled-coil motif.  The peptides were to 
have either a FRET donor or acceptor on the N-terminus and a thiol-reactive maleimide 
linker on the C-terminus so the peptides could be conjugated to the chromodomain via a 
cysteine (Fig. 5.2).   If the coiled-coils have favorable binding then the receptors should 
be dimerized in solution to promote cooperative binding to the modified histone peptide.   
! -&,!
As long as cooperative binding results in 100-fold enhanced binding then 
background noise from a receptor binding to a single PTM should be relatively low.  
Such phenomenon is not unprecedented as demonstrated by Melkko and coworkers who 
used duplex DNA as a scaffold to generate a bidentate biotin ligand for streptavidin.8 The 
bidentate ligand had a 2000-fold improvement in binding affinity to streptavidin 
compared to the free biotin due to the chelate effect.  Williams and coworkers used 
duplex DNA as a scaffold for two peptides to form a bivalent affinity reagent, which is 
able to bind to two different sites of a protein.9 The bivalent reagent with two peptides 
had an affinity to the target protein 4000-fold more favorable than the individual 
peptides. 
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(A) 
 
(B) 
 
Figure 5.2.  (A) Initial design of the coupled receptors.  The coiled-coil peptides are 
labeled with a FRET pair and will dimerize when the recognition domains bind the dual-
modified histone tail.  FRET will be used to visualize the presence of two modifications 
of interest, which in this case are H3 K9Me3 and H3 K27Me3.  (B) Synthetic scheme for 
the initial design. 
 
ii.  Chromodomain Cysteine Mutants 
The receptors were to be conjugated using a cysteine within the receptor and a 
thiol-reactive functional group such as a maleimide or bromoacetamide within the coiled-
coil peptides.  A naturally occurring cysteine is already located near the binding pocket of 
HP1! chromodomain at position 63.  The cysteine, which is shown to face the interior of 
the protein in the crystal structure, appeared to be unreactive and biotin-maleimide could 
not be conjugated to the chromodomain.  Therefore, four cysteine point mutations were 
! -'-!
made to the chromodomain at locations shown to be more solvent exposed and appeared 
to be involved in minimal interactions with other neighboring residues (Fig. 5.3). 
 
 
Figure 5.3.  The location of the four different cysteine point mutations made to the 
HP1! chromodomain.  The chromodomain is shown in green.  The mutated amino acids 
are shown in purple.  The trimethyllysine is shown in yellow.  The aromatic cage is 
shown in green sticks (PDB 1KNE). 
 
 (1)  Structural Characterization 
Circular dichroism spectrum of each mutant was collected to determine how the 
cysteine mutations affected the global structure of the chromodomain (Fig. 5.4).  The 
minima at 208 nm and 222 nm and the exciton coupling peak at 232 nm for each mutant 
are consistent with the native chromodomain.  Therefore the global structure was not 
perturbed by the point mutations.  The thermal stability was also ascertained by thermal 
denaturation monitored at 222 nm by circular dichroism (Fig. 5.5).  All mutants have a 
melting temperature within 2 oC of the wild-type proteins, confirming the stability of each 
chromodomain. 
E23 
 
 
 
 
 
    K28 
 
 
M38 
 
 
 
 
R74 
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Figure 5.4.  Circular dichroism spectra comparison of HP1! Chromodomain to the 
cysteine mutants at 25oC in 10 mM sodium phosphate pH 7.4 with 2 mM DTT.  These 
are the averages of three runs. 
 
 
Figure 5.5. Thermal denaturation monitored by circular dichroism at 222 nm of HP1! 
Chromodomain WT and the cysteine mutants in 10 mM sodium phosphate pH 7.4 and 
2 mM DTT. 
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Table 5.1.  Melting temperatures of HP1! chromodomain and the cysteine mutants 
determined using the thermal denaturation curves in Fig. 5.5.  The Tm values were 
estimated from the inflection points of the curve. 
 WT E25C K28C M38C R74C 
Tm (
oC) 47 47 47 46 45 
 
 (2)  Binding Studies 
The HP1! chromodomain cysteine mutants must maintain binding affinity to the 
H3 K9Me3 for them to be viable receptors.  The affinity of the chromodomain cysteine 
mutants for the H3 K9Me3 histone tail was confirmed using fluorescence anisotropy.  The 
binding curves are shown in Fig. 5.6 through Fig. 5.9 and the dissociation constants are 
summarized in Table 5.2.  In each case the cysteine mutants have similar or even slightly 
higher binding affinity for the trimethyllysine 9 Histone H3 peptide.  Therefore the 
residues that were mutated are not important for binding affinity and can be manipulated 
without having and effect on binding affinity. 
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Figure 5.6.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with chromodomain wild-type and E23C.   The experiments were 
performed in 50 mM potassium buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
 
 
Figure 5.7.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with chromodomain wild-type and K28C.   The experiments were 
performed in 50 mM potassium buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
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Figure 5.8.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with chromodomain wild-type and M38C.   The experiments were 
performed in 50 mM potassium buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
 
 
Figure 5.9.  Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM H3 
K9Me3 histone tail with chromodomain wild-type and R74C.   The experiments were 
performed in 50 mM potassium buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. 
Each curve is an average of 3 runs. 
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Table 5.2. Fluorescence anisotropy binding data from Fig. 5.6 through Fig. 5.9 of 
HP1! chromodomain with H3 K9Me3. The dissociation constants are in µM with the 
R2 in parenthesis.   The experiments were performed in 50 mM potassium buffer pH 
8.0, 25 mM NaCl, and 4 mM DTT at 25 °C. Each curve is an average of 3 runs. 
Chromodomain KD (µM) 
 WT 17 ± 1 (0.999) 
 E23C 14 ± 2 (0.993) 
 K28C 22 ± 3 (0.993) 
 M38C 11 ± 1 (0.998) 
 R74C 10 ± 2 (0.987) 
 
iii.  Coiled-coil Design 
Alpha-helical coiled-coils are protein motifs that are ubiquitous in biological 
systems.  They are important for cytoskeleton formation, mediation of protein-protein 
interactions involved in DNA expression, viral pathogenesis, and a number of other 
biological functions. Therefore the structure and design of coiled-coils have been 
extensively characterized.10 
A coiled-coil is a structure that consists of two to four strands of amphipathic 
peptides engaged in a left-handed twist.  The peptide sequences consist of seven-residue 
or heptad repeats commonly denoted as a-b-c-d-e-f-g (Fig. 5.10).  To promote coiled-coil 
packing, hydrophobic residues are placed in three and four residues apart (positions a and 
d).  Isoleucine residues placed in position a and leucine residues are placed in position d 
to promote dimmer formation and disfavor trimers.11 Residues e and g neighbor the 
hydrophobic core and consist of charged side chains that can promote either a 
heterodimer or homodimer depending on the charge of the residues.12 
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 (A) 
 
 (B) 
 
 
Figure 5.10.  (A) X-ray structure of the GCN4 leucine zipper (pdb 2azt).  (B) Generic 
helical wheel diagram.  
 
The coiled-coil used in this study was based on the de novo three-heptad repeat, 
ISAL E3/K3 sequence, which was designed by Hodges and coworkers.  The coiled-coil 
was designed with a hydrophobic core consisting of isoleucines and leucines, which 
interlock in a knobs-in-holes fashion and has a reported KD of 9 µM.
13, 14 Like the 
original sequences, glutamates were incorporated in the g and e positions of the E3 
peptide and lysine residues were incorporated in the g and e positions of the K3 peptide.  
Having complementary charged residues in these positions promotes the formation of 
heterodimers so two different PTM receptors are coupled together (Fig. 5.11A).13, 15 The 
two receptors must also be aligned in the same direction so they can bind to a single 
histone tail.  Proper alignment was accomplished designing parallel coiled-coils.  In 
nature, parallel GCN4 leucine zippers contain an asparagine in a single a position of each 
g
a
b
c
d
e
f
a
b
c
d
e
f
g
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peptide (Fig. 5.10A).  Though the incorporation of polar residues within the core is 
destabilizing, they form an intermolecular H-bond in a parallel coiled-coil, but are 
misaligned in an anti-parallel coiled-coil.  Thus, they are significantly disfavored in 
antiparallel coiled-coils and in trimers and promote parallel dimers.16 In the de novo 
design one asparagine was incorporated into the hydrophobic core (a2 position) of each 
peptide to promote a parallel orientation orientation.17 
 
(A) 
                   
 
 (B) 
 
Figure 5.11.  (A) Circular dichroism spectra of the ISAL E3/K3.13  (B) Helical wheel 
diagram of the I(N)SAL E4/K4 sequences.  Arrows indicate point of interaction between 
the two peptides. 
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The peptides were initially synthesized without the linker or fluorophore for 
preliminary characterization by circular dichroism (Fig. 5.12).  The minimum at 
approximately 200 nm indicates that the two peptides do not form a coiled-coil, even in 
an equi-molar heterogeneous mixture.  Though the ISAL E3/K3 peptides are capable of 
forming heterodimers, the asparagines are likely too destabilizing to the hydrophobic 
core. 
To further stabilize the structure, the coiled-coil was extended to a four-heptad 
repeat with a tyrosine at position 21 for measuring concentration by UV/VIS (I(N)SAL 
E4/K4).  The CD spectra of the individual peptides show a minimum at 200 nm, which 
indicates a random coil structure.  An equi-molar mixture of the two peptides yields two 
minima at 208 nm and 222 nm, which confirm !-helix structure (Fig. 5.13). 
 
 
Figure 5.12.  Circular dichroism spectra of I(N)SAL E3/K3 peptides.  Measurements 
were taken in 10 mM NaPO4 pH 7.0 with a total peptide concentration of 100 µM (50 
µM of each peptide for the equi-molar E3/K3 mixture). 
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Figure 5.13.  Circular dichroism spectra of I(N)SAL E4/K4 peptides.  Measurements 
were taken in 10 mM NaPO4 pH 7.0 with a total peptide concentration of 100 µM (50 
µM of each peptide for the mixture). 
 
A low dissociation constant in the nanomolar range between the coiled-coil 
peptides was necessary to promote cooperative binding of the coupled receptor to the 
dual-modified histone tail  The low nanomolar range is ideal because the coiled-coils will 
be dimerized in solution.  Guanidine denaturation was used to measure the dissociation 
constant between the two peptides.  Samples of 100 µM mixtures of I(N)SAL E4/K4 
peptides were prepared with increasing concentrations of guanidine hydrochloride.  
Denaturation was monitored by circular dichroism at 222 nm, which is a characteristic 
minimum for !-helices.  The concentration of guanidine was increased until the 
denaturation curve reached a plateau (Fig. 5.14).  From this data, the $G of folding in the 
presence of various concentrations of guanidine was calculated using the data in the most 
linear region of the denaturation curve (Fig. 5.15).  The $G of folding in the absence of 
denaturant was determined by extrapolation to yield a final KD of 3 µM.  Though this is a 
strong KD compared to the previously reported value for ISAL E3/K3 (9 µM), a value in 
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the low nanomolar range was desired.  A dissociation constant in the nanomolar range is 
preferred so the receptors will be dimerized in solution prior to binding to the histone 
peptides.13 Therefore, the coupled receptors were redesigned to incorporate a covalent 
link between the coiled-coil peptides at the C-terminus as opposed to relying on self-
assembly. 
 
               
 
Figure 5.14.  Guanidine denaturation of I(N)SAL E4/K4 monitored by CD at 222 nm 
in 50 mM potassium phosphate pH7.0, 100 mM NaCl buffer at 25oC. 
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Figure 5.15. The $G of folding in the presence of various concentrations of guanidine 
was calculated using the data from the linear region of the denaturation curve in Fig. 
5.15.  
 
iv.  New System Design 
  (1)  Covalently Linked Coiled-coils 
In the new design, we introduced a covalent link at the C-terminus of the coiled-
coils.  Since the coiled-coils were covalently linked at the C-terminus, there was no 
longer a need for asparagines within the hydrophobic core of the peptide to promote a 
parallel coiled-coil.  The ISAL E4/K4 peptides were also reduced to a three-heptad repeat 
due to the added stability of linking the two peptides and the removal of the polar residue 
from the core.  Shortening the peptides by seven amino acids improved the yield of the 
peptides and the length of time required for solid phase peptide synthesis.   
First, the coiled-coils were covalently linked using a disulfide bond between two 
cysteine residues at the C-terminus with two glycine residues as spacers at both the N- 
and C-termini.  Disulfide exchange of the peptide was monitored over the course of four 
days to confirm that the parallel heterodimer is favored over parallel homodimer (Fig. 
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5.16).  As shown on Day 1, the peptides first appeared as monomers with a small amount 
of homodimer or heterodimer.  By the fourth day, equilibration was complete and the 
primary peak observed in the heterogeneous mixture was the heterodimer with only a 
small peak for the ISAL K3-GGC monomer, due to a presence of a slight excess of the 
peptide.  The Keq was calculated to be 79 with a favorable $G of -1.8 Kcal/mol while a 
statistical mixture of homodimers to heterodimer would yield a Keq of only 4.  Thus, the 
equilibrium strongly favors the heterodimer over the two homodimers. 
The structure of the peptide was also characterized using circular dichroism to 
confirm the presence of !-helical structure (Fig. 5.17).  It is clear that the mixture of the 
two different peptides results in the formation of !-helix while the homogenous mixtures 
remain as random coil, which demonstrates the stability of the heterodimer compared to 
the homodimers. 
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Figure 5.17. Circular dichroism spectra of ISAL E3/K3 peptides after 4 days of 
disulfide exchange.  Measurements were taken in 10 mM NaPO4 pH 7.0 with a total 
monomer concentration of 100 µM. 
 
Though disulfide linkages are commonly used for covalent bonds, this method is 
not practical for the design of the coupled receptors because the peptides will be linked to 
the chromodomain using a thiol-reactive linker on the peptides and a cysteine within the 
chromodomain.  Therefore, the bioorthogonal copper-catalyzed Huisgen cycloaddition 
was used to covalently link the ISAL E3/K3 peptides (Fig. 5.18).  An azido-lysine was 
incorportated at the C-terminus of the ISAL K3 peptide with a 2-glycine spacer (BrAc-
ISAL K3-azidoK).  A propargyl glycine was incorportated at the C-terminus of the ISAL 
E3 peptide with a 2-glycine spacer (BrAc-ISAL E3-propargylG).  The peptides were both 
capped with a 2-glycine spacer with a bromoacetate on the N-terminus.  
The !-helical structure of the linked coiled-coiled coils was verified by circular 
dichroism and compared to the coiled-coils before cycloaddition (Fig. 5.19).  While both 
have !-helical structure, it is clear that linking the two peptides promotes assembly, 
which will be necessary for proper alignment of the two receptors. 
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Figure 5.18.  Final construction of the coupled receptors using the Huisgen 
cycloaddition, with a myc tag (green) fused to the chromodomain (red and blue). 
 
 
Figure 5.19.  Circular dichroism spectra of the BrAc-ISAL E3-propargylG and BrAc-
ISAL K3-azidoK peptides before and after cycloaddition.  Measurements were taken in 
10 mM NaPO4 pH 7.0. 
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 (2)  Tagging the Receptors 
Since the two receptors will be covalently linked, FRET is not longer necessary 
for detection.  Use of a tag for an antibody rather than a FRET pair is more sensitive and 
requires less optimization.  Therefore a myc-tag was inserted into the HP1! 
chromodomain on the N-termins preceding the N-terminal histidine tag. 
The HP1! chromodomain-myc fusion protein was visualized on a microarray and 
is selective for the H3 K9Me3 peptide over lower methylation states and phosphorylated 
peptides (Fig. 5.20).  The peptides and layout used in the microarry can be found in Table 
5.3 and Table 5.4.  As expected, the signal is strongest for H3 K9Me3 peptide then the H3 
K9Me2 (Table 5.5).  Only a small signal is visualized for the monomethylated peptide 
and no signal for the phosphorylated peptides or peptides with no methyl marks.  The 
results are positive in that the chromodomains can be used to supplement antibodies.  
However this data emphasizes the importance of optimizing the conditions such that only 
dual modifications are visualized on the blot and minimal background signal from single 
modifications is observed.  Lowering receptor concentrations used in the microarray and 
increasing the number of washes can minimize the background signal. 
! -(+!
 
Figure 5.20.  Peptide array where positive binding by myc-HP1! chromodomain was 
visualized using an anti-mic antibody and Alexafluor 647 labeled anti-mouse secondary 
antibody.  Positive binding is shown as red spots and negative interactions are shown as 
green spots. 
 
 
Table 5.3.  List of all peptides and their identifying number used in the microarray in 
Fig. 5.20. 
Peptide # Sequence 
 H3 [1-20] 
1 ARTKQTARKSTGGKAPRKQL-K(Biot)-NH2 
2 ARTKQTARKSTGGK(Ac)APRKQL-K(Biot)-NH2 
3 ARTKQTARK(Ac)STGGKAPRKQL-K(Biot)-NH2 
4 ARTK(Ac)QTARKSTGGKAPRKQL-K(Biot)-NH2 
5 ARTK(Ac)QTARKSTGGK(Ac)APRKQL-K(Biot)-NH2 
6 ARTKQTARK(Ac)STGGK(Ac)APRKQL-K(Biot)-NH2 
7 ARTK(Ac)QTARK(Ac)STGGKAPRKQL-K(Biot)-NH2 
8 ARTK(Ac)QTARK(Ac)STGGK(Ac)APRKQL-K(Biot)-NH2 
10 ARTKQTARKSTGGKAPRK(Ac)QL-K(Biot)-NH2 
11 ARTKQTARKSTGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
12 ARTKQTARK(Ac)STGGKAPRK(Ac)QL-K(Biot)-NH2 
13 ARTK(Ac)QTARKSTGGKAPRK(Ac)QL-K(Biot)-NH2 
14 ARTKQTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
15 ARTK(Ac)QTARKSTGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
16 ARTK(Ac)QTARK(Ac)STGGKAPRK(Ac)QL-K(Biot)-NH2 
17 ARTK(Ac)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
18 ARTK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
! -(,!
19 ARTK(Me3)QTARK(Ac)STGGKAPRKQL-K(Biot)-NH2 
20 ARTK(Me3)QTARKSTGGK(Ac)APRKQL-K(Biot)-NH2 
21 ARTK(Me3)QTARKSTGGKAPRK(Ac)QL-K(Biot)-NH2 
22 ARTK(Me3)QTARK(Ac)STGGK(Ac)APRKQL-K(Biot)-NH2 
23 ARTK(Me3)QTARK(Ac)STGGKAPRK(Ac)QL-K(Biot)-NH2 
24 ARTK(Me3)QTARKSTGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
25 ARTK(Me3)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
26 ARpTK(Me3)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
27 ArpTK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
28 AR(Me2a)pTK(Me3)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
29 AR(Me2a)pTK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
30 AR(Me2a)TK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
31 5-Fam-ARTKQTARKSTGGKAPRKQL-K(Biot)-NH2 
32 ARTK(Me2)QTARKSTGGKAPRKQL-K(Biot)-NH2 
33 ARTK(Me2)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
34 ARTK(Me)Q TARKSTGGKAPRKQL-K(Biot)-NH2 
35 ARTK(Me)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
36 ARTKQTARKpSTGGKAPRKQL-K(Biot)-NH2 
37 ARTK(Ac)QTARK(Ac)pSTGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
38 ARTK(Me3)QTARKpSTGGKAPRKQL-K(Biot)-NH2 
39 ARTK(Me3)QTARK(Ac)pSTGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
40 AR(Me2a)TK(Me3)QTARKpSTGGKAPRKQL-K(Biot)-NH2 
41 AR(Me2a)TK(Me3)QTARK(Ac)pSTGGK(Ac)APRK(Ac)QL-K(Biot)-NH2     
42 ARTKQTARK(Me3)STGGKAPRKQL-K(Biot)-NH2 
43 ARTK(Ac)QTARK(Me3)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
44 ARTK(Me2)QTARK(Ac)STGGKAPRK(Ac)QL-K(Biot)-NH2 
45 ARTK(Me)QTARK(Ac)STGGKAPRK(Ac)QL-K(Biot)-NH2 
47 AR(Me2a)TKQTARKSTGGKAPRKQL-K(Biot)-NH2 
48 AR(Me2a)TK(Ac)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
50 AR(Me2a)TK(Me3)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
51 AR(Me)TK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
52 AR(Me)TK(Me3)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
53 ACitTKQTARKSTGGKAPRKQL-K(Biot)-NH2 
54 AcitTK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
55 AcitTK(Me3)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
56 AcitTK(Ac)QTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
 H4 [1-23] 
58 Ac-SGRGKGGKGLGKGGAKRHRKVLR-Peg-Biot 
59 Ac-SGRGK(Ac)GGK(Ac)GLGK(Ac)GGAK(Ac)RHRKVLR-Peg-Biot 
66 Ac-SGRGK(Ac)GGKGLGKGGAKRHRKVLR-Peg-Biot 
67 Ac-SGRGKGGK(Ac)GLGKGGAKRHRKVLR-Peg-Biot 
68 Ac-SGRGKGGKGLGK(Ac)GGAKRHRKVLR-Peg-Biot 
69 Ac-SGRGKGGKGLGKGGAK(Ac)RHRKVLR-Peg-Biot 
70 Ac-SGRGK(Ac)GGKGLGK(Ac)GGAKRHRKVLR-Peg-Biot 
71 Ac-SGRGKGGK(Ac)GLGKGGAK(Ac)RHRKVLR-Peg-Biot 
72 Ac-SGRGK(Ac)GGK(Ac)GLGK(Ac)GGAKRHRKVLR-Peg-Biot 
! -).!
 H3 [15-41] 
90 Ac-APRK18QLATK23AARK27SAPSTGGVK36K37PHRY-GG-K(Biot)-NH2 
91 Ac-APRK(Me3)QLATKAARKSAPSTGGVKKPHRY-GG-K(Biot)-NH2 
93 Ac-APRKQLATKAARKSAPSTGGVK(Me3)KPHRY-GG-K(Biot)-NH2 
95 Ac-APRK(Me3)QLATKAARKSAPSTGGVK(Me3)KPHRY-GG-K(Biot)-NH2 
 H3 [74-84] 
100 Ac-IAQDFK79TDLRF-Peg-K(Biot)-NH2 
101 Ac-IAQDFK(Me3)TDLRF-Peg-K(Biot)-NH2 
102 Ac-IAQDFK(Me2)TDLRF-Peg-K(Biot)-NH2 
103 Ac-IAQDFK(Me)TDLRF-Peg-K(Biot)-NH2 
104 IAQDFKTDLRF-Peg-K(Biot)-NH2 
 H3 [27-45] 
120 KSAPSTGGVK(Me3)KPHRYKPGT-G-K(Biot)-NH2 
121 KSAPSTGGVK(Me2)KPHRYKPGT-G-K(Biot)-NH2 
122 KSAPSTGGVK(Me)KPHRYKPGT-G-K(Biot)-NH2 
123 KSAPSTGGVK(Ac)KPHRYKPGT-GG-K(Biot)-NH2 
124 KSAPSTGGVK36K37PHRYKPGT-GG-K(Biot)-NH2 
 H3 [1-20] 
132 ARTK(Me3)QTARK(Me3)STGGKAPRKQL-K(Biot)-NH2 
133 ARTKQTARK(Me2)STGGKAPRKQL-K(Biot)-NH2 
134 ARTKQTARK(Me)STGGKAPRKQL-K(Biot)-NH2 
137 ARTKQTARKSTGGKAPRK(Me3)QL-K(Biot)-NH2 
138 ARTKQTARKSTGGKAPRK(Me2)QL-K(Biot)-NH2 
139 ARTKQTARKSTGGKAPRK(Me)QL-K(Biot)-NH2 
144 ARTKQTARK(Ac)phSTGGKAPRKQL-K(Biot)-NH2 
145 ARTKQTARK(Me3)phSTGGKAPRKQL-K(Biot)-NH2 
146 ARTKQTARK(Me2)phSTGGKAPRKQL-K(Biot)-NH2 
147 ARTKQTARK(Me)phSTGGKAPRKQL-K(Biot)-NH2 
148 ARTK(Me3)QTARK(Ac)phSTGGKAPRKQL-K(Biot)-NH2 
157 AR(Me2s)TK(Me3)QTARKSTGGKAPRKQL-K(Biot)-NH2 
162 ARTKQpTARKSTGGKAPRKQL-K(Biot)-NH2 
163 ARTK(Me3)QpTARKSTGGKAPRKQL-K(Biot)-NH2 
164 ARTK(Me2)QpTARKSTGGKAPRKQL-K(Biot)-NH2 
165 ARTKQpTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
166 ARTK(Me3)QpTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
167 ARTK(Me2)QpTARK(Ac)STGGK(Ac)APRK(Ac)QL-K(Biot)-NH2 
 H2A[1-17] 
300 Ac-SGRGK5QGGK9ARAK13AK15TR-Peg-Biot 
301 Ac-SGRGK(Ac)QGGK(Ac)ARAK(Ac)AK(Ac)TR-Peg-Biot 
302 Ac-SGRGK(Ac)QGGKARAKAKTR-Peg-Biot 
303 Ac-pSGRGK(Ac)QGGKARAKAKTR-Peg-Biot 
304 Ac-SGR(Me2a)GK(Ac)QGGKARAKAKTR-Peg-Biot 
305 Ac-pSGR(Me2a)GK(Ac)QGGKARAKAKTR-Peg-Biot 
306 Ac-SGCitGK(Ac)QGGKARAKAKTR-Peg-Biot 
307 Ac-pSGCitGK(Ac)QGGKARAKAKTR-Peg-Biot 
308 Ac-pSGRGK(Ac)QGGK(Ac)ARAK(Ac)AK(Ac)TR-Peg-Biot 
! -)-!
309 SGRGK(Ac)QGGK(Ac)ARAK(Ac)AK(Ac)TR-Peg-Biot 
310 pSGRGK(Ac)QGGK(Ac)ARAK(Ac)AK(Ac)TR-Peg-Biot 
 H2B[1-24] 
400 PEPAKSAPAPKKGSKKAVTKAQKK-Peg-Biot 
401 PEPAK(Me3)SAPAPKKGSKKAVTKAQKK-Peg-Biot 
402 PEPAK(Me2)SAPAPKKGSKKAVTKAQKK-Peg-Biot 
403 PEPAK(Me)SAPAPKKGSKKAVTKAQKK-Peg-Biot 
 
Table 5.4.  A map of the microarry in Fig. 5.20 with the peptides listed by their identifying number.1   
subarray 1 and 3 
IgG 1 IgG   2 IgG  3 IgG   4 
(A1-A6) (A7-A12) 
(A13-
A18) 
(A19-
A24) 
(A25-
A30) 
(A31-
A36) 
(A37-
A42) 
(A43-
A48) 
F 5 100 6 120 7 58 8 
(B1-B6) (B7-B12) 
(B13-
B18) 
(B19-
B24) 
(B25-
B30) 
(B31-
A36) 
(B37-
B42) 
(B43-
B48) 
90 10 F 11 121 12 59 13 
(C1-C6) (C7-C12) 
(C13-
C18) 
(C19-
C24) 
(C25-
C30) 
(C31-
C36) 
(C37-
C42) 
(C43-
C48) 
91 14 101 15 F 16 66 17 
(D1-D6) (D7-D12) 
(D13-
D18) 
(D19-
D24) 
(D25-
D30) 
(D31-
D36) 
(D37-
D42) 
(D43-
D48) 
93 18 102 19 122 20 F 21 
(E1-E6) (E7-E12) (E13-E18) (E19-E24) (E25-E30) (E31-E36) (E37-E42) (E43-E48) 
95 22 103 23 123 24 67 25 
(F1-F6) (F7-F12) (F13-F18) (F19-F24) (F25-F30) (F31-F36) (F37-F42) (F43-F48) 
69 26 104 27 123 28 68 29 
(G1-G6) (G7-G12) 
(G13-
G18) 
(G19-
G24) 
(G25-
G30) 
(G31-
G36) 
(G37-
G42) 
(G43-
G48) 
162 145 144 137 147 138 148 139 
(H1-H6) (H7-H12) 
(H13-
H18) 
(H19-
H24) 
(H25-
H30) 
(H31-
H36) 
(H37-
H42) 
(H43-
H48) 
blank blank blank blank blank blank blank blank 
(I1-I6) (I7-I12) (I13-I18) (I19-I24) (I25-I30) (I31-I36) (I37-I42) (I43-I48) 
blank blank blank blank blank blank blank blank 
(J1-J6) (J7-J12) (J13-J18) (J19-J24) (J25-J30) (J31-J36) (J37-J42) (J43-J48) 
blank blank blank blank blank blank blank blank 
(K1-K6) (K7-K12) 
(K13-
K18) 
(K19-
K24) 
(K25-
K30) 
(K31-
K36) 
(K37-
K42) 
(K43-
K48) 
blank blank blank blank blank blank blank blank 
(L1-L6) (L7-L12) (L13-L18) (L19-L24) (L25-L30) (L31-L36) (L37-L42) (L43-L48) 
                
IgG 30 IgG 32 IgG 33 IgG 34 
(M1-M6) (M7-M12) 
(M13-
M18) 
(M19-
M24) 
(M25-
M30) 
(M31-
M36) 
(M37-
M42) 
(M43-
M48) 
70 35 301 36 305 37 F 38 
(N1-N6) (N7-N12) 
(N13-
N18) 
(N19-
N24) 
(N25-
N30) 
(N31-
N36) 
(N37-
N42) 
(N43-
N48) 
71 39 302 40 F 41 309 42 
(O1-O6) (O7-O12) 
(O13-
O18) 
(O19-
O24) 
(O25-
O30) 
(O31-
O36) 
(O37-
O42) 
(O43-
O48) 
72 43 F 44 306 45 310 157 
(P1-P6) (P7-P12) (P13-P18) (P19-P24) (P25-P30) (P31-P36) (P37-P42) (P43-P48) 
! -)%!
F 47 303 48 307 50 400 51 
(Q1-Q6) (Q7-Q12) 
(Q13-
Q18) 
(Q19-
Q24) 
(Q25-
Q30) 
(Q31-
Q36) 
(Q37-
Q42) 
(Q43-
Q48) 
300 52 304 53 308 54 401 55 
(R1-R6) (R7-R12) 
(R13-
R18) 
(R19-
R24) 
(R25-
R30) 
(R31-
R36) 
(R37-
R42) 
(R43-
R48) 
402 IgG 403 167 56 IgG F IgG 
(S1-S6) (S7-S12) (S13-S18) (S19-S24) (S25-S30) (S31-S36) (S37-S42) (S43-S48) 
163 146 164 132 165 133 166 134 
(T1-T6) (T7-T12) (T13-T18) (T19-T24) (T25-T30) (T31-T36) (T37-T42) (T43-T48) 
blank blank blank blank blank blank blank blank 
(U1-U6) (U7-U12) 
(U13-
U18) 
(U19-
U24) 
(U25-
U30) 
(U31-
U36) 
(U37-
U42) 
(U43-
U48) 
blank blank blank blank blank blank blank blank 
(V1-V6) (V7-V12) 
(V13-
V18) 
(V19-
V24) 
(V25-
V30) 
(V31-
V36) 
(V37-
V42) 
(V43-
V48) 
blank blank blank blank blank blank blank blank 
(W1-W6) 
(W7-
W12) 
(W13-
W18) 
(W19-
W24) 
(W25-
W30) 
(W31-
W36) 
(W37-
W42) 
(W43-
W48) 
blank blank blank blank blank blank blank blank 
(X1-X6) (X7-X12) 
(X13-
X18) 
(X19-
X24) 
(X25-
X30) 
(X31-
X36) 
(X37-
X42) 
(X43-
X48) 
subarray 2 
and 4 
              
134 166 133 165 132 164 146 163 
(A1-A6) (A7-A12) 
(A13-
A18) 
(A19-
A24) 
(A25-
A30) 
(A31-
A36) 
(A37-
A42) 
(A43-
A48) 
IgG F IgG 56 167 403 IgG 402 
(B1-B6) (B7-B12) 
(B13-
B18) 
(B19-
B24) 
(B25-
B30) 
(B31-
A36) 
(B37-
B42) 
(B43-
B48) 
55 401 54 308 53 304 52 300 
(C1-C6) (C7-C12) 
(C13-
C18) 
(C19-
C24) 
(C25-
C30) 
(C31-
C36) 
(C37-
C42) 
(C43-
C48) 
51 400 50 307 48 303 47 F 
(D1-D6) (D7-D12) 
(D13-
D18) 
(D19-
D24) 
(D25-
D30) 
(D31-
D36) 
(D37-
D42) 
(D43-
D48) 
157 310 45 306 44 F 43 72 
(E1-E6) (E7-E12) (E13-E18) (E19-E24) (E25-E30) (E31-E36) (E37-E42) (E43-E48) 
42 309 41 F 40 302 39 71 
(F1-F6) (F7-F12) (F13-F18) (F19-F24) (F25-F30) (F31-F36) (F37-F42) (F43-F48) 
38 F 37 305 36 301 35 70 
(G1-G6) (G7-G12) 
(G13-
G18) 
(G19-
G24) 
(G25-
G30) 
(G31-
G36) 
(G37-
G42) 
(G43-
G48) 
34 IgG 33 IgG 32 IgG 30 IgG 
(H1-H6) (H7-H12) 
(H13-
H18) 
(H19-
H24) 
(H25-
H30) 
(H31-
H36) 
(H37-
H42) 
(H43-
H48) 
blank blank blank blank blank blank blank blank 
(I1-I6) (I7-I12) (I13-I18) (I19-I24) (I25-I30) (I31-I36) (I37-I42) (I43-I48) 
blank blank blank blank blank blank blank blank 
(J1-J6) (J7-J12) (J13-J18) (J19-J24) (J25-J30) (J31-J36) (J37-J42) (J43-J48) 
blank blank blank blank blank blank blank blank 
(K1-K6) (K7-K12) 
(K13-
K18) 
(K19-
K24) 
(K25-
K30) 
(K31-
K36) 
(K37-
K42) 
(K43-
K48) 
blank blank blank blank blank blank blank blank 
(L1-L6) (L7-L12) (L13-L18) (L19-L24) (L25-L30) (L31-L36) (L37-L42) (L43-L48) 
! -)&!
                
139 148 138 147 137 144 145 162 
(M1-M6) (M7-M12) 
(M13-
M18) 
(M19-
M24) 
(M25-
M30) 
(M31-
M36) 
(M37-
M42) 
(M43-
M48) 
29 68 28 124 27 104 26 69 
(N1-N6) (N7-N12) 
(N13-
N18) 
(N19-
N24) 
(N25-
N30) 
(N31-
N36) 
(N37-
N42) 
(N43-
N48) 
25 67 24 123 23 103 22 95 
(O1-O6) (O7-O12) 
(O13-
O18) 
(O19-
O24) 
(O25-
O30) 
(O31-
O36) 
(O37-
O42) 
(O43-
O48) 
21 F 20 122 19 102 18 93 
(P1-P6) (P7-P12) (P13-P18) (P19-P24) (P25-P30) (P31-P36) (P37-P42) (P43-P48) 
17 66 16 F 15 101 14 91 
(Q1-Q6) (Q7-Q12) 
(Q13-
Q18) 
(Q19-
Q24) 
(Q25-
Q30) 
(Q31-
Q36) 
(Q37-
Q42) 
(Q43-
Q48) 
13 59 12 121 11 F 10 90 
(R1-R6) (R7-R12) 
(R13-
R18) 
(R19-
R24) 
(R25-
R30) 
(R31-
R36) 
(R37-
R42) 
(R43-
R48) 
8 58 7 120 6 100 5 F 
(S1-S6) (S7-S12) (S13-S18) (S19-S24) (S25-S30) (S31-S36) (S37-S42) (S43-S48) 
4 IgG 3 IgG 2 IgG 1 IgG 
(T1-T6) (T7-T12) (T13-T18) (T19-T24) (T25-T30) (T31-T36) (T37-T42) (T43-T48) 
blank blank blank blank blank blank blank blank 
(U1-U6) (U7-U12) 
(U13-
U18) 
(U19-
U24) 
(U25-
U30) 
(U31-
U36) 
(U37-
U42) 
(U43-
U48) 
blank blank blank blank blank blank blank blank 
(V1-V6) (V7-V12) 
(V13-
V18) 
(V19-
V24) 
(V25-
V30) 
(V31-
V36) 
(V37-
V42) 
(V43-
V48) 
blank blank blank blank blank blank blank blank 
(W1-W6) 
(W7-
W12) 
(W13-
W18) 
(W19-
W24) 
(W25-
W30) 
(W31-
W36) 
(W37-
W42) 
(W43-
W48) 
blank blank blank blank blank blank blank Blank 
(X1-X6) (X7-X12) 
(X13-
X18) 
(X19-
X24) 
(X25-
X30) 
(X31-
X36) 
(X37-
X42) 
(X43-
X48) 
1
 Each peptide was printed as 6 sequential spots on the four subarrays.  The layout of subarrays 1 
through 4 are identical. Locations of a given peptide was printed are given in parenthesis. 
 
Table 5.5.  Quantification of fluorescence of HP1! chromodomain bound to histone 
peptides on the array shown in Fig. 5.20. 
Histone H3 modification Average intensity 
k9me3 0.0666 
k9me2 0.0433 
k4me3 k9me3 0.0383 
k9me3 + 3 ac 0.0239 
k9me1 0.0047 
k9me3 s10ph 0.0000 
k9me2 s10ph 0.0000 
k9me1 s10ph 0.0000 
 
 
! -)'!
 
v.  Putting the Components Together 
Once the separate components were characterized for structure and binding 
affinity, the next step is to piece the components together.  Though the ultimate goal is to 
combine receptors that are selective for two different Histone H3 modifications, two 
HP1! chromodomains were be combined because the protein is already expressed and 
well characterized.  First, a single chromodomain R74C mutant with a myc-tag was 
conjugated to the BrAc-ISAL K3-azidoK peptide using approximately three equivalents 
of peptide with TCEP.  After 24 hours the reaction was analyzed by LC/MS.  The LC 
trace of the reaction is shown in Fig. 5.21A.  There is one sharp peak (peak 1) and a 
smaller, uneven peak (peak 2).  The peak 1 shows a mass corresponding to 3386.8 Da, 
which is consistent with BrAc-ISAL K3-azidoK (3215.7 Da) that has been substituted 
with TCEP on the N-terminus, which indicates that TCEP acts a nucelophile and should 
be omitted from reactions of this type (Fig. 5.21B).  Peak 2 contains masses that closely 
correspond to both unconjugated and conjugated chromodomain (8516.3 Da and 
11729.98 Da respectively) (Fig. 5.21C).  The low resolution of the instrument made it 
difficult to measure the exact mass. Though the BrAc-ISAL K3-azidoK was in excess, 
much of it reacted with the TCEP (Fig. 5.22).  Therefore, not all of the chromodomain 
was able to form conjugate with the peptide. 
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(A) 
 
(B) 
 
(C) 
 
Figure 5.21.  LC/MS of conjugation reaction between ISAL K3-azidoK and HP1! 
chromodomain R74C.  (A) LC/MS trace of the conjugation reaction.  (B) Mass spectrum 
of peak 1.  (C) Mass spectrum of peak 2. 
 
!
! -))!
 
Figure 5.22.  Reaction of TCEP with bromoacetate in BrAc-ISAL K3-azidoK 
 
The AcBr-ISAL E3-propargylG and AcBr-ISAL K3-azidoK peptides were 
already linked using the copper-catalyzed cycloaddition.  Therefore two HP1! 
chromodomain cysteine mutants were conjugated to the coiled-coil (Fig. 5.23).  The first 
reaction had a 1:3 ratio of coiled-coil to chromodomain in 50 mM potassium phosphate, 
pH 8, 25 mM NaCl and the second had a 1:4 ratio of coiled-coil to chromodomain in the 
same buffer.  The third was similar to the first reaction with 10 equivalents of TCEP, 
which was included before the TCEP was shown to react extensively with the 
bromoacetate cap.  Each reaction was performed on a 9 nmol scale of coiled-coil in a 
total volume of 100 µL.  The reactions were visualized by SDS-PAGE after 1 day then 
after 4 days at 4o C (Fig. 5.24 and Fig. 5.25 respectively).  Reactions one and two 
proceeded at approximately similar rates after four days regardless of the different 
chromodomain concentrations.  The reaction with TCEP did not proceed after four days, 
most likely because the TCEP had reacted with the coiled-coil.  There are some lighter 
bands indicating a large protein, which may indicate an impurity, aggregate, or a small 
side product due to the presence of the less reactive cysteine in the HP1! chromodomain. 
The conditions for the first reaction were chosen for a larger scale reaction (0.336 
µmol coiled-coil, 1.009 µmol chromodomain R74C) to minimize the use of material and 
once complete the fully reacted conjugate were isolated using size exclusion 
Br
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O
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chromatography.  As shown in Fig. 5.26, a single band appears at approximately 20 kDa, 
which is consistent with the mass of the conjugated coiled-coil with two chromodomains. 
 
 
Figure 5.23.  Conjugation of two HP1! chromodomain R74C mutants to linked coiled-
coil peptides with the N-terminal bromoacetate. 
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Figure 5.24.  15% SDS-PAGE of the coiled-coil/chromodomain conjugation reaction 
after one day and visualized with Coomassie blue.  (1) Protein ladder, (2) HP1! 
chromodomain R74C, (3) reaction one (1:3 coiled-coil: chromodomain), (4) reaction two 
(1:4 coiled-coil: chromodomain), (5) reaction three (1:3 coiled-coil: chromodomain, 10 
eq TCEP).   The red box indicates bands that appear to correspond to fully reacted coiled-
coil with chromodomain and the black box indicates unreacted chromodomain. 
 
 
Figure 5.25.  15% SDS-PAGE of the coiled-coil/chromodomain conjugation reaction 
after four days (same volume of reaction was loaded on the gel).  (1) Protein ladder, (2) 
reaction one (1:3 coiled-coil: chromodomain), (3) reaction two (1:4 coiled-coil: 
chromodomain), (3) reaction three (1:3 coiled-coil: chromodomain, 10 eq TCEP).   The 
red box indicates bands that appear to corresponds for fully reaction coiled-coil with 
chromodomain and the black box indicates unreacted chromodomain. 
 
!!!1       2     3  4  5 
!!!1     2        3   4   
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Figure 5.26. 15% SDS-PAGE of the coiled-coil/chromodomain conjugation reaction 
before and after purification.  (1) Protein ladder, (2) conjugation before purification, (3) 
conjugation after purification by size exclusion.  The band corresponding to the conjugate 
is indicated in the red box. 
 
vi.  Binding Studies with the Conjugate 
Fluorescence anisotropy studies were performed using a peptide containing a two-
H3 K9Me2 repeat sequence ((H3 K9Me2)2) and the conjugate is shown in Fig. 5.23.  The 
trimethyllated version was not used because the synthesis proved to be difficult with low 
yields.  The data shows a significant increase in anisotropy when 5 µM conjugate is 
added to 1 µM peptide and immediately the signal plateaus (Fig. 5.27).  If accurate, the 
curve fit yields a KD of 1.5 ± 1 µM, which is nearly a 20-fold improvement over binding 
compared to HP1! chromodomain bound to H3 K9Me2.   
Ideally the concentration of the fluorophore-labelled peptide should be 10-fold 
lower than the dissociation constant when performing anisotropy studies.  Therefore the 
experiments were repeated using 200 nM peptide rather than 1 µM.  The conjugate was 
also filtered to remove any potential aggregates that can affect the anisotropy 
1               2                              3  
  
! -*.!
measurements.  The dissociation constant between the conjugated and H3 K9Me2 was 
measured in addition to the repeat sequence, (H3 K9Me2)2 (Fig. 5.28).  No binding is 
detected in the case of the H3 K9Me2 sequence.  However, a dissociation constant of 3.7 
± 1 µM is measured in the case of the repeat sequence, which is 10-fold more favorable 
than the native chromodomain bound to the native peptide.  For this data to be reliable 
more conjugate will be synthesized and the experiments will be repeated.  Additionally, 
the measurements between the native chromodomain and H3 K9Me2 to verify that no or 
minimal binding is detected at the lower peptide concentration.  Other binding 
experiments will also include repeat sequences with only one dimethyllysine rather than 
two.  The system can also be optimized by varying the distances between the coiled-coils 
and receptors and the distances between the sites of modification on the histone tail 
peptide.  By altering these distances, we hope to enhance cooperative binding of the 
bivalent receptor. 
 
  
! -*-!
 
Figure 5.27. Fluorescence anisotropy binding experiments of 1 µM 5(6)-FAM (H3 
K9Me2)2 with conjugate.   The experiments were performed in 50 mM potassium buffer 
pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C.  This curve represents one run. 
 
 
Figure 5.28. Fluorescence anisotropy binding experiments of 200 nM 5(6)-FAM (H3 
K9Me2)2 and H3 K9Me2 with conjugate.   The experiments were performed in 50 mM 
potassium buffer pH 8.0, 25 mM NaCl, and 4 mM DTT at 25 °C.  This curve represents 
one run. 
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D. Experimental 
i.  Protein Expression and Purification 
The DNA plasmid containing the cloning region of Drosophila HP1! 
chromodomain was supplied by the Khorasanizadeh lab.  The cysteine mutants were 
generated using the same conditions as described in Chapter III.18 The primers used for 
the cysteine mutants are shown in Table 5.6. 
An N-terminal myc tag was inserted into HP1! chromodomain using primers 
containing the myc sequence.  The total reaction volumes were 50 µL with 1 µL DNA 
plasmid (~30 ng/µL), 1 µL dimethyl sulfoxide (DMSO), 1 µL of forward and reverse 
primers (0.01 mmol), 2.5 µL dNTP mix (10 mM), 5 µL 5X PFU buffer, 36.5 µL dH2O, 
and 2 µL PfuUltra hotstart DNA polymerase (Strategene) was added last.  The 
thermocycler settings are given in Table 5.6.  Once isolated, DNA and protein expression 
and purification was carried out as described in Chapter III.  The primers for the insert 
are shown in Table 5.7. 
 
Table 5.6.  Thermocycler conditions for generating HP1! chromodomain with the myc-
tag. 
Temperature (oC) Time Cycles 
Hot start: 95 30 sec 1 
Melt: 95 
Anneal: 45 
Extend: 68 
1 min 
1 min 
13 min 
20 
Find extend: 72 5 min 1 
Pause: 4 hold  
 
 
 
! -*&!
Table 5.7.  The forward primers used for generating HP1! chromodomain cysteine mutants and 
for inserting the N-terminal myc-tag.  The point mutations are in red. 
Mutant Primer Sequence 
E23C C GAA GAG GAG GAG GAG TGC TAC GCC GTG GAA AAG ATC 
K28C GAG GAG GAG TAC GCC GTG GAA TGC ATC ATC GAC AGG C 
M38C CGG GTG CGC AAG GGA TGT GTG GAG TAC TAT CTG AAA TGG 
R74C CAG CAG TAC GAG GCG AGC TGC AAG GAT TAA GGA TCC GGC 
myc-tag
1 
T TTT GTT TAA CTT TAA GAA GGA GAT ATA CAT ATG GAG CAG AAG 
CTG ATA TCC GAG GAG GAC CTG AAA AAA CAC CAC CAC CAC CAC 
CAC GCC GAA GAG GAG G 
1The sequence containing the myc-tag is highlighted in green with the start codon in blue and an 
EcoRV site underlined.  The N-terminal His6-tag is orange. 
 
ii.  Circular Dichroism characterization of HP1!  Chromodomain 
CD measurements were performed on an Aviv 62DS Circular Dichroism 
Spectrometer.  All CD experiments were performed as described in Chapter III. 
iii.  Synthesis of Histone Tail Peptides 
The H3 K9Me2/3 peptides were synthesized, purified, and characterized as 
described in Chapter III. 
iv.  Fluorescence Anisotropy 
Fluorescence anisotropy experiments were carried out as described in Chapters III 
and IV. 
v.  Microarray of myc-HP1!  Chromodomain7 
The peptide microarrays were prepared and analyzed by the Strahl lab. The slides 
were washed overnight with 20 #M chromodomain in PBS, 1% BSA, 0.3% Tween-20 
followed by detection with anti-myc antibody and Alexafluor 647 labeled anti-mouse 
secondary antibody (Fig. 5.24). 
 
 
 
! -*'!
vi.  Imidazole-1-sulfonyl azide hydrochloride 
!
!
The reagent for the azotransfer reaction was synthesized as previously described. 
1
H NMR (400 MHz, CD3OD): ( 7.69 (d, J = 7.6, 2H).
19 
vii. !!+N-Fmoc+D-azidolysine 
 
A 2.2744 g (6.173 mmol) amount!of !/[/8EDM/Q/lysine was added to a 100 mL 
round bottom flask with imidazole-1-sulfonyl azide (1.5526 g, 7.407 mmol, 1.2 
equivalents), and potassium carbonate (1.7068 g, 12.35 mmol, 2.00 equivalents).  The 
mixture was stirred in 30 mL methanol and purged with nitrogen gas for 20 mins and 
15.6 g Cu(II)SO4!5H2O was slowly added.  The reaction was allowed to continue 
overnight under nitrogen gas.   
The reaction was concentrated under vacuum, diluted with 400 mL water and 
acidified with 6N HCl.  The product was extracted once with 200 mL ethyl acetate and 
twice with 150 mL ethyl acetate.  The extracts were combined and washed with 500 mL 
water and dried with anhydrous Na2SO4.  The ethyl acetate was removed under vacuum.  
The product was isolated as a white solid by chromatography using silica gel 5% (v/v) 
MeOH in CH2Cl2. 
1
H NMR (400 MHz, CD3OD): ( 7.69 (d, J = 7.6, 2H), ( 7.60 (t, J = 
+HN N
S
N
O
O
N+
N-
Cl-
O N
H
O
OH
N
N+
N-
O
! -*(!
8.0, 2H), ( 7.31 (t, J = 7.2, 2H), ( 7.24 (t, J = 7.2, 2H), ( 4.30 (d, J = 6.8, 2H), ( 4.19 (m, 
1H), ( 4.13 (t, J = 6.8, 1H), ( 3.17 (m, 2H),  ( 1.90-1.35 (m, 6H); 
viii. Tris-triazole ligand 
 
Methyl azido acetate (0.9278 g, 8.06 mmol) was added to a solution of 
tripropargyl amine (0.2656 g, 2.015 mmol) in 4 mL acetonitrile using a 25 mL round 
bottom flask in an ice bath. [Cu(CH3CN)4]PF6 (0.246 g, 0.066 mmol) was added to the 
solution.  Slowly, 1.2 mL DIPEA was added and purged with nitrogen for 10 mins.  The 
reaction proceded overnight while capped with a septum.  The reaction was concentrated 
by vacuum and dissolved in 1 mL 5% MeOH in CH2Cl2 and isolated by chromatography 
using silica gel with 5% MeOH in CH2Cl2 as the mobile phase.  H
1 (400 MHz, CD2Cl2): 
( 7.842 (s, 1H), ( 5.185 (s, 2H), ( 3.815 (s, 2H), ( 3.803 (s, 3H). 
ix.  Synthesis of Coiled-coil and (H3 K9Me2)2 Peptide 
Coiled-coil peptides were synthesized using automated solid phase peptide 
synthesis with a Thuramed tetras synthesizer on a 0.06 mmol scale.  Fmoc protected 
amino acids were used with a Clear amide resin from Peptides International, Inc.  Amino 
acid residues were activated with HBTU (O-benzotriazole-N,N,N’,N’,-
tetramethyluronium hexafluorophosphate) and HOBT (N-hydroxybenzotriazole) with 
DIPEA (diisopropylethylamine) in DMF (N,N-dimethylformamide).  Amino acids were 
deprotected twice with 2% DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) and 2% piperidine 
N
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in DMF for 15 mins each step.  Each amino acid was coupled on double cycles of 60 
mins each to improve coupling.  Peptides were capped on the N-terminus with an acetyl 
cap using a 5 mL solution of 5% acetic anhydride and 6%2,6-lutidine in DMF and 
allowed to mix for 30 mins.  Peptides capped with bromoacetic acid were done so as 
follows.  Four equivalents of HOBt, 4 equivalents of HBTU, and 4 equivalents of 
bromoacetic acid to peptide were dissolved in 5 mL DMF and added to the resin.  Four 
equivalents of DIPEA were added last and the reaction was allowed to bubble with 
nitrogen for 20 mins.  This sequence of steps was repeated twice.  Cleavage of the 
peptides from the resin was performed in 95% trifluoroacetic acid (TFA), 2.5% H2O, 
2.5% triisopropylsilane (TIPS) for three hours.  If cysteine was included in the sequence 
then 200 µL of ethane dithiol (EDT) was added to the cleavage cocktail.  The TFA was 
evaporated off by blowing the reaction with nitrogen.  Cold diethyl ether was used to 
precipitate the product.  The product was extracted with deionized water and 
subsequently lyophilized to a powder for HPLC.   
The (H3 K9Me2)2 peptide was synthesized as described in Chapter III only using 
Clear amide resin as opposed to Wang resin to improve yields.  The N-terminus was 
capped with 5(6)-carboxyfluorescein as previously described. 
Peptides were purified by reversed-phase HPLC.  A Waters semi-preparative 
HPLC system with an Atlantis Prep OBD dC-18 semi-preparative column was used for 
separation with a gradient of 0% to 100% solvent B over 60 mins with solvent A (95:5 
water:acetonitrile, 0.1% TFA) and solvent B (95:5 acetonitrile:water, 0.1% TFA).   
Peptides containing a variation of the ISAL E3 sequence eluted after 50% B so they were 
purified using a modified method.  First gradient of 0% to 30% solvent B was reached in 
! -**!
2 mins and the column equilibrated at 30% for 5 mins.  The gradient then proceeded to 
100% solvent B in 42 mins.  Peptides were then lyophilized and the molecular weight of 
the peptide was confirmed by ESI-TOF mass spectrometry (Table 5.8). 
 
Peptide sequences: 
I(N)SAL E3: Ac-EISALEKENSALEKEISALEKGGGY-NH2 
I(N)SAL K3: Ac-KISALKEKNSALKEKISALKEGGGY-NH2 
I(N)SAL E4: Ac-EISALEKENSALEKEISALEYEISALEK-NH2 
I(N)SAL K4: Ac-KISALKEKNSALKEKISALEYEISALEK-NH2 
G-ISAL E3-GGC: Ac-GEISALEKEISALEYEISALEKGGC-NH2 
ISAL K4-GGC: Ac-KISALKEKISALKYKISALKEGGC-NH2 
AcBr-ISAL E3-propargylG: AcBr-GGEISALEKEISALEYEISALEKGG(pG)-NH2 
AcBr-ISAL K3-azidoK: AcBr-GGKISALKEKISALKYKISALKEGG(azidoK)-NH2 
(H3 K9Me2)2: FAM-ARTKQTAR(KMe2)STGGKAARTKQTAR(KMe2)STKKA-NH2 
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Table 5.8. Mass spectrometry data for the peptides synthesized and linked by disulfide 
exchange or by Huisgen cycloaddition for this study. 
Peptide Expected Mass (Da) Experimental Mass (Da) 
I(N)SAL E3 2705.4 2705.1 
I(N)SAL K3 2702.5 2702.4 
I(N)SAL E4 3475.8 3476.0 
I(N)SAL K4 3472.0 3472.0 
G-ISAL E3-GGC 2680.3 2679.5 
ISAL K3-GGC 2619.5 2618.4 
ISAL E3/K3-disulfide linked 5297.8 5298.3 
AcBr-ISAL E3-propargylG 2806.3 2806.2 
AcBr-ISAL K3-azidoK 2861.6 2861.3 
ISAL E3/K3-click 5667.8 5668.1 
(H3 K9Me2)2 3514.9 3514.8 
 
x.  Copper catalyzed Huisgen Cycloaddition 
The ISAL E3-propargylG peptide and ISAL K3-azidoK peptides were each 
dissolved in a small volume of 10 mM potassium phosphate pH 8.0 buffer and the 
concentrations were determined by absorbance at 280 nm (*280=1490 cm
-1M-1).  The two 
peptides were combined in a 10 mL round bottom flask (12.63 µmol ISAL E3 
propargylG, 12.484 µmol ISAL K3 azido K).  The solution was degassed with nitrogen 
gas for 20 mins.  To the solution, 1 equivalent (12.484 µmol, 5.9 mg) of tris-triazole 
ligand and 2 equivalents of Cu(ACN4)PF6 (24.968 µmol, 9.3 mg) were added to give a 
total reaction volume of  3.9 mL.  After 45 hours the reaction was diluted with 10 mL of 
dH2O and stored at -20
o C.  The following day the reaction was filtered and purified by 
HPLC as described above using a gradient of 0% to 100% B over 60 mins.  The product 
was confirmed by mass spectrometry (Table 5.5). 
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xi.  Disulfide Exchange of Coiled-coils 
A 4 mL solution with 50 µM ISAL K3-GGC and 50 µM G-ISAL E3-GGC in 10 
mM sodium phosphate pH 7.4 buffer was prepared in a 20 mL glass scintillation vial.  
Solutions with 100 µM of either peptide were also prepared as controls.  The reactions 
were monitored using reverse-phase HPLC with a Waters Alliance HPLC system and an 
Atlantis dC18 4 µm, 4.6x150 mm analytical column.  The gradient used was 0%-65% 
solvent B over 130 mins with 50 µL of each of the three solutions.  The HPLC trace was 
monitored at both 280 nm and 214 nm.  Each peak from the ISAL K3/E3 mixture was 
collected on the third day because all three species were visible.  The samples were 
lyophilized, dissolved in methanol, and analyzed by mass spectrometry (Table 5.5). 
The equilibrium constant was calculated using the integration of the peaks 
(µV/sec) monitored at 280 nm after four days using Eq. 5.1 (Fig. 5.17) where AE3/K3 
refers to area under the ISAL E3/K3 peak, AE3 refers to area under the ISAL E3 peak, 
and AK3 refers to area under the ISAL K3 peak. 
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                                              Eq. 5.1 
 
The free energy of binding can be calculated using Eq. 5.2. 
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xii. Circular Dichroism Characterization of Coiled-coils 
CD measurements were performed on an Aviv 62DS Circular Dichroism 
Spectrometer.  CD data was obtained for the chromodomain at 100 #M total peptide 
concentration (100 µM for homogenous solutions or 50 µM of each peptide in 
heterogeneous mixtures) in 10 mM Na2HPO4, pH 7.4.   Wavelength scans were 
performed in triplicate and averaged.  Scans were performed at 25o C from 260-185 nm.  
All scans were corrected by subtracting the spectrum of the buffer used in the experiment 
and the signal was converted to Mean Residue Ellipticity (MRE) using Eq. 5.3.  Where 
signal refers to circular dichroism signal, l is path length in cm, c is conentration in M, 
and r is the number of amino acid residues. 
 
                                                              
  
! 
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#
1
r
                                             Eq. 5.3 
 
Guanidine denaturation experiments were carried out for I(N)SAL E4/K4 coiled-
coils and monitored using circular dichroism at 222 nm.  Solutions with 50 µM of each 
peptide and guanidine hydrochloride (0 M to 5 M) in 50 mM potassium phosphate pH7.0, 
100 mM NaCl buffer were equilibrated at room temperature for 20 mins prior to analysis.  
Each measurement was taken with a buffer with the corresponding guanidine 
concentration as a blank.  The signal was converted to MRE using Eq. 5.3 (Fig. 5.15). 
The free energy in the presence of denaturant ($GD) was calculated using Eq. 5.4 
where FF is fraction folded, %D is MRE when fully denatured, %F is MRE when fully 
folded, and Fu is fraction unfolded. 
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    Eq 5.4 
         
From this calculation the energy of folding for the linear portion of the graph is 
Fig. 5.15 can be plotted against guanidine concentration (Fig. 5.16).  The energy of 
binding without denaturant ($GH2O) is equivalent to the Y-intercept in Fig. 5.16 and the 
dissociation constant can be calculated using Eq. 5.5. 
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D
)                                           Eq. 5.5 
 
xiii.  Conjugation of Coiled-coils and Chromodomain 
The linked BrAc-capped coiled-coils were dissolved in 50 mM potassium 
phosphate pH 8.0, 25 mM NaCl and the concentration was determined using a NanoDrop 
spectrophotometer (&280 = 2980 cm
-1M-1).  The coiled-coil peptide was added to the 
appropriate amount of HP1! chromodomain R74C (3 or 4 equivalents) and TCEP (10 
equivalents if applicable).  The reaction was stirred for the time indicated at 4oC while 
covered with aluminum foil.  For the large scale reaction 0.336 µmol coiled-coil was 
added to 1.009 µmol chromodomain R74C in a total volume of 5 mL.  After four days the 
reaction was filtered and loaded on to an Akta Express FPLC from GE Healthcare and 
purified on HiLoad 16/60 Superdex 200 Gel Filtration column with a 50 mM potassium 
! -+%!
phosphate pH7.0, 25 mM NaCl buffer as the mobile phase.  The protein was concentrated 
using an Amicon Ultracentrifugation filter by Millipore (3000 MWCO) to 131.4 µM as 
determined by UV/VIS (e280=40005 cm
-1M-1). 
xiv.  Fluorescence Anisotropy with the Conjugate 
The anisotropy measurements shown in Fig. 5.24 were performed using the 
various volumes of 131.4 µM conjugate stock with 1 µM (H3 K9Me2)2 peptide in 50 mM 
potassium phosphate, pH 8.0, 25 mM NaCl, 2 mM DTT (50 µL total volume).  The 
peptide, and appropriate volumes of conjugate and additional buffer were mixed by 
pipetting in a Corning 385 well plate (Corning 3573) and centrifuged for 1 min at 4000 
rpm and allowed to equilibrate at room temperature for 30 mins.  Measurements were 
taken and analyzed as described in Chapter III. 
The measurements shown in Fig. 5.25 were performed using the 131.4 µM 
conjugate stock, which was re-filtered with a 0.22 micron filter.  The new concentration 
was determined to be 80.6 µM.  Appropriate volumes of conjugate and buffer were added 
directly to the peptide in the Corning 385 well plate to obtain a peptide concentration of 
200 nM and the samples were mixed by pipetting ten times.  The plate was centrifuged, 
equilibrated, and analyzed as previously described. 
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